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through short -helixes and have a flexible and adaptable DNA binding domain while weak nucleosome 
binders use -sheets or unstructured regions and have a higher rigidity within their DNA binding domain. 
Through the experiments presented in this dissertation we present the first study revealing the shared 
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ABSTRACT 
MECHANISM OF NUCLEOSOME TARGETING BY PIONEER 
TRANSCRIPTION FACTORS 
Meilín M. Fernández García 
Kenneth S. Zaret 
 
 Transcription factors (TFs) forage the genome to instruct cell plasticity, 
identity, and differentiation. These developmental processes are elicited through 
TF engagement with chromatin. Yet, how and which TFs can engage with 
chromatin and thus, nucleosomes, remains largely unexplored. Pioneer TFs are 
TF that display a high affinity for nucleosomes. Extensive genetic and 
biochemical studies on the pioneer TF FOXA, a driver of fibroblast to hepatocyte 
reprogramming, revealed its nucleosome binding ability and chromatin targeting 
lead to chromatin accessibility and subsequent cooperative binding of TFs. 
Similarly, a number of reprogramming TFs have been suggested to have 
pioneering activity due to their ability to target compact chromatin and increase 
accessibility and enhancer formation in vivo. But whether these factors directly 
interact with nucleosomes remains to be assessed. Here we test the nucleosome 
binding ability of the cell reprogramming TFs, Oct4, Sox2, Klf4 and cMyc, that are 
required for the generation of induced pluripotent stem cells. In addition, we also 
test neuronal and macrophage reprogramming TFs. Our study shows that 
reprogramming TFs bind nucleosomes with a range of nucleosome binding 
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affinities, indicating that although specific cocktails of TFs are required for 
reprogramming, mechanistically these TFs show differential nucleosome 
interacting behaviors. These results allowed us to assess differential features 
between TFs nucleosome binding ability and to correlate their binding with 
reprogramming potential.  
To determine how general is nucleosome binding we extended our 
analysis to screen 593 of the 2,000 predicted human TFs in the genome for 
potential nucleosome binding and validated their binding in solution. Based on 
3D structural analysis, we proposed that strong nucleosome binders anchor DNA 
through short a-helixes and have a flexible and adaptable DNA binding domain 
while weak nucleosome binders use b-sheets or unstructured regions and have a 
higher rigidity within their DNA binding domain. Through the experiments 
presented in this dissertation we present the first study revealing the shared 
structural features contributing to nucleosome binding potential of pioneer TFs 
and thus allow for predication of novel pioneer TFs with cell reprogramming 
potential.  
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CHAPTER 1: INTRODUCTION 
1.1 Transcription Factor Medicated Cell Reprogramming : A Low Efficiency 
Process 
 During development, cells commit to a resolved identity that dictates their 
specialized functions. A stable and specialized cellular identity is determined 
by the epigenetic and transcriptional states and the genome configuration that a 
cell acquires during differentiation stages.  Differentiation stages are orchestrated 
by the hierarchical expression of transcription factors (TFs), key proteins that 
decode the information in our DNA to regulate expression and repression of 
genes. Pioneering work by John Gurdon first demonstrated that when Xenoupus 
nuclei from a specialized cell are transferred into an enucleated oocyte it results 
in the full development of a frog. These studies showed that specialized cells still 
contain the developmental capacity to drive Xenoupus oocytes, through 
embryonic development (Gurdon, 1962). Later work by Shinya Yamanaka 
demonstrated that the identity of a specialized cell can be reverted back to a 
pluripotency state by forced expression of specific TFs, a process known as cell 
reprogramming, which results in induced pluripotent stem cells (Figure 1.1) 
(Nakagawa et al., 2008; Takahashi and Yamanaka, 2006). These breakthrough 
experiments revolutionized the field of stem cell biology and defined TFs as the 
master regulators of cell identity conversion and plasticity.   
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 Stem cells and in vitro reprogrammed cells have greatly advanced the 
field of regenerative medicine, as these cells may be used for cell replacement 
therapies in cases of tissue damage. For example, heart regeneration may be 
achieved by induced cardiomyocyte replacement, and liver damaged can be 
repaired by transplantation of induced hepatocytes (Huang et al., 2011; Ieda, 
2013; Park et al., 2019; Song et al., 2012). In addition, reprogrammed cells 
provide the unique opportunity for disease-modeling with patient-specific cells in 
cases where the relevant cell types are otherwise unattainable, such as 
neurodegenerative disorders of the brain (Wang et al., 2019).  
Over the last decade much work has been done to understand the 
pathways underlying cell reprogramming of somatic cells to pluripotency. 
Integration of population and single cell genome-wide technologies have allowed 
the description of a comprehensive road map of cells progression through fate 
change. These studies included the identity of surface markers crucial for iPSC 
isolation, single cell transcriptome analysis, chromatin landscape transitions, 3D 
chromatin organization, and TF dynamics during reprogramming (Beagan et al., 
2016; Buganim et al., 2012a; Cacchiarelli et al., 2015; Chronis et al., 2017; 
Hansson et al., 2012; Hussein et al., 2014; Li et al., 2017; Paik et al., 2018; Polo 
et al., 2012; Soufi et al., 2012; White et al., 2016). Still, generation of mature 
reprogrammed cell populations remains a problematic, highly variable, and 
inefficient process with reported reprogramming efficiencies ranging from 
0.00002 – 1 % (Malik and Rao, 2013; Omole and Fakoya, 2018). Therefore, 
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considerable barriers need to be overcome in order to facilitate clinical translation 
of cell reprogramming technologies. These challenges stress the need to better 
understand the unique characteristics that allow reprogramming TFs to induce 
such drastic changes in cell fate. 
 
1.2 Cell Reprogramming Transcription Factors 
 MyoD, a skeletal muscle-specific TF required for myogenesis, was the first 
reported TF to induce direct cell reprogramming of fibroblasts to myoblasts, a 
process where cells undergo reprogramming without transitioning through a 
pluripotent state (Davis et al., 1987). Two decades later Oct4, Sox2, Klf4 and 
cMyc (OSKM) were identified as the embryonic stem cell (ESCs)-specific TFs 
cocktail, from a 24 gene pool, required for the reprogramming of fibroblasts to 
induced pluripotent stem cells  (Figure 1.1) (Takahashi and Yamanaka, 2006). 
These cells had ESC-like phenotype and were therefore name induced 
pluripotent stem cells (iPSCs).  
 These early examples of TF-mediated reprogramming triggered numerous 
screens to identify cell lineage-specific TFs that could induce direct cell 
reprogramming of somatic cells into distantly related cell types from all three 
germ layers (Figure 1.1) (Huang et al., 2011; Laiosa et al., 2006; Song et al., 
2012; Vierbuchen et al., 2010). These screens used cDNA pools of cell type-
specific TFs followed by single TF cDNA subtraction to narrow down genes 
required for direct cell reprogramming. Results from these experiments revealed 
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that only a subset of the tested TFs were capable of inducing direct cell 
reprogramming from fibroblasts, including: PU1, C/EBPα, and GATA1 for 
hematopoietic reprogramming (Feng et al., 2008; Laiosa et al., 2006); Foxa, 
Gata4, and Hnf1α for hepatocyte reprogramming (Figure 1.1) (Huang et al., 
2011; Huang et al., 2014; Sekiya and Suzuki, 2011; Yu et al., 2013); and Ascl1, 
Myt1l, and Brn2 for neuronal cell reprogramming (Vierbuchen et al., 2010). 
These experiments revealed the existence of lineage-specific TF combinations 
capable of erasing mature cell identity and driving acquisition of a new identity. 
However, how these reprogramming TFs initially interact with repressed 
chromatin to reactivate a developmentally silenced program was not understood.   
 Pervasiveness of a select group of TFs required for cell reprogramming 
opened the question as to what makes these TFs unique and what features 
enable TFs with the ability to reprogram cells. It has been suggested that within 
this subset of factors there is a hierarchy of reprogramming dominance. Although 
multiple studies have identified alternative TF combinations to OSKM for iPSCs 
reprogramming, Oct4 and Sox2 remained constant within most TFs combinations 
(Feng et al., 2009; Nakagawa et al., 2008; Yu et al., 2007). Furthermore, 
expression of Oct4 alone is sufficient to generate iPSCs from mouse neuronal 
stem cells (Kim et al., 2009). In contrast, Klf4 can be replaced by Esrrb while 
cMyc can be omitted for reprogramming and is thus dispensable for this process 
(Feng et al., 2009; Nakagawa et al., 2008; Yu et al., 2007). However, in most 
circumstances S, K, and M are also needed for efficient reprogramming to 
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iPSCs(Takahashi and Yamanaka, 2006).  
 In neuronal cell reprogramming Ascl1 is dominant over Myt1l and 
Brn2(Wapinski et al., 2013). Similar to Oct4, expression of Ascl1 alone in 
fibroblast is sufficient to drive neuronal cell reprogramming (Wapinski et al., 
2013). Still, Brn2 and Myt1l were required to enhance reprogramming efficiency. 
Additionally, in hepatocyte reprogramming from fibroblasts, three different studies 
identified TFs that could promote hepatocyte conversion, but among them only 
FoxA was a common TF (Huang et al., 2014; Sekiya and Suzuki, 2011; Yu et al., 
2013). Removal of FoxA2 or FOXA3 from hepatocyte reprogramming protocols 
inhibited the formation of epithelial colonies, but expression of Hnf4α was not 
required. These findings support the hypothesis that within a subset of 
reprogramming factors, there is a hierarchy in reprogramming ability. Early work 
on one of the reprogramming TFs FOXA, provided clues about the molecular 
features of strong reprogramming TFs and hierarchy of reprogramming ability.  
 
1.3 Pioneer Transcription Factors in Cellullar Reprogramming and 
Development 
 Dominant reprogramming TFs play a crucial role in cell development. 
FoxA, the dominant reprogramming factor required for fibroblast to hepatocyte 
conversion (Du et al., 2014; Huang et al., 2011; Huang et al., 2014; Yu et al., 
2013) is also required for hepatic specification of the gut endoderm (Gualdi et al., 
1996). During liver development, FoxA directly accesses the albumin enhancer 
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when it is packaged in nucleosomal DNA within transcriptionally silent, closed 
chromatin. This binding promotes accessibility of the enhancer and subsequent 
activation of albumin, a highly liver-specific gene (Chaya et al., 2001; Cirillo et al., 
2002; Cirillo and Zaret, 1999a; Gualdi et al., 1996). In vitro, FoxA can remodel 
the compacted albumin enhancer into a local open state by displacing linker 
histone in the absence of  ATP-chromatin remodelers  (Cirillo et al., 2002). Unlike 
FoxA, ATP-dependent chromatin remodelers are sensitive to linker histone-
bound nucleosomes (Hill and Imbalzano, 2000; Ramachandran et al., 2003). 
FoxA1-mediated DNA accessibility, as determined by an increase in DNAse 
hypersensitivity, leads to cooperative binding of subsequent TFs (Figure 2) 
(Cirillo et al., 2002; Cirillo et al., 1998; Cirillo and Zaret, 1999a; Iwafuchi-Doi et 
al., 2016). Therefore, unlike most TFs, FoxA binding to DNA is not inhibited by 
nucleosome structure. These distinguishing features of FoxA led to its 
identification as a “pioneer factor”– a novel class of developmental regulators 
with nucleosome binding activity and ATP-independent local chromatin 
remodeling activity (Figure 1.2).   
 As cells undergo mitosis, chromosomes condense and transcriptional 
levels decrease (Naumova et al., 2013; Palozola et al., 2017). Still, FoxA is 
retained in mitotic chromatin due to its high nucleosome binding affinity. 
Furthermore, genomic sites that retain FoxA binding through mitosis correlate 
with higher than predicted nucleosome occupancy (Caravaca et al., 2013; 
Kadauke et al., 2012; Sekiya et al., 2009). Therefore, FoxA1 was shown to play a 
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role in the maintenance of cellular memory through mitosis. This work highlighted 
the importance of TFs interactions with silenced chromatin for the initiation of 
chromatin accessibility and progression through cell differentiation and 
reprogramming. 
Similar to FoxA1, dominant reprogramming TFs have been suggested to 
have pioneering activity through their engagement with target sites within 
compacted chromatin and the resulting chromatin changes that initiate cell 
reprogramming. Work from the Zaret lab used genome-wide nucleosome 
occupancy data to reveal that the iPSC TFs OSK, but not cMyc, co-occupy 
closed chromatin regions that contain key pluripotency genes only 48 hr into 
reprogramming (Soufi et al., 2012). Furthermore, cooperative binding of OSK is 
crucial for the initiation of proper enhancer selection and thus for fibroblast 
identify silencing. However, the addition of cMYC strongly biased OSKM to 
promoters poised for activation (Chronis et al., 2017). 
Genome-wide mapping of Ascl1, Brn2, and Myt1L during neuronal 
reprogramming showed that Ascl1 preferentially localizes to closed chromatin 
and is targeted to neuronal-specific enhancers (Wapinski et al., 2013). In 
contrast, Brn2 and Myt1L cannot access closed chromatin, preferentially target 
open chromatin and thus have a less dominate role in at the initial stages of 
neuronal reprogramming (Wapinski et al., 2013). Expression of Ascl1 alone 
followed by single-cell transcriptome analysis in fibroblast showed that Ascl1 is 
sufficient to robustly induce reactivation of neuronal genes, downregulation of cell 
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cycle genes, and initiate neuronal reprogramming  (Chanda et al., 2014; Treutlein 
et al., 2016).  In contrast, Myt1L localizes to open and accessible promoters to 
execute transcriptional repression and downregulate non-neuronal genes (Mall et 
al., 2017). These findings show that neuronal reprogramming is dependent on 
the precise match between dominant TFs and chromatin context for the onset of 
neuronal identity acquisition followed by the repression of alternative identities. 
Hematopoietic TFs PU1, CEBPa and CEBPb have been demonstrated to 
reprogram fibroblast to macrophage like cells with PU1, CEBPa and CEBPb 
suggested to act as pioneer factors in different contexts; PU1 in macrophage 
conversion, CEBPa in B Cell conversion and CEBPb in adipose cells (Feng et 
al., 2008; Heinz et al., 2010; Pundhir et al., 2018; Siersbaek et al., 2011; Tagore 
et al., 2015; van Oevelen et al., 2015). PU.1 and CEBPa TFs suggested to have 
pioneering roles during B cell to macrophage reprogramming by distinct 
mechanisms of chromatin targeting. In vivo genomic and chromatin state 
analysis by MNase-seq of PU.1 and CEBPa during B cells to macrophages 
reprogramming revealed that PU1 target nucleosome-enriched chromatin and 
induces chromatin accessibility, while CEBPa binding to nucleosome-enriched 
regions is strongly dependent on PU.1 and EBF1 (Barozzi et al., 2014; Boller et 
al., 2016; Li et al., 2018; van Oevelen et al., 2015). EBF1 has also been shown to 
bind compacted chromatin and induce lineage-specific chromatin accessibility 
(Boller et al., 2016; Li et al., 2018). Moreover, knock down of PU.1 in B cells 
compromises CEBPa binding to nucleosome-enriched enhancers (Heinz et al., 
 
 
9 
2010; Tagore et al., 2015). This leaves the open question of whether CEBPa 
truly targets nucleosomes and thus acts as a pioneer.  
While significant research has been done to parse the epigenetic 
mechanism of TFs driving direct cell reprogramming toward neuronal and 
hematopoietic cell types (Vignoles et al., 2019), the epigenetic mechanism of  
direct cell reprogramming toward cardiac, pacemaker cells, keratinocytes 
suggesting novel pioneer TFs such as Isl1, Hand2, and TFAP2C/p63 
respectively are just beginning to be explored (Fernandez-Perez et al., 2019; 
Gao et al., 2019; Li et al., 2019). Moreover, direct cellular reprogramming toward 
peripheral red bloods cells remains difficult and TFs cocktails have not yet been 
identified. Therefore, characterization of the unique features of pioneer 
transcription factors will allow the prediction of TFs with pioneering and 
reprogramming potential. 
Studies correlating TF binding co-occurrence with chromatin accessibility 
in vivo suggest a hierarchical model of TF-mediate reprogramming. In this model, 
factors sufficient for reprogramming access compacted chromatin, leading to the 
recruitment of additional factors. Finally, supporting TFs target open chromatin 
and repress the host identity (Mall et al., 2017; Wapinski et al., 2013). The 
hierarchical model place TF nucleosome binding ability as a determinant of 
reprogramming potential. Nonetheless models based on genetic correlations 
alone are insufficient to distinguish between intrinsic nucleosome targeting ability 
and chromatin engagement through cooperative interactions. Moreover, whether 
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these factors have the inherent biochemical ability to bind nucleosomes remains 
to be assessed. Thus, the requirement for nucleosome binding by these factors 
as a seminal event in the initiation steps of reprogramming has not been 
determined. 
 
1.4 Chromatin Barriers to Transcription Factor DNA Accessibility  
TFs work in the context of chromatin where DNA is hierarchically 
packaged into a 3D genome conformation that controls the diverse regulatory 
mechanisms of gene activation and repression (Figure 1.3 ) (Luger, 2003; Luger 
et al., 1997). Regulation of the 3D genome organization and its dynamics across 
time and space results in a 4D nucleome network that controls cellular 
differentiation into specialized cells (Figure 1.1 ) (Dekker et al., 2017; Mirny et al., 
2019; Zheng and Xie, 2019).  
Nucleosomes are the principal packing elements of DNA and therefore, 
the fundamental determinants of DNA accessibility for essentially all DNA-
templated processes. They are formed by the association of 146 bp of DNA 
wrapped around two histone dimers of H2A-H2B and a H3-H4 tetramer (Figure 
1.4 )(Luger, 2003; Luger et al., 1997). The histone octamer forms histone-DNA 
contacts at the interior minor groove of DNA, serving as the first level of DNA 
constraint modulating the binding of TFs to DNA and chromatin regulators 
(Luger, 2003; McGinty and Tan, 2015). The tight packing of DNA by histones 
impedes accessibility of TFs to DNA and inhibits TF transcriptional activity 
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(Blomquist et al., 1996; Schild-Poulter et al., 1996; Taylor et al., 1991). Moreover, 
rotational phasing of the TF DNA binding sites within the nucleosome has been 
shown to limit TF binding (Liu and Kraus, 2017; Sekiya et al., 2009). 
 As described above, pioneer TFs can overcome such constraints. 
Nucleosomes can also allow binding of diverse proteins such as pioneer TFs, 
epigenetic modifiers and chromatin remodelers that alter the nucleosome 
structure, positioning and compaction (Hughes and Rando, 2014; McGinty and 
Tan, 2015). The nucleosome’s acidic patch, a negatively charged region on the 
nucleosome surface, serves as the landing pad for nucleosome binding proteins 
including regulator of chromosome condensation RCC1, polycomb repressive 
complex PRC1, centromere protein, CENPC, among others (Figure 1.4) (Allu et 
al., 2019; Kato et al., 2013; Makde et al., 2010; McGinty et al., 2014; Wang et al., 
2013). However, these nucleosome binding proteins interact with chromatin 
through non-specific interactions, which does not allow the targeting to cell type 
specific genes. On the other hand, TFs recognize unique sequences within DNA. 
Therefore, pioneer TFs play a crucial role in the gene specific targeting and 
recruitment of chromatin regulators and allow access of nucleosome-inhibited 
binding of TFs to target sites in closed chromatin to direct competence for a 
specific cell lineage.  
TFs display sensitivity to the multiple states of chromatin compaction 
where nucleosome presence is inhibitory for the binding of most TFs. Our lab has 
identified heterochromatic domains which are refractory to OSKM binding during 
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iPSCs reprogramming (Soufi et al., 2012). Differentially bound regions (DBRs) 
were initially described as histone 3 lysine 9 trimethylation (H3K9me3)- enriched 
mega-base scale domains (Figure 1.3) (Soufi et al., 2012).  These DBRs contain 
pluripotency genes with restricted expression to few cells in the late stages of 
iPSCs reprogramming stages (Buganim et al., 2012b). More recently our lab 
showed that H3K9me3 heterochromatin domains are biophysically distinct 
domains that are sonication resistant therefore revealing structural subtypes of 
heterochromatin (Becker et al., 2017). Additionally, liver specific genes located 
with these sonication resistant domain failed to activate during direct cell 
reprogramming of fibroblast to hepatocytes therefore, impeding efficient 
reprogramming (Becker et al., 2017). These studies, highlighted the role of TFs 
chromatin state sensitivity in restricting manipulation of cell fate. Continued 
research on the impediment of TF chromatin restriction will allow the design of 
better reprogramming protocols and facilitate cell reprogramming translation for 
therapeutic technologies.   
 
1.5 Transcription Factor Screens: DNA and Chromatin Interacting 
Behaviors 
 Proteins that recognize the nucleosome as a substrate cannot be reliably 
predicted by genomic analysis and while there are over 2,000 predicted human 
TFs in the genome (Kummerfeld and Teichmann, 2006; Lander ES, 2001; 
Messina et al., 2004; Vaquerizas et al., 2009; Venter JC, 2001), only a minority of 
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sequence-specific DNA chromatin binding proteins have been assayed for 
nucleosome interaction (Blomquist et al., 1996; Haswell and O'Shea, 1999; Liu 
and Kraus, 2017; Perlmann, 1988; Schild-Poulter et al., 1996).  
 Multiple high throughput studies have described the profile of TFs 
sequence-specific DNA interactome and their sensitivity for DNA methylation by 
systematic evolution of ligands by exponential enrichment (SELEX) and ChIP-
seq (Hu et al., 2009; Jolma et al., 2013; Yin et al., 2017). More recently the 
development of combinatorial technologies that allow parallel analysis of DNA 
accessibility and gene expression have allowed the discovery of associations 
between chromatin state, TF motif enrichment  and gene expression (Cao et al., 
2018; Clark et al., 2018; Cusanovich et al., 2015). But these technologies had 
been unable to incorporate TF-chromatin interaction profiles into the analysis due 
to limitations in the high number of cells required for these assays and the 
requisite of DNA-sequence specificity of TFs. These constraints limit the 
identification of TFs with nucleosome binding potential and make it challenging 
for computational tools to predict the general rules underlying nucleosome 
binding and pioneer activity.  
 To elucidate the molecular mechanisms that mediate TF access to 
nucleosomal sites and the nucleosome-interacting behaviors of such TFs, two 
recent publications developed novel approaches (Yan et al., 2018; Zhu et al., 
2018). Yan et. al. systematically compared the properties of yeast nucleosome-
displacing factors (NDFs). Similar to pioneer TFs, NDFs access embedded sites 
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within compacted DNA, but unlike pioneer TFs, NDFs induce depletion of 
nucleosomes (Yan et al., 2018). This study identified TFs with strong and weak 
nucleosome displacing activity. Furthermore, this study showed that strong NDFs 
antagonize nucleosome formation through DNA replication dependent 
mechanisms in yeast (Yan et al., 2018).  
 Research by Zhu et al from Taipale’s group developed nucleosome 
consecutive affinity purification –SELEX to test nucleosome binding of over 200 
TFs. CAP-SELEX consists of pull down assays with recombinant nucleosomes 
assembled with 147 bp and 200 bp DNA libraries followed by analysis of TF 
sequence-specific enrichment (Zhu et al., 2018). In agreement with previous 
findings, nucleosomes inhibited the binding of most TFs but also revealed 
position-specific binding such as, periodic and dyad binding to nucleosomal DNA. 
In conclusion these publications revealed the interaction landscape between TFs 
and the nucleosome (Yan et al., 2018; Zhu et al., 2018). Nonetheless the 
molecular features of TFs that permit or preclude binding to nucleosomal DNA 
and the chromatin perturbations that immediately succeed binding, to promote 
cooperative interactions with other factors, remain to be understood. 
 
1.6 Conclusions   
 Based on the shared occupancy at silent chromatin of FoxA and 
reprogramming TFs, I sought to investigate the nucleosome binding abilities of 
reprogramming TF as a required step for the initiation of reprogramming. 
 
 
15 
Although it has been proposed that TF-mediated chromatin opening is a 
generalized mechanism to access regulatory regions as an initial step in 
reprogramming and differentiation, these models have been based on genome-
wide ChIP-seq data, which cannot differentiate between direct interaction with 
chromatin or close proximity mediated by intermediate proteins. Therefore, my 
thesis work tests the ability of reprogramming factors to directly engage with 
nucleosomes (chapter 2) and systematically assess the ability of the direct 
reprogramming TFs toward multiple cell types to bind reconstituted nucleosomes 
(chapter 3). Additionally, by TF screening methods I was able to identify TFs with 
previously unreported pioneering activity (Chapter 3). Indeed, revealing that 
nucleosome binding is a characteristic of strong reprogramming TFs and further 
predicting TFs for unreported reprogramming protocols such as erythrocyte direct 
cell reprogramming (Figure 1.1). My thesis work describes the unique structural 
features of reprogramming TFs and provides insights into the initial step in the 
mechanisms of cell reprogramming. 
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1.7 Figures 
 
 
 
 
Figure 1.1 | Transcription Factor Mediated Cell Reprogramming 
Transcription factors (TFs) that mediate reprogramming of fibroblast toward 
induced pluripotent stem cells or the direct cell reprogramming towards induced 
neurons, induced hepatocytes, induced macrophages and other hematopoietic 
lineages.  
 
 
 
 
 
17 
 
 
 
Figure 1.2 | Mechanisms of Chromatin Organization 
DNA is packaged into nucleosomes by histone octamers composed of H2A, 
H2B, H3 and H4. These are positively-charged and adhere strongly to 
negatively-charged DNA. Nucleosomes then fold into heterogeneous groups of 
nucleosomes clutches (Ricci et al., 2015). These clutches are compressed and 
folded in interphase into loops by architectural proteins like CTCF and cohesion. 
DNA loops are then arranged into compartments by transcriptional state 
into heterochromatin and euchromatin (Mirny et al., 2019). DNA compartments 
and DNA loops are then studied through time to build spatial models of the 
dynamic spatiotemporal regulation of chromatin (Dekker et al., 2017). Figure 
adapted from (Dekker et al., 2017; Mirny et al., 2019).  
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Figure 1.3 | Chromatin Binding by Pioneer Transcription Factors 
Before gene activation DNA is highly compacted into low signal or repressed 
heterochromatin inhibiting binding of most TFs. Pioneer TFs scan low signal 
chromatin and access target sites within silent chromatin but this binding is 
inhibited at differentially bound regions (DBRs) enriched for H3K9me3. Upon 
binding pioneer TFs then induce local chromatin accessibility and through 
cooperative interactions allow subsequent binding of TFs and chromatin 
modifiers to induce cell type specific gene activation.  
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Figure 1.4 | Surface topology and charge of the nucleosome core particle.  
(A) Surface of nucleosome core particle viewed down the DNA superhelical axis 
in space-filling representation.  
(B) Surface electrostatic potential of nucleosome core particle contoured from −5 
to +5 kT/e calculated with ABPS.164 Location of acidic patch is indicated (Figure 
from (McGinty and Tan, 2015) 
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CHAPTER 2: PIONEER TRANSCRIPTION FACTORS TARGET 
PARTIAL DNA MOTIFS ON NUCLEOSOMES TO INITIATE 
REPROGRAMMING 
 
2.1 Preface 
 The manuscript presented in this chapter was originally published online 
16 April 2015 in Cell, Volume 161 (Soufi et al., 2015b). It has been reformatted 
here in accordance with University of Pennsylvania dissertation formatting 
guidelines.  
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2.2 Respective Contributions 
Dr. Abdenour Soufi and Dr. Kenneth S. Zaret. conceived the study. Under 
the guidance of Dr. Soufi and Dr. Zaret I carried out plasmid cloning, DNA 
purifications, histones purifications, nucleosome reconstitutions, EMSAs and 
competition experiments as well as dissociation constant analyses resulting in 
Figure 2.1D, Table 1, Figure 2.2A and supplemental Figures 2.S1, 2.S2 
presented. Dr. Soufi, Arthur Jaroszewicz, and Dr. Mateo Pellegrini performed 
genome sequencing experiments and analysis including MNase-seq data 
analysis. With the guidance or Dr. Soufi, Nebiyu Osman carried out 
the recombinant protein purifications of transcription factors. Dr. Soufi performed 
DNAse footprinting experiments with samples that I prepared. Dr. Soufi also 
carried out the motif and 3D structure analysis. Dr. Soufi and Zaret contributed to 
supervision of personnel, data interpretation, and writing the manuscript. While I 
contributed to the manuscript revision and discussions that led to the final 
proposed model of transcription factors flexibility within the DNA binding domain.  
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2.3 Abstract 
Pioneer transcription factors (TFs) access silent chromatin and initiate 
cell-fate changes, using diverse types of DNA binding domains (DBDs). FoxA, 
the paradigm pioneer TF, has a winged helix DBD that resembles linker histone 
and thereby binds its target sites on nucleosomes and in compacted chromatin. 
Herein, we compare the nucleosome and chromatin targeting activities of Oct4 
(POU DBD), Sox2 (HMG box DBD), Klf4 (zinc finger DBD), and c-Myc (bHLH 
DBD), which together reprogram somatic cells to pluripotency. Purified Oct4, 
Sox2, and Klf4 proteins can bind nucleosomes in vitro, and in vivo they 
preferentially target silent sites enriched for nucleosomes. Pioneer activity relates 
simply to the ability of a given DBD to target partial motifs displayed on the 
nucleosome surface. Such partial motif recognition can occur by coordinate 
binding between factors. Our findings provide insight into how pioneer factors 
can target naive chromatin sites. 
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2.4 Introduction 
 Silent chromatin is packed with nucleosomes, acting as a barrier to 
targeting by most transcription factors (TFs) (Adams and Workman, 1995; Mirny, 
2010). However, a select group of transcription factors (TFs) known as pioneer 
factors have the combined ability to access their target sites in silent chromatin 
and initiate cell-fate changes (Iwafuchi-Doi and Zaret, 2014; Zaret and Carroll, 
2011). The winged-helix DNA binding domain (DBD) of the pioneer factor FoxA 
(Clark, 1993), which is similar to that of linker histone(Ramakrishnan et al., 
1993), allows the protein to bind its DNA motif exposed on a nucleosome and 
access to silent chromatin (Cirillo et al., 2002; Cirillo et al., 1998; Cirillo and 
Zaret, 1999a). Such activity is necessary for liver induction (Lee et al., 2005). 
Other TFs involved in cell reprogramming can target their sites in silent chromatin 
(Montserrat et al., 2013; Soufi et al., 2012; Takahashi and Yamanaka, 2006; 
Wapinski et al., 2013), but they possess DBDs that differ from that of FoxA. 
Whether such reprogramming factors directly bind nucleosomes and how the 
structures of their respective DBDs relate to nucleosome binding, and hence 
pioneer activity, has not been assessed. 
Transcription factors containing major structural classes of DBDs, 
including Pit-Oct-Unc (POU), Sry-related High Mobility Group (HMG), Zinc 
Fingers (ZF), and basic-helix-loop-helix (bHLH), represented by O, S, K, and M, 
respectively, have been used in the most dramatic example of cellular 
reprogramming: the conversion of differentiated cells into induced pluripotent 
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stem cells (Takahashi and Yamanaka, 2006). We previously compared genomic 
chromatin features of human fibroblasts, prior to the ectopic expression of 
OSKM, to where the factors first bind the genome during their initial expression 
(Soufi et al., 2012). This allowed us to assess how OSKM target pre-existing 
states in chromatin, as opposed to assessing chromatin states after the factors 
are bound. The data showed that Oct4, Sox2, and Klf4, but not c-Myc, could 
function as pioneers during reprogramming by virtue of their ability to mostly 
target “closed” chromatin sites that are DNase I resistant and “naive” by virtue of 
lacking evident active histone modifications (Soufi et al., 2012). Recently, single-
molecule imaging analysis using fluorescently tagged proteins monitored in living 
cells proposed that Sox2 guides Oct4 to its target sites (Chen et al., 2014); the 
chromatin status of the sites was unknown. However, we previously found that 
the ectopic Oct4 and Sox2 bind most extensively to separate sites in chromatin 
(Soufi et al., 2012), leaving open how the bulk of chromatin targeting is achieved. 
While many of initial binding events were promiscuous and not retained in 
pluripotent cells, many others occurred at target genes that are required for 
conversion to pluripotency. 
Ascl1, Pax7, and Pu.1 have emerged as pioneer transcription factors 
based on targeting closed chromatin and their ability to reprogram cells, though 
assessments of direct interaction with nucleosomes has been lacking (Barozzi et 
al., 2014; Budry et al., 2012; Wapinski et al., 2013). In light of the bHLH factor c-
Myc being unable to bind closed chromatin on its own (Soufi et al., 2012), it was 
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surprising that Ascl1, another bHLH factor, can bind closed chromatin during 
reprogramming fibroblasts to neuron-like cells (Wapinski et al., 2013). Studies 
that have examined the correlation between co-existing TF binding and 
nucleosome occupancy, without characterizing the “pre-bound” chromatin state, 
could not address questions about initial chromatin access. 
Generating induced pluripotent stem (iPS) cells, using the OSKM factors, 
has proved to be highly valuable for research, with great potential for 
regenerative medicine (Robinton and Daley, 2012). In an attempt to increase the 
efficiency of reprogramming, efforts have focused on explaining how somatic 
cells respond to the ectopic expression of OSKM (Buganim et al., 2012b; Papp 
and Plath, 2013; Soufi, 2014). To gain insights into the molecular mechanisms 
that impart OSKM access to closed chromatin, we measured the fundamental 
interaction between the factors and nucleosomes, in vivo and in vitro, by three 
mutually supportive approaches: biochemical assays, genomics, and structural 
analysis. We find that the inherent ability of DBDs to recognize one face of DNA 
on nucleosome, as seen by targeting a part of their canonical motif on 
nucleosome-enriched sequences in chromatin, is the primary determinant of 
pioneer factor activity. These findings can explain the pioneer activity of a diverse 
set of reprogramming factors containing different structural classes of DBDs as 
well as the synergistic behavior of pioneer and non-pioneer factors. 
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2.5 Results   
 
Oct4, Sox2, Klf4, and c-Myc Show a Range of Nucleosome Binding In Vitro 
The interaction of full-length O, S, K, and M, as used in reprogramming, 
with nucleosomes is not known. Therefore, we purified and refolded the full-
length O, S, and K factors, along with c-Myc and its obligate heterodimerization 
partner Max from bacterial cells, representing post-translational unmodified 
proteins (Figure 2.1A; Figure 2.S1A). We also obtained the full-length O, S, K, 
and M expressed in human HEK293 cells and purified under native conditions, 
representing post-translational modified versions of the proteins (Figure 2.1A). To 
quantify the DNA binding activities of the proteins, the apparent equilibrium 
dissociation constants (KD) were determined using two different methods: from 
the decrement in the amount of free DNA (total KD) and from the appearance of 
the first DNA-bound complex (specific KD), in electrophoretic mobility shift 
assays (EMSA). As expected, the bacterial (bact.) and the mammalian (mamm.) 
expressed, recombinant O, S, K, and M proteins bound to DNA probes 
containing canonical motifs, as previously reported for the purified DBDs (Farina 
et al., 2004; Nakatake et al., 2006; Rodda et al., 2005) (Figure 2.S1B; Table 2.1), 
and bound with much lower affinity to non-specific DNA sequences of the same 
length (Figure 2.S1C). The bact. reconstituted Myc:Max heterodimers formed a 
complex that migrated more slowly than Max homodimers, and no protein-DNA 
complexes with similar mobility to Max homodimers were observed even at the 
highest concentrations, confirming that the c-Myc:Max preparation did not 
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contain Max homodimers (Figure 2.S1B). The mamm. c-Myc did not show any 
specific DNA binding activity in the absence of its partner Max, as seen 
previously (Wechsler et al., 1994). These data demonstrate that the recombinant 
full-length OSKM proteins were highly active in specific DNA binding. 
To measure the direct interactions between OSKM and nucleosomes, we 
identified a nucleosome-enriched site in the fibroblast genome that is efficiently 
targeted by OSKM (Soufi et al., 2012), focusing on the LIN28B locus that is 
important for reprogramming and pluripotency (Shyh-Chang et al., 2013; Yu et 
al., 2007) RNA sequencing (RNA-seq) data showed that LIN28B is silent in 
human fibroblasts and remains silent after 48 hr OSKM induction, revealing that 
OSKM binding precedes LIN28B gene activation (data not shown). We selected 
a region downstream of the LIN28B poly(A) site that is strongly enriched for a 
nucleosome in pre-induced human fibroblasts, as measured by MNase 
sequencing (MNase-seq) (Kelly et al., 2012) and was targeted by all four factors 
at 48 hr post-induction (Figure 2.1B). We used PCR on human fibroblast DNA to 
generate a 162-bp, Cy5-labeled LIN28B-DNA, which was assembled into 
nucleosomes (LIN28B-nuc) by salt gradient dilution with purified recombinant 
human histones (Figure 2.S1D). The nucleosomes exhibited protection from low 
concentrations of DNase I except at the ends of the LIN28B fragment, compared 
to free DNA, indicating translational positioning around the center of the 162-bp 
LIN28B sequence (Figure 2.1C, top two boxes), similar to the observed position 
of the center of the MNase-seq peak (Figures 2.1B and 2.1C). Ten-fold higher 
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concentrations of DNase generated an approximately 10-bp DNase-cleavage 
repeat pattern on LIN28B-nuc, reflecting rotational positioning of nucleosomes 
within the population (Figure 2.1C, bottom). 
It is generally accepted that nucleosomes act as a barrier to DNA binding 
by TFs (see Introduction), though exceptions have been noted (Perlmann, 1988). 
Interestingly, Oct4, Sox2, and Klf4, but not c-Myc:Max, showed binding to the 
LIN28B-nuc (Figure 2.1D). Remarkably,both mamm. and bact. Oct4 and Sox2 
showed similar or lower apparent KD values for LIN28B-nuc compared to 
LIN28B-DNA, indicating similar or higher affinity to nucleosome than to free DNA 
(Figure 2.1D; Table 2.1). On the other hand, Klf4 was able to bind LIN28B-nuc 
with a higher apparent KD value compared to free DNA, indicating substantial 
nucleosome binding, but at a lower affinity than to free DNA (Figure 2.1D; Table 
2.1). c-Myc:Max did not yield saturated binding to LIN28B-nuc, even at the 
highest concentrations of protein used, and thus the apparent KD must be in the 
μM range (Figure 2.1D; Table 2.1). In conclusion, both mammalian and bacterial 
expressed O, S, K, and M exhibit the same relative range of affinities to LIN28B-
nuc, and O, S, and K have an independent nucleosome binding activity. 
 
Specific and Non-Specific DNA Interactions Contribute to Nucleosome 
Binding 
It is well recognized that TFs show both sequence-specific and non-
specific interactions with their DNA targets  (Biggin, 2011). To measure the 
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contribution of specificity on OSK binding to LIN28B nucleosomes, we carried out 
EMSA in the presence of increasing amounts of specific and non-specific DNA 
sequences that we had already characterized as competitors (Figures 2.S1B and 
2.S1C; Table 2.1). EMSA competition experiments show that a 40-fold molar 
excess of non-labeled DNA probes containing specific binding sites, but not 
probes containing non-specific sequences, can displace LIN28B-DNA complexes 
with each of the OSKM proteins, indicating specific interaction with LIN28B-DNA 
(Figure 2.2A, left panel), similar to OSKM interaction with their canonical sites 
(Figure 2.S2A). As expected, bact. and mamm. O, S, or K in complexes with 
LIN28B-nuc were displaced in the presence of a 40× molar excess of unlabeled, 
specific competitors (Figure 2.2A, lanes 16, 19, and 22). A 40× or lower (range 
from 5× to 20×) molar excess of non-specific DNA failed to displace bact. and 
mamm. Oct4 from the LIN28B-nuc (Figures 2.2A, lane 17, and 2.S2B, lanes 14–
16), demonstrating specific binding by Oct4 to the nucleosomes in vitro. 
By contrast, a 40× excess of non-specific DNA competed almost all of 
Sox2 and Klf4 from binding to LIN28B-nuc (Figure 2.2A, lanes 20 and 23). 
Importantly, lower levels of non-specific competitor, from 5× to 20×, did not 
compete to the same extent as specific competitor with LIN28B-nuc for binding 
either Sox2 or Klf4 (Figures 2.S2C and 2.S2D, compare lanes 10 to 11–13 
versus 14–16). Thus, both specific and non-specific interactions contribute to 
Sox2 and Klf4 binding to nucleosomes in vitro. 
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DNase footprinting showed that each of the O, S, K, and M factors protect 
sequences on LIN28B-free DNA that resemble their canonical motifs (Figures 
2.2B and 2.2C, dash boxes). In addition, at the concentrations used for 
footprinting, Sox2, Klf4, and c-Myc also show non-specific protection of the 
LIN28B-free DNA (Figure 2.2B, peaks labeled by asterisks). DNase footprinting 
of LIN28B-nuc bound to Oct4 and Sox2 show that the factors protect part of their 
canonical motifs, agreeing with the specific binding to nucleosomes seen with 
EMSA competition experiments (Figures 2.2B and 2.2C). However, Sox2 and 
Klf4 protect both specific and non-specific nucleotides on LIN28B-nuc, supporting 
the non-specific contribution of Sox2 and Klf4 to nucleosomes as seen in EMSA 
competition experiments (Figure 2.2B). The Klf4 binding site is close to the 
predicted nucleosome dyad axis, where DNase cleavage is minimal, thus 
precluding an accurate assessment of specific footprinting. Expectedly, c-Myc 
showed minimal protection of LIN28B-nuc, confirming the weak affinity to 
nucleosomes. Altogether, the O, S, and K reprogramming factors employ specific 
and nonspecific nucleosome interactions to different extents. 
 
Range of Nucleosome Binding In Vitro Is Observed in Genome Targeting In 
Vivo 
We assessed whether OSKM, 48 hr post-induction, targeted sites with 
pre-existing nucleosome enrichment in fibroblast chromatin. Pooling seven 
replicates from the MNase-seq data set (GSM543311) allowed a high-resolution 
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map of nucleosomes with 6.6-fold genome coverage. First, we curated the sites 
where O, S, K, or M targeted alone, by identifying O, S, K, or M peaks that are 
500 bp or more apart from each other. The sites were arranged in rank order by 
the number of chromatin immunoprecipitation sequencing (ChIP-seq) tags in the 
central 200 bp, from high- to low-affinity sites. This analysis confirms that each of 
the O, S, K, and M factors is highly enriched at the central 200 bp within a 2-kb 
region (Figure 2.3A, blue boxes). Interestingly, Sox2 bound most frequently alone 
(n = 41,107) compared to Oct4 (n = 22,495), Klf4 (n = 28,212), and c-Myc (n = 
23,885). Subsequently, MNase tags across the respective 2-kb regions were 
counted, reflecting local nucleosome enrichment. Read-density heatmaps 
showed a range of nucleosome enrichment at the central 200-bp regions that 
were targeted by O, S, K, or M factors alone (Figure 2.3A, red boxes). Notably, 
Oct4 targets were the most highly enriched for nucleosomes, followed by Sox2, 
and then Klf4 throughout the respective TF rank-ordered binding profiles. By 
contrast, MNase tags in the c-Myc targeted sites were diminished. Also, we did 
not observe pre-phased arrays of nucleosomes at OSKM target sites, indicating 
that the initial association with nucleosomes proceeds repositioning, if any. 
Remarkably, the extent of nucleosome targeting of O, S, K, and M in vivo 
correlates with the relative abilities of the factors to bind nucleosomes in vitro 
(Figure 2.1D; Table 2.1). 
To assess the contribution of non-specific binding in vivo, we counted the 
number of O, S, K, and M peaks at 48 hr post-induction as function of false 
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discovery rate (FDR) threshold. Remarkably, while O, K, and M peak numbers 
begin to stabilize above an FDR of 0.5% (used in our study) (slopes of 1.6, 1.5, 
and 1.3 respectively), the number of Sox2 peaks continues to increase (slope of 
2.1) with higher FDR (Figure 2.S3A). Thus, it appears that Sox2 employs a 
measure of non-specific targeting in vivo, as we observed in vitro. 
 
O, S, K, and/or M Synergistic Targeting of Nucleosomes In Vivo and In Vitro 
It has been previously suggested that transcription factors can access 
nucleosomal DNA by cooperative binding in order to compete with histones 
(Polach and Widom, 1996). To investigate the contribution of synergy between 
O, S, K, and/or M to nucleosome targeting, we studied sites that were co-
targeted by multiple factors within a range of 100 bp or less from each other, i.e., 
within one nucleosome. In general, we observed that all possible O, S, K, and/or 
M combinations targets were enriched for nucleosomes except for KM targets, 
and the co-bound sites, on average, were more enriched for nucleosomes than 
singly bound sites (Figures 2.3B and 2.S3B). Notably, there were more S, K, 
and/or M combinations that included Oct4 and showed higher nucleosome 
enrichment at initially targeted sites, compared to binding combinations lacking 
Oct4 (Figures 2.3B and 2.S3, compare C–I to J–M). For example, c-Myc showed 
the most nucleosome targeting when co-bound with Oct4, followed by with Sox2, 
while c-Myc showed weak targeting to nucleosomes with Klf4 (Figure 2.S3, 
compare E to K and M). Interestingly, the KM combination was the most frequent 
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at nucleosome-depleted promoters, similar to KM targeting DNase hypersensitive 
regions (Soufi et al., 2012) (Figure 2.S3M, red plot). Nevertheless, KM still 
targeted nucleosome-enriched sites at TSS-distal regions (Figure 2.S3M, blue 
plot). 
To further investigate synergistic targeting with Oct4, we assessed binding 
by each of the bact. Sox2, Klf4, and c-Myc:Max (1 nM) to the reconstituted 
LIN28B-nuc (2 nM) in the presence of low amounts of Oct4 (0.3 nM). EMSA 
showed that all the three recombinant proteins are able to bind with Oct4 to 
nucleosomal DNA in vitro, forming higher order complexes (Figure 2.3C). 
Notably, c-Myc:Max binding to LIN28B-nuc was enabled in the presence of Oct4 
(Figure 2.3C, right panel). To assess the presence of histones in the LIN28B-nuc 
in the complexes, we transferred the proteins from an EMSA gel to a 
polyvinylidene fluoride (PVDF) membrane and blotted for H3 and H2B (Figure 
2.S4). Though the c-Myc antibody was the weakest, all LIN28B-nuc-bound 
complexes showed detectable amounts of H3, and to a lesser extent H2B, 
indicating the factors bind together to nucleosomes. In summary, Oct4, Sox2, 
and Klf4 enable c-Myc to target nucleosomal sites both in vivo and in vitro. 
 
O, S, and K Separately Recognize Partial Motifs on Nucleosomes 
To identify DNA motifs that are associated with O, S, and K alone 
targeting to nucleosomes in vivo, the respective targeted sites were rank ordered 
according to nucleosome enrichment in the central 200 bp. This allowed us to 
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separate nucleosome-enriched from nucleosome-depleted regions that were 
individually targeted by O, S, or K. By these criteria, 85%, 80%, and 65% of the 
genomic sites initially targeted by Oct4, Sox2, and Klf4, respectively, were 
enriched for nucleosomes (Figures 2.4A–2.4C, red boxes). We used de novo 
motif analysis, separately analyzing the targets that were enriched for 
nucleosomes (Figures 2.4A–2.4C, red boxes, upper portion) from those that were 
depleted of nucleosomes, i.e., free DNA targets (Figures 2.4A–2.4C, red boxes, 
lower portion). While O, S, and K primarily targeted sequences similar to their 
canonical motifs at nucleosome-depleted and nucleosome-enriched sites, motifs 
occurring at nucleosome-enriched sites showed distinctive features (Figures 
2.4D–2.4F). 
Strikingly, while Oct4 targeted its canonical octamer sequence at 
nucleosome-depleted sites (∼49% of n = 3,375), Oct4 targeted hexameric motifs 
resembling one or another half of the octamer motif at nucleosome-enriched sites 
(42% and 28%, respectively, of n = 19,120) (Figure 2.4D). Sox2 targeted its 
canonical HMG box motif at nucleosome-depleted sites (64% of n = 8,221), while 
targeting a more degenerate motif lacking the sixth “G” nucleotide in the 
nucleosomal motif (∼74% out of n = 32,886) (Figure 2.4E, arrowhead). Finally, 
Klf4 alone targeted its nonameric motif at nucleosome-depleted sites (94% of n = 
9,874), whereas Klf4 targeted a hexameric motif that was missing the three 
terminal nucleotides at nucleosome-enriched sites (90% of n = 18,338) (Figure 
2.4F, see dashed lines). 
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These findings agree with the above DNase footprinting of LIN28B-nuc 
bound to the factors (Figure 2.2B, right panels), with Oct4 and Sox2 protecting a 
part of their canonical motifs on one side of the LIN28B-nuc DNA (Figures 2.2B 
and 2.2C; right). On free DNA, Klf4 protected the first three nucleotides of its 
motif on the upper strand while protecting the remaining six nucleotides of its 
motif on the bottom strand (Figure 2.S5A). However, Klf4 did not protect the first 
three nucleotides on the upper strand of LIN28B-nuc, as they were not exposed 
to DNase I digestion, indicating that Klf4 may be interacting with part of its motif 
exposed on the other strand (Figures 2.2B and 2.2C). 
These data show that the O, S, and K factors can independently target 
nucleosomes using partial or degenerate motifs, and that each of the factors 
targets their full canonical motif in the absence of nucleosomes at a target site. 
Targeting of partial motifs at nucleosomal sites by OS or OK together also 
reveals partial motifs for each of the factors (data not shown). 
 
The Molecular Basis for O, S, and K Nucleosomal Targeting 
In order to define the molecular basis that govern O, S, and K interactions 
with nucleosomal DNA, we interrogated the three dimensional structures of O, S, 
and K DBDs in complexes with their canonical motifs that were deposited in the 
RCSB Protein Data Bank. Oct4 contains a bipartite POU domain, composed of 
an N-terminal POU-specific (POUS) and a C-terminal POU-homeodomain 
(POUHD), separated by a linker region. The X-ray structure of Oct4-POU-DNA 
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complex confirms that the POUS and POUHD each bind one-half of the 
octameric motif on DNA (Esch et al., 2013) (Figure 2.4G, lower panels). The 
truncated POUS and POUHD can bind their respective half motif DNA probes in 
vitro, independently from each other (Verrijzer et al., 1992). Interestingly, the 
isolated DNA-bound state of either POUS or POUHD accommodates less than 
half of the DNA surface across the circumference of the double helix (DNA 
surface occupied 606 and 718 Å2, respectively), leaving the opposite DNA 
surface solvent-exposed and potentially free to interact with histones in a 
nucleosome conformation (Figure 2.4G, red dashed arrows in upper panels). 
However, once both POUS and POUHD are bound to the full motif (1,321 Å2), 
less than a quarter of the DNA circumference is solvent-exposed and hence 
would be incompatible with nucleosome binding, due to steric hindrance (Figure 
2.4G, red dashed arrow in lower panel). Thus, the two POU domains do not 
target directly adjacent half sites on nucleosomes, as seen in free DNA, but the 
exposure of the separate half sites on nucleosomes is enough for Oct4 initial 
targeting. 
Sox2 binds DNA through its HMG box, inducing a sharp bend and 
widening of the minor groove (Remenyi et al., 2003) (Figure 2.4H, lower-left 
panel). Our motif analysis showed that Sox2 targets a degenerate motif within 
nucleosomes, missing one “G” nucleotide at the sixth position (Figure 2.4E). This 
“G” nucleotide is positioned at the angle of the induced bend and makes direct 
contacts with the N46 residue at the N-terminal tail of Sox2-HMG (Remenyi et al., 
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2003) (Figures 2.4E and 2.4H, arrowhead). Remarkably, mutation of this one 
amino acid (N46Q) within Sox2-HMG results in a significant decrease in DNA-
bending ability without affecting DNA binding (Scaffidi and Bianchi, 2001). In 
transient transfection assays, the Sox2-N46Q mutant displays higher 
transactivation activity from the Fgf4 enhancer compared to Sox2 wild-type 
(Scaffidi and Bianchi, 2001). Furthermore, mutation of the “G” nucleotide in the 
sixth position of the motif has the unique ability, among all mutations tested, to 
abolish DNA bending by wild-type Sox2 (Scaffidi and Bianchi, 2001). Together 
these data indicate that Sox2 would not induce extensive DNA-distortion when 
targeting the nucleosomal motif, since that motif lacks the “G” nucleotide. To 
further support these observations, we superimposed the 3D structure of DNA 
bound by wild-type Sox2 and Sox2-N46Q mutant on nucleosomal DNA and after 
1,000 cycles refinement we calculated the root-mean-square deviation (RMSD) 
as a measure of the average distance between the phosphate backbone for the 
best fit. These analysis reveal that the less distorted DNA is more compatible 
with nucleosomal DNA (RMSD = 0.86 Å) compared to the extensively distorted 
DNA (RMSD = 6.83 Å) (Figure 2.4H, right panel). In conclusion, our data indicate 
that Sox2 engages nucleosomes by recognizing a degenerate motif that involves 
less DNA distortion, better filling the curvature and widened minor groove of DNA 
around the histone octamer. 
Klf4 recognizes the nonameric DNA motif using all three C2H2-type ZFs 
(three nucleotides per ZF) located at the C terminus (Schuetz et al., 2011) 
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(Figure 2.4F). However, we identified a hexameric motif, lacking the last three 
nucleotides, enriched within nucleosomal targets (Figure 2.4F, 90%). Mutagenic 
studies have shown that the hexameric motif represents the minimal essential 
binding site for Klf4 (Shields and Yang, 1998). Recently, X-ray crystallography 
has revealed the structures of Klf4 bound to the hexameric and nonameric sites 
(Schuetz et al., 2011) (Figure 2.4I). Klf4 uses its two most C-terminal ZFs, out of 
the three, to recognize the hexameric motif, occupying one side of the DNA 
double helix (595 Å2) and leaving more than half of the opposite surface 
potentially free to interact with histones in a nucleosome (Figure 2.4I, red dashed 
arrow in upper-right panel). Klf4 bound to the nonameric motif, with all three ZFs, 
fills up more than half of the DNA surface (847 Å2) and would hinder binding to 
nucleosomes (Figure 2.4I, red dashed arrow in lower-right panel). This analysis 
suggests that Klf4 employs two of its three ZFs to engage nucleosomes. 
Interestingly, the observed adaptability of O, S, and K to recognize partial motifs 
correlates with the apparent flexibility of their respective DBDs that we modeled 
during their transition from the DNA-free to the DNA-bound states (Figures 
2.S5B–2.S5G). 
 
c-Myc Recognizes a Partial Motif Enriched on Nucleosomes through Co-
Binding with Other Factors 
Using the partitioning method in Figures 2.4A–2.4C, a subset of c-Myc 
targeted sites (33%, n = 5,494) were enriched for nucleosomal DNA, while the 
 
 
39 
majority of sites (77%, n = 18,391) did not exhibit enrichment (Figure 2.5A). Motif 
analysis revealed that c-Myc nucleosomal targets were enriched for an E-box 
motif that is missing the two central nucleotides (CANNTG) compared to the 
canonical E-box (CACGTG) (Figure 2.5B, double arrowheads in top panel). 
However, nucleosome-depleted targets were enriched for a less degenerate E-
box motif that we and others have previously reported to be associated with c-
Myc binding at enhancers (Lin et al., 2012; Nie et al., 2012; Soufi et al., 2012) 
(Figure 2.5B, single arrowhead in bottom panel). Interestingly, c-Myc-alone (i.e., 
without OSK) nucleosomal targets were additionally enriched for a homeobox 
(73%) motif that is highly similar to the POUHD motif, compared to nucleosome-
depleted sites (48%) (Figure 2.5C). Likewise, the majority of c-Myc sites that co-
targeted with Oct4 (76%, n = 2,219) that are enriched for nucleosomes contain 
centrally a degenerate E-box motif similar to that identified in nucleosomal c-Myc-
alone targets (Figures 2.5D and 2.5E). The separate halves of the POU motif 
were also enriched at the OM targeted sites, indicating that Oct4 uses one or the 
other DBD while co-binding with c-Myc (Figure 2.5F). In conclusion, c-Myc 
targets nucleosomal sites either with O, S, K, or with endogenous homeodomain 
factors, recognizing a centrally degenerate E-box motif. 
The basic region of bHLH domain, not bound to DNA, appears to be 
unfolded in solution (Sauve et al., 2004) (Figure 2.6A; Figure 2.S6A). Upon DNA 
binding, the basic region folds as an extension of helix-1 and will be referred to 
as basic-helix-1 (bH) (Nair and Burley, 2003) (Figures 2.6D and 2.S6B, blue 
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helices). Notably, the most conserved four nucleotides of the E-box (CANNTG) 
face toward the interaction interface between bHLH and DNA, while the 
degenerate central two nucleotides (CANNTG) face the exterior part of the DNA 
helix (Figure 2.6B, see cyan and magenta arrowheads). The transition between 
DNA free and DNA bound by molecular morphing indicates that the bH follows a 
gradual folding trajectory across the major groove of DNA (Figures 2.6A–2.6D 
and 2.S6B). The interaction between a partially folded bHLH and the CANNTG 
drives the initial recognition of the E-box without making contacts with the central 
nucleotides (NN), resulting in the centrally degenerate E-box motif that we 
observed for c-Myc at the nucleosome-enriched sites (Figure 2.6B). 
Importantly, the partially folded c-Myc only occupies one-half the DNA 
helix surface, leaving the other half solvent-exposed and potentially nucleosome 
compatible (Figure 2.6B, red dashed arrow). Apparently, the partially folded c-
Myc-DNA complex requires further assistance from other factors such as Oct4 or 
other homeodomain-containing proteins to remain associated with DNA. The 
interaction between a partially folded bHLH and a centrally degenerate E-Box 
motif has been observed by X-ray crystallography for Mitf, which shares 86% 
sequence homology across the basic region with c-Myc (Figure 2.S6C) 
(Pogenberg et al., 2012). Once fully folded, the c-Myc bHLH adopts a rigid 
structure, stabilizing DNA binding and resulting in less-degenerate E-box motif, 
which would be incompatible with nucleosomes (Figure 2.6D). We conclude that 
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partially unfolded c-Myc targets a centrally degenerate E-box motif, thereby 
adapting to a nucleosome template when assisted by other factors. 
 
Predicting Pioneer Activity among Different bHLH Factors in 
Reprogramming 
To gain insights on how bHLH proteins may differentially target 
nucleosomes in reprogramming, we examined the 3D structures of a range of 
bHLH-DNA complexes that have been used in reprogramming experiments (El 
Omari et al., 2013; Longo et al., 2008; Ma et al., 1994). Interestingly, the basic 
helix-1 from the different bHLH domains extends across the DNA helix to variable 
extents (Figures 2.6E–2.6I). Motif analysis was also carried out on genomic sites 
bound by these factors from available ChIP-seq data. Notably, in conjunction with 
our findings on c-Myc, the length of the bH α helix negatively correlates with the 
degeneracy of the central nucleotides (CANNTG) of the de novo motifs that we 
identified for each factor (Figures 2.6E–2.6I). 
To further test this correlation, we examined the recent findings that the 
bHLH factor Ascl1 can act as a pioneer factor during reprogramming fibroblasts 
to neurons(Wapinski et al., 2013). We measured nucleosome enrichment in pre-
induced mouse embryonic fibroblasts (MEF) within Ascl1 initial targets in MEFs 
after 48 hr induction (Teif et al., 2012; Wapinski et al., 2013). Unlike c-Myc, the 
majority of Ascl1 sites (73%, n = 3,019) were enriched for nucleosomes (Figure 
2.S6D). Importantly, the basic helix-1 of Ascl1 is considerably shorter compared 
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to that of c-Myc, leaving more of the DNA surface solvent exposed (Figure 2.6E). 
Similar to c-Myc, Ascl1 target nucleosomes were enriched (99.3%) for an E-box 
motif with degenerate central two nucleotides (CANNTG) compared to the E-box 
seen in 98.7% of sites depleted from nucleosomes (Figure 2.S6E). Ascl1 
nucleosomal targets contain an extra “G” nucleotide at the 3′-end of the E-box 
motif, which is missing in the nucleosome-depleted sites, resulting in more 
specific targeting of nucleosomes despite the centrally degenerate E-box 
(Figures 2.6E and 2.S6E). 
Ascl1 and Olig2 exhibited the shortest bH regions, by molecular modeling, 
compared to X-ray crystals of NeuroD, MyoD, and Tal1, with longer bHs. To 
verify that the observed bH lengths were not due to the methodology, we 
examined the amino-acid composition of the basic regions in all bHLH factors 
(Figure 2.6J). The bH-DNA interaction is mainly driven by positively charged 
residues (and hence the name basic). Interestingly, the Ascl1 bH ends at the last 
(N-terminal end) basic residue (arginine), which is positioned further upstream 
(toward the C terminus) compared to the other factors (Figures 2.6J and 2.6R, 
residues in blue boxes). The last basic residue of Olig2-bH falls in between Ascl1 
and the rest of the factors. In conclusion, the basic helix-1 of pioneer bHLH 
factors such as Ascl1 is intrinsically shorter, allowing the factors to bind 
nucleosomes more efficiently. 
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2.6 Discussion  
The introduction of a defined set of TFs, such as OSKM, into differentiated 
cells can result in cell-fate conversion (Takahashi and Yamanaka, 2006), and yet 
it has been clear that the different factors have different contributions or 
“strengths” in cell-type conversion. This provided the basis for our effort to tackle 
the long-standing problem of how TFs initially target their sites in closed 
chromatin. The pioneer factor theory partly answers this question by suggesting 
that a select group of TFs, such as FoxA, access closed chromatin by a direct 
interaction with nucleosomal DNA through a DBD that resembles the structure of 
a linker histone (Iwafuchi-Doi and Zaret, 2014; Zaret and Carroll, 2011). We 
previously found that the diverse set of DBDs exhibited by O, S, K, and M, which 
are structurally different from a linker histone, have differential abilities to access 
closed chromatin (Soufi et al., 2012). Here, we revealed that the relative 
tendencies of O, S, K, and M to initially target nucleosomal sites in 
reprogramming reflect their inherent ability to bind nucleosomes in vitro and their 
ability to recognize partial motifs on nucleosomes in vivo. This is different from 
what was observed for FoxA1, which recognizes the same motif on free DNA and 
nucleosomes (Cirillo et al., 1998; Li et al., 2011). Factors that cannot bind 
nucleosomes on their own, such as c-Myc, associate with other factors to target 
degenerate E-boxes on nucleosomes. Our new approach is in contrast to the 
previous predictions of pioneer factors by fitting fully folded DBDs, in their naked 
DNA-bound state, on nucleosomes through a docking mechanism. 
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We found that the bipartite POU domain of Oct4 can target partial motifs 
exposed on nucleosomes using separate PouS or PouHD domains. The single 
motif targeted by each domain is longer than each half of the octamer motif, thus 
providing greater binding specificity than a half motif. In addition, mass 
spectroscopy analysis has identified histones as interacting partners of Oct4 in 
mouse ES cells (Pardo et al., 2010), indicating an additional affinity contribution 
by protein-histone interactions. The bipartite domain-Pax family of TFs can bind 
DNA using both domains and still occupy half of the DNA surface and would 
therefore be compatible with nucleosome binding (Garvie et al., 2001; Xu et al., 
1999) (Figure 2.S7, right, compared to POU TFs). This agrees with the finding 
that Pax7 is a pioneer factor that uses full motif recognition during initial targeting 
(Budry et al., 2012). Thus, bipartite TFs have to either employ one DBD or 
position both DBDs on the same surface of DNA in order to interact with 
nucleosomes. Notably, the pioneer activity of a Zebrafish homolog of an Oct 
protein was observed during the maternal-to-zygote transition (Lee et al., 2013; 
Leichsenring et al., 2013), suggesting that targeting nucleosomal sites may be a 
general method for de novo programming of the genome. 
The high affinity of Sox2 for nucleosomes may be due to the pre-bent 
conformation of DNA, which widens the DNA minor groove and favors initial 
minor groove sensing. While bending naked DNA by Sox2 requires minimal work 
(Privalov, 2009), the energy cost would impede Sox2 to further bend DNA on 
nucleosomes. We find that Sox2 would not further bend nucleosomal DNA 
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because it recognizes a partial motif that diminishes the extreme bending of the 
full motif. Sox family members share the recognition of the core motif but display 
diverse preferences outside the core in naked DNA (Badis et al., 2009). Our 
findings reveal greater flexibility with regard to Sox2 core motif preferences on 
nucleosomes than was previously recognized. In addition, we showed evidence 
for both specific and nonspecific binding by Sox2 in vitro and in vivo. The stable, 
motif-driven targeting by Sox2 on nucleosomes in the ChIP-seq data show much 
lower co-binding with Oct4 (Soufi et al., 2012) than seen in live imaging (Chen et 
al., 2014), leaving open whether the latter approach depicts nucleosomal or free 
DNA binding during genome scanning. 
Klf4 showed higher affinity to free DNA compared to nucleosomes in vitro, 
and its initial targets in vivo were enriched for nucleosomes, though less so than 
compared to Oct4 and Sox2. Klf4 targets nucleosomes in vivo using two out of its 
three zinc fingers, recognizing a hexameric motif. This explains how the affinity of 
Klf4 to nucleosomes is lower than that to free DNA. The pioneer factor GATA4 
binds nucleosomes modestly in vitro (Cirillo and Zaret, 1999a) and targets a 
hexameric motif in vivo (Zheng et al., 2013). Notably, GATA4 only contains two 
zinc fingers. The Gils zinc finger family 1 (Gli1) greatly enhances reprogramming 
when co-expressed with OSK (Maekawa et al., 2011). Interestingly, despite 
containing five ZFs, Glis1 only employs two ZFs (number four and five) to 
recognize its targets (Pavletich and Pabo, 1993). The repressor ZFP57/Kap1, 
which is known to be associated with closed chromatin, also recognizes a 
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hexameric motif despite containing an array of seven zinc fingers (Quenneville et 
al., 2011). This suggests that zinc finger proteins in general may use two zinc 
fingers to initially target hexameric motifs exposed on nucleosomes. Klf4 also 
showed non-specific interactions with nucleosomes, suggesting a similar genome 
searching mechanism as Sox2. 
Various examples have been reported on the overexpression of bHLH 
factors in cancer, including c-Myc, Tal1, and Olig2 (Lin et al., 2012; Nie et al., 
2012; Palii et al., 2011; Sanda et al., 2012; Suva et al., 2014). In all of these 
cases, the bHLH factors have been associated with degenerate E-box motifs and 
co-binding with other factors. We propose that the extent to which basic helix-1 
lays on DNA and co-binds with pioneer factors is reflected in the recognized 
motif, predicting bHLH ability to bind nucleosomes and access closed chromatin. 
Interestingly, the mutation of two amino acids within the basic helix-1 that 
interacts with central E-box makes the non-myogenic bHLH factor E12 able to 
convert fibroblasts to muscle cells (Davis and Weintraub, 1992). The 
homeodomain factor PBX primes MyoD targets to induce myogenic potential 
(Maves et al., 2007). Furthermore, the hematopoietic TAL1-E45 heterodimer 
employs one of the two bHLH domains using LMO2 as an adaptor to interact with 
GATA1 (El Omari et al., 2013). Hence, in addition to their intrinsic structures, 
bHLH factors co-binding with DNA-binding and non-DNA binding proteins appear 
to be involved in stabilizing the interaction of the partially folded bHLH factors to 
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nucleosomes. These features are relevant to the multitude of bHLH factors 
functioning in development, cancer, and reprogramming experiments. 
The differential ability of TFs to recognize their target sites on 
nucleosomes supports a hierarchical model where pioneer factors are the first to 
gain access to their targets in silent chromatin. We also observe that the initial 
targeting can occur for non-pioneer proteins when they bind in conjunction with 
pioneer factors that allow the former to recognize their DBDs to a reduced motif 
that is compatible with nucleosome binding. Further studies are needed to 
understand the secondary events that lead to subsequent changes in local 
chromatin structure and the formation of large complexes at gene regulatory 
sequences. By understanding the mechanistic basis by which certain 
transcription factors are especially capable of initiating cell-fate changes, we 
hope to modulate the process and ultimately control cell fates at will. 
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2.7 Main Figures 
 
 
Figure 2.1 | Oct4, Sox2, Klf4, and c-Myc Display Differential Affinity to 
Nucleosomes In Vitro 
(A) Recombinant purified mammalian and bacterial O, S, K, M, and bacterial Max 
(X) proteins analyzed by SDS-PAGE and Coomassie staining. The respective 
OSKMX bands run at the expected sizes when compared to the sizes of protein 
standards. The OSKM DNA binding activity and specificity are shown in Figures 
2.S1A–2.S1C. 
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(B) O, S, K, and M ChIP-seq profiles (blue, red, orange, and green, respectively) 
48 hr post-induction and MNase-seq profile (black) in fibroblasts across the 
LIN28B locus within the displayed genomic location. 
(C) DNase I footprinting showing the protection of LIN28B-DNA before and after 
nucleosome reconstitution in vitro. Electropherograms of 5′-6FAM end-labeled 
LIN28B (top strand) oligonucleotides generated by digesting free DNA (blue) and 
nucleosomal DNA (red) with DNase I. The amount of DNase I used is indicated 
on top of each panel. Shaded boxes represent the DNase-I-protected regions 
within LIN28B-nuc in the expected ∼10-bp pattern. See Figure 2.S1D for details 
about nucleosome reconstitution. 
(D) Representative EMSA showing the affinity of increasing amounts of 
recombinant O, S, K, and M proteins (bact. top panels and mamm. bottom 
panels) to Cy5-labeled LIN28B-DNA (left panels) and LIN28B-nucleosome (right 
panels). EMSA of O, S, K, and M to DNA probes containing specific and non-
specific targets are shown in Figures 2.S1B and 2.S1C. 
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Figure 2.2 | The Contribution of Non-Specific Binding to Nucleosome 
Targeting In Vitro 
(A) Representative EMSA showing the affinity of recombinant O, S, K, and M 
proteins (bact. top panels and mamm. bottom panels) to LIN28B-DNA (left 
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panels) and LIN28B-nucleosome (right panels) in the presence of 40-fold molar 
excess of specific competitor (“s” lanes) or non-specific competitor (“n” lanes) or 
absence of competitor (“-“ lanes). Competition assays showing the specificity of 
O, S, K, and M to their canonical DNA probes and to LIN28B DNA and 
nucleosome under lower titration of competitor are shown in Figure 2.S2. 
(B) DNase I footprinting showing the protection of LIN28B-DNA (left panels) and 
LIN28B-nuc (right panels) in the absence (blue lines) or presence (red lines) of 
O, S, K, and M. Electropherograms of 5′-6FAM end-labeled LIN28B (top strand) 
oligonucleotides generated by DNase I digestion of DNA (0.006 U) and 
nucleosomal DNA (0.06 U). Dashed boxes and stars represent specific and non-
specific sites protected by O, S, K, and M, respectively. 
(C) A cartoon representation of the 162-bp LIN28B DNA (left) and nucleosome 
(right) highlighting the binding sites of O, S, K, and M in vitro in blue, red, orange, 
and green, respectively, as measured by DNase I footprinting. The protected 
DNA sequences are indicated. 
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Figure 2.3 | Oct4, Sox2, Klf4, and c-Myc Display a Range of Nucleosome 
Targeting In Vivo 
(A) Read density heatmaps (in color scales) showing the intensity of O, S, K, and 
M ChIP-seq signal (blue) and MNase-seq (red) spanning ±1 kb from the center of 
the O, S, K, and M peaks where each factor binds alone within 500-bp threshold. 
The analyzed sequences were organized in rank order, from high to low number 
ChIP-seq reads within the central 200 bp (double arrows). The number of 
targeted sites is indicated. 
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(B) As in (A), but showing where the OS, OK, and OM factors peaks are within 
100 bp or less apart from each other. The full possible OSKM combinations are 
shown in Figure 2.S3. 
(C) The binding affinity of S, K, and M (1 nM) in the presence of Oct4 (0.3 nM) to 
LIN28B nucleosomal DNA (lanes 4, 6, and 8, respectively) or absence of Oct4 
(lanes 3, 5, and 7). The binding of Oct4 on its own (lane 2) and free LIN28B 
nucleosomes (lane 1) are indicated. The histone content of the nucleosome 
bound complexes is shown in Figure 2.S4. 
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Figure 2.4 | Oct4, Sox2, and Klf4 Recognize Partial Motifs on Nucleosomes 
(A–C) Same as in Figure 2.3A, but the sites were organized in a descending rank 
order according to the MNase-seq tags within the central 200 bp. The 
nucleosome-enriched sites were separated from the nucleosome-depleted sites 
(dashed line) for each factor. 
(D–F) Logo representations of de novo motifs identified in the O, S, and K 
nucleosome-enriched targets (top) and nucleosome-depleted targets (bottom). 
The motifs were aligned to canonical motifs (middle). The number of targets 
analyzed and percentage of motif enrichments are indicated. 
(G–I) Cartoon representations of the 3D structures of O (PDB-3L1P), S (PDB-
1GT0), and K (PDBs-2WBS and 2WBU) DBDs in complexes with DNA 
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containing canonical motifs. Side and top views are shown for O and K, and 
dashed curved arrows are shown to represent the extent of exposed DNA 
surface (G and I). The 3D structure of the less distorted DNA (top) and 
extensively distorted DNA (bottom) were superimposed on nucleosomal DNA 
(PDB-3LZ0, gray) to display the extent Sox2-nucleosome binding compatibility by 
measuring RMSD of the fit. 
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Figure 2.5 | c-Myc Recognition of Degenerate E-Box on Nucleosome Is 
Assisted by Binding with Co-Factors 
(A–F) Same as shown in Figures 2.4A–2.4F, but for c-Myc alone and OM targets. 
(C) The enrichment of an associated motif (HD) is measured within c-Myc alone 
targets containing or depleted from nucleosomes. The data indicate that c-Myc is 
driven to a degenerate E-box on nucleosomes, in part, by homeodomain factors 
∗∗p < 0.001. 
 
 
57 
 
Figure 2.6 | The Folding Extent of bHLH Basic Helix-1 on DNA Anti-
Correlates with Targeting Centrally Degenerate E-Box Motifs on 
Nucleosomes 
(A–D) The folding trajectory of basic helix-1 of c-Myc upon DNA binding showing 
the possible conformations of c-Myc:Max heterodimers (B and C) that are 
compatible with nucleosome binding. See Figure 2.S6A for c-Myc Morph. The 
initial DNA-free state (A) and the fully folded DNA-bound state (D), which is 
incompatible with nucleosome binding, are indicated. The associated motifs for 
each c-Myc:Max conformation are shown in the left. See Figure 2.S6B for Mitf 
structure in complexes with E-box with variable central nucleotides. 
(E–I) Cartoon representations of various bHLH reprogramming factors in 
complexes with DNA containing their canonical motifs (right). The de novo motifs 
identified for each factor from ChIP-seq data are indicated (left). The cyan and 
pink arrows represent the position of the exposed nucleotides within the central 
E-box motif not making base-contacts with the relative bHLH conformation. The 
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central two nucleotides (CANNTG) are colored in purple in the DNA cartoon. The 
color scheme of the bHLH along with leucine zipper (LZ) is shown at the bottom. 
(J) Alignment of amino-acid sequences of the basic region of Ascl1, Olig2, 
NeuroD, MyoD, Tal1, and c-Myc. The last basic residue at the C-terminal end is 
highlighted in blue. See Figures 2.S6D and 2.S6E for MNase enrichment and 
motif analysis of Asl1. 
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2.8 Supplemental Figures 
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Figure 2.S1 | Recombinant Oct4, Sox2, Klf4, and c-Myc Show Specific DNA-
Binding Activities In Vitro, Related to Figure 2.1 
(A) Schematic diagram showing the DNA-binding domains organization of the 
full-length Oct4, Sox2, Klf4, c-Myc and Max (O, S, K, M and X) proteins. The 
number of amino acids is indicated. 
(B) Representative EMSAs showing the affinity of increasing amounts of 
recombinant bacterial (bact.) and mammalian (mamm.) –expressed O, S, K, and 
M proteins to Cy5-labeled DNA probes containing their respective canonical 
binding sites. The concentrations used for each protein (nM) are indicated above 
each lane. Lanes are numbered underneath each gel. Black arrows indicate the 
migration of Free DNA and DNA-protein complexes. DNA sequences of the Cy5-
labeled probes are shown in the Extended Experimental Procedures. 
(C) Same as in (B) but showing EMSAs with DNA probes containing non-specific 
sequences for each protein. 
(D) SDS-PAGE and coomassie staining showing the homogeneity of the 
recombinant human histones (H2A, H2B, H3, and H4) purified from bacteria 
under denaturing conditions (left panel) and then refolded to H2A/H2B dimers 
and H3/H4 tetramers (middle-panel). EMSA (right panel) showing free Cy5-
labeled LIN28B DNA and Cy5-labeled LIN28B DNA assembled to nucleosomes 
in vitro by salt gradient dilution with the refolded H2A/H2B dimers and H3/H4 
tetramers. LIN28B DNA was generated by PCR using the primers shown in 
Extended Experimental Procedures. DNA was visualized using Ethidium-
Bromide staining (Et-Br) and Cy5 fluorescence (Cy5) as indicated underneath 
each gel in the right panel. The sizes of protein standards in kDa and DNA 
standards in bp are shown. 
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Figure 2.S2 | Recombinant Oct4, Sox2, Klf4, and c-Myc Show a Range of 
Specificity to Free DNA versus Nucleosomal DNA In Vitro, Related to Figure 
2.2 
(A) Representative EMSA showing the affinity of recombinant bact. O, S, K, M-X 
and X proteins (1 nM) to Cy5-labeled probes (2 nM) containing canonical sites in 
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the presence of 40 fold molar excess of specific non-labeled competitor (s) or 
non-specific non-labeled competitor (n) or absence of competitor (-). 
(B–E) Representative EMSAs showing the affinity of recombinant O, S, K, and M 
proteins (bact. top panels and mamm. bottom panels) (1 nM) to Cy5-labeled 
LIN28B free DNA (lanes 1–8) and Cy5-labeled LIN28B nucleosomal (nuc.) DNA 
(lanes 9–16) (2 nM) in the presence of 5, 10 and 20-fold molar excess of non-
labeled specific competitor (s) (lanes 3–5 and 11–13) or non-labeled non-specific 
competitor (n) (lanes 6—8 and 14—16) or absence of competitor (-) (lanes 2 and 
10). Concentrations of competitors in nM are indicated above each lane. Lanes 
are numbered underneath each gel. Full black arrow heads indicate free and TF-
bound LIN28B-DNA, and white arrow heads indicate free and TF-bound LIN28B 
nucleosomal DNA. Brown boxes show Klf4-LIN28B-nucleosome complexes 
under prolonged exposure. 
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Figure 2.S3 | Oct4, Sox2, Klf4, and c-Myc Show a Range of Affinity and 
Specificity to Nucleosomes In Vivo, Related to Figure 2.3 
(A) The O, S, K, and M ChIP-seq peaks at 48 hr post induction in human 
fibroblasts were called using different FDR thresholds to show the extent of non-
specific DNA binding for each factor in vivo. The plots are color coded as 
indicated. 
(B) Nucleosome enrichment as measured by MNase-seq in human fibroblasts 
within regions bound by O, S, K, and/or M combinations at 48 hr post induction in 
fibroblast. 
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The bottom and top of the box represent the 25th and 75th percentile and the 
middle band is the 50th percentile of the MNase-seq value; whisker ends 
represent the min and max values. Outlier values are eliminated. 
(C–M) Read density heatmaps (top panels) in red color scale (0—20) showing 
the intensity of MNase-seq tags, spanning ± 1 kb from the center of the O, S, K, 
and/or M peaks where the factors bind within 100 bp or less from each other. The 
number of targeted sites is indicated above. Metaplots (bottom panels) showing 
the average nucleosome enrichment (MNase-seq tags) within the same O, S, K, 
and/or M sites shown above but separated into TSS-proximal (red) and TSS-
distal groups (blue). Sites that were within 1 kb to the nearest TSS were 
considered proximal, while sites that were more than 1 kb away from the nearest 
TSS were considered distal. 
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Figure 2.S4 | Oct4, Sox2, Klf4, and c-Myc Bind to Nucleosome Containing 
H2A and H3 Histones, Related to Figure 2.3 
Representative EMSAs showing the binding of Oct4 (1 nM) on its own and in 
combination with Sox2, Klf4, and c-Myc-Max (3 nM) (left panels). The proteins 
from EMSA were transferred onto a PVDF membrane (WEMSA) and blotted for 
H3, H2B, Oct4, and/or Sox2, Klf4 and Myc as indicated (the three panels on the 
right). Black arrow heads indicate the observed TF-nucleosome complexes. 
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Figure 2.S5 | The Apparent Flexibility of Oct4, Sox2, Klf4, and c-Myc DBDs 
Correlate with Their Nucleosome Binding Compatibility, Related to Figure 
2.4 
(A) DNase-I footprinting showing the protection of LIN28B-DNA in the absence 
(blue lines) or presence (red lines) of Klf4. Electropherograms of 5′-6FAM end-
labeled LIN28B oligonucleotides generated by DNase-I digestion of DNA (0.006 
U) of the top-strand (top panel) or the bottom-strand (bottom panel). Dashed 
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boxes represent specific sites protected by Klf4 and the corresponding sequence 
is indicated underneath. 
(B, C, and D) Cartoon representation showing the three dimensional structures of 
O, S, and K free of DNA as determined by NMR. All the NMR-determined 3D 
states are aligned and shown by transparent colors to indicate the measured 
flexibility of the free DBDs. The PDB ids of each structure are indicated. 
(E, F, and G) The gradual transition of O, S, and K DBDs from DNA-free to DNA-
bound was measured by morphing (Extended Experimental Procedures). Arrows 
and color transparency indicate the extent of the apparent flexibility of each DBD. 
The used color scheme is shown at the bottom. 
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Figure 2.S6 | The HLH Factors Compatibility with Nucleosomes Correlates 
with Central Degenerate E-Box Motif, Related to Figures 2.5 and 2.6 
(A) Same as Figure 2.S5 (B, C, and D) for Myc-Max bHLH hetero dimer not 
bound to DNA. 
(B) Same as Figure 2.S5 (E, F, and G) for the transition of Myc-Max bHLH from 
DNA-free to DNA-bound states. 
(C) Pair-wise sequence alignment (left panel) of the basic region of Mitf and c-
Myc showing identical amino-acids (∗) and highly similar amino acids (:, .). 
Cartoon representations of Mitf bHLH in complexes with DNA containing the 
canonical E-box motif (middle panel) and centrally degenerate E-box (right 
panel). The motifs bound and PDB ids are indicated above. The cyan and pink 
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arrows represent the position of the exposed nucleotides within the central E-box 
motif not making base-contacts with the relative bHLH conformation. The central 
two nucleotides (CANNTG) are colored in purple in the DNA cartoon. The color 
scheme of the bHLH along with leucine zipper (LZ) is shown at the bottom. 
(D) Read density heatmaps (in color scales) showing the intensity of Ascl1 ChIP-
seq signal (blue) 48 hr post induction in MEFs and MNase-seq (red) in non-
induced MEFs spanning ± 1 kb from the center of the Ascl1 peaks. The analyzed 
sequences were organized in a descending rank order according to the MNase-
seq tags within the central 200 bp (double arrows). The number of targeted sites 
is indicated. The nucleosome enriched sites were separated from the 
nucleosome depleted sites (dashed line). 
(E) Logo representations of de novo motifs identified in Asl1 nucleosome-
enriched targets (top) and nucleosome-depleted targets (bottom). The motifs 
were aligned to canonical motifs (middle). The number of targets analyzed and 
percentage of motif enrichments are indicated. 
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Figure 2.S7 | Nucleosome Binding Compatibility of Bipartite DBDs, Related 
to Figure 2.6 
(A) Cartoon representations of the 3-D crystal structures of the Pou domains 
(blue) of Oct4 and Brn5 in complexes with DNA (red) containing canonical motifs. 
Side and top views are shown and dashed curved arrows are shown to represent 
the extent of exposed DNA surface. The PDB ids are indicated. 
(B) Same as (A) for the Paired domains of Pax5 and Pax6. 
(C) Cartoon representation (left panel) showing the three dimensional structures 
of the bipartite paired (PRD and HD) domain of Pax8 free of DNA as determined 
by NMR. All the NMR-determined 3D states are aligned and shown by 
transparent colors to indicate the measured flexibility of the free DBD. The 
gradual transition of the paired domain from DNA-free to DNA-bound was 
measured by morphing (Extended Experimental Procedures). Color transparency 
indicates the extent of the apparent flexibility. The motif recognized by the paired 
domains is shown above. The color scheme is shown at the bottom. 
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2.9 Supplemental Tables 
 
Table 2.1 | Recombinant O, S, K, and M Show a Range of Affinities to 
Nucleosomes 
Apparent dissociation constants (KD) were derived from EMSA to represent the 
relative affinities of bacterial (bact.) and mammalian (mamm.) O, S, K, and M to 
their canonical sites, LIN28B-free DNA, and LIN28B nucleosomes (nuc.). 
Apparent KD were derived from two separate binding curves representing two 
experimental replicates, fitted to the experimental data within R2 values of ∼0.97, 
and expressed in nM units. Apparent KD were quantified from the fractional 
decrement of free DNA or nuc, designated as “total” binding, or from the first 
bound-DNA/nuc complexes, representing “specific” binding. ND, not determined 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apparent KD (nM) 
Oct4 Sox2 Klf4 c-Myc 
bact. mamm. bact. mamm. bact. mamm. bact. mamm. 
Total canonical 0.61 0.64 0.37 0.98 2.49 1.46 1.88 ND 
Specific canonical 0.76 1.04 0.45 1.50 3.18 1.95 0.77 ND 
Total LIN28B DNA 0.75 0.93 0.38 1.46 1.25 0.41 8.28 ND 
Specific LIN28B DNA 0.92 2.05 0.68 3.83 2.26 1.12 6.25 ND 
Total LIN28B nuc. 1.09 1.34 0.34 1.06 5.96 3.45 ND ND 
Specific LIN28B nuc. 1.17 1.84 0.39 1.43 7.21 13.97 ND ND 
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2.10 Materials and Methods 
 
Protein Expression and Purification 
 
 
The bacterial expression plasmids pET-28B-huOct4, pET-28B-huSox2, 
pET-28B-huKlf4, and pET-28B-huMyc encode the human O, S, K, and M, 
respectively, fused to an N-terminal 6X histidine tag. The O, S, K, and M cDNA 
sequences were generated by PCR from the respective lentiviral constructs used 
for generating human iPS cells (Hockemeyer et al., 2008), introducing a NotI and 
EcoRI restriction sites for inserting into the pET-28B plasmid. The histidine-
tagged O, S, K, and M proteins were expressed in E. Coli Rosetta (DE3) pLysS 
(Novagen # 70956-3). Transformed cells were grown at 37°C to a density of 0.5 
at A600 nm and protein expression was induced by 0.5 mM IPTG for 4 hr for 
Oct4, 2 hr for Sox2, and overnight for Klf4 and c-Myc at 30°C. The proteins were 
purified over Hi-trap HP nickel-charged columns (GE healthcare # 17-5248-01) 
under denaturing conditions. The purified proteins Oct4 and Sox2 were refolded 
by initially dialyzing to 2 M Urea in 2 M increment gradients and then to 0 M Urea 
using a desalting column (GE healthcare # 17-1408-01). The purified denatured 
Klf4 was refolded by dialyzing to 2 M Urea in 2 M increment gradients and 
refolded by diluting directly to 1 μM concentration in DNA binding buffer (10 mM 
Tris-HCl pH 7.5, 1 mM MgCl2, 10 uM ZnCl2, 10 mM KCl, 1 mM DTT, 5% 
glycerol, 0.5 mg/ml BSA). The c-Myc:Max heterodimer complex was 
reconstituted as described previously (Farina et al., 2004). The recombinant 
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human histones were expressed and purified as described previously (Tanaka et 
al., 2004). 
The mammalian expressed human O, S, K, and M recombinant proteins 
were obtained from OriGene (Oct4 # TP311998, Sox2 # TP300757, Klf4 # 
TP306691, c-Myc # TP301611). The DDK-tagged mammalian proteins were 
expressed in HEK293 cells (human embryonic kidney cells) and purified under 
native conditions using anti-DDK affinity column followed by conventional 
chromatography steps. 
Due to the presence of contaminants (Figure 2.1A), the mammalian 
protein concentrations were calculated by quantifying the intensity of each of the 
O,S,K,M bands running at the expected sizes in SDS-PAGE (without including 
the contaminants) and comparing it with their respective bacterial counterparts; 
the latter having been quantitated by direct protein measurements using 
absorbance at 280 nM. To reduce error the band intensities were quantified 
under variable concentrations. 
 
Nucleosome Reconstitution 
 
 
The 162-bp LIN28B DNA fragment was created by PCR with end-labeled 
primers. The fluorescent-tagged DNA fragments were gel extracted and further 
purified using ion-exchange liquid chromatography by MonoQ (GE Healthcare). 
The nucleosomes were reconstituted by mixing purified human H2A/H2B dimers 
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and H3/H4 tetramers with LIN28B-DNA at 1:1 molar ratio of histone 
octamer:DNA using a salt-urea gradient. 
 
The 162 bp LIN28B DNA fragment corresponds to the genomic location: 
 
hg18-chr6:105,638,004-105,638,165 
AGTGGTATTAACATATCCTCAGTGGTGAGTATTAACATGGAACTTACTCCAACAATACA
GATGCTGAATAAATGTAGTCTAAGTGAAGGAAGAAGGAAAGGTGGGAGCTGCCATCACT
CAGAATTGTCCAGCAGGGATTGTGCAAGCTTGTGAATAAAGACA 
 
The DNA sequence was created by PCR with end-labeled primers (see 
below for sequences). The 162 bp fluorescent-tagged DNA fragments were gel 
extracted and further purified using ion-exchange liquid chromatography on a 
Mono-Q column and 2 M salt step gradient. The nucleosomes were reconstituted 
as described previously (Tanaka et al., 2004). Briefly, 10 μg of Cy5 or FAM end 
labeled PCR fragment of LIN28B DNA was mixed with purified and refolded 
H2A/H2B dimers and H3/H4 tetramers at a 1:1 DNA:Histone-octamer molar ratio 
in 10 mM Tris-HCl pH8, 5 M Urea, 2 M NaCl, 1 mM EDTA, 0.1 mg/ml BSA. The 
nucleosomes were assembled using salt-urea gradient by dialyzing against a 
solution containing 2, 1.5, 1, 0.8, and then 0.6 M NaCl and 10 mM Tris–HCl pH 
8.0, 5 M Urea, 1 mM EDTA, 10 mM 2-mercaptoethanol for 4 hr in each buffer at 
4°C. The nucleosomes were then dialyzed against a no Urea buffer containing 
0.6 M NaCl and 10 mM Tris–HCl pH 8.0, 1 mM EDTA, 1 mM 2-mercaptoethanol 
and then the same buffer containing 0.1 M NaCl for 8 hr at 4°C. The 
reconstituted nucleosomes were heat shifted by incubating at 37°C for 6 hr. 
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DNA Binding Reactions 
 
The end-labeled oligonucleotides containing specific or non-specific sites 
(see below for sequences), LIN28B-DNA, and LIN28B-nucleosomes were 
incubated with recombinant proteins in DNA-binding buffer (10 mM Tris-HCl 
(pH7.5), 1 mM MgCl2, 10 μM ZnCl2, 1 mM DTT, 10 mM KCl, 0.5 mg/ml BSA, 5% 
Glycerol) at room temperature for 60 min. Free and bound DNA were separated 
on 4% non-denaturing polyacrylamide gels run in 0.5X Tris–borate–EDTA and 
visualized using a PhosphorImager using Cy5 fluorescence setting (excitation at 
633 nm and emission filter 670 BP 30) and high sensitivity setting. The apparent 
dissociation constant (Kd) was calculated in two ways: 
 
1.Total Kd was calculated to quantify the total affinity of each protein to DNA 
accounting for both specific and non-specific binding by assuming that the 
amount of nonspecific binding is linearly proportional to the concentration of 
protein used. Total amount of DNA was quantified from Cy5 fluorescence of the 
free DNA band at 0 nM protein concentration. The amount of free DNA at each 
protein concentration was determined from the intensity of Cy5 fluorescence of 
the free DNA bands using Multi-Gauge software (Fujifilm Science lab). The 
fraction of bound DNA was calculated using the equation below: 
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛	𝐷𝑁𝐴-./0 = 1 −	 𝐷𝑁𝐴4566𝐷𝑁𝐴7.789  
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Binding curves describing the fraction of bound DNA as a function of 
protein concentration [TF] from two separate experiments were fitted to the data 
using nonlinear regression in GraphPad Prism software (version 6.04 for 
windows). The goodness of the fit was assessed using an R2 greater than 0.97. 
The Kd for each protein was calculated using the equation below and fixing 
Bmax to a maximum of 1where NS is the slope of nonspecific binding. 
 
2.Specific Kd was calculated to quantify the specific affinity of each protein to 
DNA not accounting for non-specific binding. The amount of free DNA and bound 
DNA at each protein concentration was determined from the intensity of Cy5 
fluorescence of the free DNA and the first DNA-TF complex bands using Multi-
Gauge software (Fujifilm Science lab). The fraction of bound DNA was calculated 
using the equation below: 
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛	𝐷𝑁𝐴-.:/0 = 𝐷𝑁𝐴-.:/0𝐷𝑁𝐴4566 + 𝐷𝑁𝐴-.:/0 
Binding curves describing the fraction of bound DNA as a function of 
protein concentration [TF] from two separate experiments were fitted to the data 
using nonlinear regression in GraphPad Prism software (version 6.04 for 
windows). The goodness of the fit was assessed using an R2 greater than 0.97. 
The Kd for each protein, which is determined as the protein concentration at half-
maximum DNA binding was calculated using the equation below and fixing Bmax 
to a maximum of 1. 
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For competition assays excessive amounts (from 5 to 40 fold) of non-
labeled probes containing specific and non-specific sites were added to the 
binding reaction and incubated for 60 min at room temperature to reach 
equilibrium. The binding reactions were loaded on the 4% EMSA gels as 
described above. EMSA gels were run at 80 V at room temperature. As specific 
competitors, the following DNA probes were used: FGF4 promoter for Oct4 and 
Sox2, LEFTY1 promoter for Klf4, and CDKN2D promoter for c-Myc. As non-
specific competitors the following DNA probes were used: NS for Oct4 and Sox2, 
NANOG promoter for Klf4 and c-Myc. See below for the DNA probes sequence. 
 
DNase Footprinting 
 
DNase footprinting reactions were carried out by incubating the 6-FAM 
end labeled LIN28B free (50 ng) in the presence or absence of the purified TFs 
or histone octamers with 0.006 (DNA or DNA+TFs) or 0.06 (nuc. or nuc.+TFs) 
unit of DNase-I (Worthington) in 50 μl DNA-binding buffer (10 mM Tris-HCl 
(pH7.5), 1 mM MgCl2, 10 μM ZnCl2, 1 mM DTT, 10 mM KCl, 0.5 mg/ml BSA, 5% 
Glycerol) supplemented with additional 50 μl 10 mM MgCl2 and 5 mM CaCl2 at 
25°C for 1 min. The reaction was stopped by adding 90 μl (200 mM NaCl, 30 mM 
EDTA, 1% SDS) and chilling on ice for 10 min. One tenth of reaction volume (∼20 
μl) of 3 M NaOAc (pH 5.2) was added to the reaction before the DNA fragments 
were extracted with Phenol–chloroform extraction. The DNA fragments were 
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further purified using MinElute PCR purification kit (QIAGEN) and eluted in 10 μl 
dH2O. The digested DNA fragments were separated by capillary electrophoresis 
as described previously (Zianni et al., 2006). Briefly, the digested DNA fragments 
(5 μl) were added to 4.9 μl HiDi formide (Applied Biosciences) and 0.1 μl 
GeneScan-500 LIZ size standards (Applied Biosciences). After denaturing at 
95°C for 10 min, the samples were run on an ABI 96-capillary 3730XL 
Sequencer, using G5 dye setting, running a genotyping module with an 
increased injection time of 30 s and injection voltage of 3 kV. The generated 
electropherograms were analyzed using the peak scanner software (Applied 
Biosciences) and PeakStudio V 2.2. 
 
Western Blotting After EMSA (WEMSA) 
 
The EMSA was carried out as described above with 10-fold more protein 
and nucleosomes and run on a 1.5 mm thick mini-gel cassette (life technologies 
# NC2015) containing 5% polyacrylamide gel. To avoid Cy5 fluorescence 
saturation, 90% of the nucleosome used in binding reaction was not labeled. The 
gel was then visualized using Cy5 fluorescence as described above. To charge 
the proteins, the gel was incubated for 2 hr in denaturing buffer (1% SDS, 375 
mM Tris-HCl pH 7.5) at 20°C. The proteins were transferred to a 0.22 μm Sequi-
Blot PVDF membrane (Bio-Rad) using NuPAGE transfer buffer (life technologies 
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# NP0006), supplemented with 0.1% SDS and 20% methanol for 1 hr at 100 
Volts at 4°C. 
The proteins were fixed to the membrane by incubating in 10% Glacial 
Acetic Acid for 15 min at room temperature. The membranes were blocked with 
PBS-0.1% Tween containing 10% non-fat dry milk overnight at 4°C. The primary 
antibody incubations with anti-human Oct4 antibody (0.5 μg/ml; Abcam # 
ab19857), human Sox2 antibody (1 μg/ml; R&D systems # AF2018), human 
KLF4 antibody (0.5 μg/ml; R&D systems # AF3640), human c-Myc antibody (1 
μg/ml; R&D systems # AF3696), anti-human H3 (0.5 μg/ml; abcam # ab1791), 
and anti-human H2B (0.8 μg/ml; abcam # ab1790) were performed for 2 hr at 
room temperature. The secondary antibody incubations with goat anti-rabbit IgG-
HRP (1:5000 dilution; Santa Cruz # sc-2004) and donkey anti- goat IgG-HRP 
(1:2000; Santa Cruz # sc-2020) were performed for 1 hr at room temperature. 
Blots were visualized by using SuperSignal West Pico chemiluminescent 
substrate (Thermo-Scientific # 34080) in Fujifilm LAS-4000 imaging system. The 
membranes were stripped by incubating with Restore Western-Blot Plus 
Stripping Buffer (Thermo-Scientifc # 46430) for 30 min at RT and re-blocked after 
blotting with each antibody. The same membrane was serially blotted and 
stripped with all antibodies shown. 
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Genomic Data Analysis 
 
The O, S, K, and M ChIP-seq aligned data along with the called peaks 
(FDR-controlled at 0.005) were obtained from the GEO database (GSE36570) 
(Soufi et al., 2012). The MNase-seq data (GSM543311) (Kelly et al., 2012) were 
aligned to build version NCBI36/HG18 of the human genome and seven 
replicates were pooled together generating 145,546,004.00 unique reads. The 
MNase-seq reads were extended to 150 bp to cover one nucleosome and thus 
resulting in 6.6 fold genome coverage. 
To identify regions bound by single factors, we separated peaks if their 
centers were at least 500 bp apart from each other. Sites bound by all possible 
OSKM combinations were merged if their peak centers were within 100 bp or 
less from each other. Regions spanning 1 kb upstream and downstream from the 
center of the curated peaks were divided into 10 bp bins (n = 200). Tag counts 
from O, S, K, and M ChIP-seq and MNase-seq were assigned to each 
corresponding bin and used as a measure for enrichment. The curated genomic 
locations were organized in ascending rank-order according to the tag counts 
from the central 20 bins (200 bp) as described in the text. Sites were considered 
to be nucleosome-depleted if their central 200 bp tag counts were smaller than 
that of the average 200 bp flanking regions (ratio < 1). 
bHLH factors ChIP-seq data were obtained from GEO with the accession 
code GSE43916 for Ascl1 (Wapinski et al., 2013), GSM1167583 for Tal1, 
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GSM1167584 for Mitf (Calero-Nieto et al., 2014), GSM1306365 and 
GSM1306367 for Olig2 (Suva et al., 2014), GSM751036 for NeuroD (Tennant et 
al., 2013), and GSE50415 for MyoD (MacQuarrie et al., 2013). MNase-seq data 
for MEFs were obtained from GSM1004654 (Teif et al., 2012). The ChIP-seq and 
MNase-seq data for the above factors were processed as described for OSKM in 
human fibroblasts. The mouse sequencing data were aligned to the Mouse 
genome built mm9, accordingly. 
 
Motif Analysis 
 
For de novo motif discovery, we used Discriminative DNA Motif Discovery 
algorithm (DREME) (Bailey, 2011). We focused on motifs occurring at the central 
200 bp of O, S, or K peaks, using central motif enrichment analysis (CentriMo) 
(Bailey and Machanick, 2012). We quantified the occurrences of the first hits that 
returned with the most statistical significance within the O, S, K, and M sites 
using Find Individual Motif Occurrences (FIMO) (Grant et al., 2011). Motifs that 
showed most central enrichment were considered. Moreover, the newly 
discovered motifs were compared to the JASPAR and UniPROBE motif 
databases using the Motif comparison tool (TOMTOM)(Gupta et al., 2007; 
Mathelier et al., 2014; Newburger and Bulyk, 2009). The above tools are part 
MEME-ChIP suit v.4.9.1 (Machanick and Bailey, 2011), available at 
http://meme.nbcr.net. 
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Molecular Modeling 
 
We have modeled the macromolecular motions that take place during the 
initial recognition of O, S, K, and M DBDs to their binding sites using the MORPH 
server as described previously (Krebs and Gerstein, 2000). Briefly, we used the 
DNA-free structures of O, S, K, and Myc:Max DBDs as the initial state and the 
DNA-DBDs complexes structures as the final state (see below for PDB ids used). 
Based on adiabatic mapping, the possible states accommodating the 
conformational space between free and bound states were calculated within the 
energy barriers constraints. By defining a set of hinges, the protein motion 
describing the rigid-body rotation of a small part “core” in relation to a larger part 
was directly linked protein flexibility. DNA flexibility was not accounted for in our 
molecular dynamics. The DNA-free states of Oct4-POUS, Oct4-POUHD, Klf4-
3ZFs, and c-Myc-bHLH were built based on their sequence homology (92%, 
85%, 93%, and 89%) to the experimental NMR structures of Oct1-POUS, Oct1-
POUHD, Klf5-3ZFs and Max-bHLH, respectively (PDBs: 1POU, 1POG, 2EBT, 
and 1R05) (Assa-Munt et al., 1993; Sauve et al., 2004) using Modeler program 
(Sali and Blundell, 1993). The DNA-free structure of Sox2-HMG has been solved 
using NMR and submitted to the protein databank under the PDB id 2LE4. The 
structures of DNA in complex with Oct4-POU, Sox2-HMG, Klf4-2ZFs, Klf4-3ZFs 
and Myc:Max-bHLH (PDBs: 1GT0, 2WBS, 2WBU, and 1NKP) were solved using 
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X-ray crystallography (Esch et al., 2013; Nair and Burley, 2003; Remenyi et al., 
2003; Schuetz et al., 2011). The Sox2-HMG N46Q mutant was modeled based 
on its sequence homology (94%) to hSRY-HMG mutant (PDB: 1J47) (Murphy et 
al., 2001) as described above. The DNA bound to Sox2 wt or Sox2 N46Q mt was 
superimposed on the nucleosomal DNA obtained from PDB-3LZ0 (Vasudevan et 
al., 2010) using the super command from Pymol (Version 1.5.0.1 Schrödinger, 
LLC) and the RMSD was calculated using the rms_curr command between the 
phosphate backbone carbon atoms. The DNA accessible surface area (ASA) 
exposed to solvent was calculated from free-DNA or bound to Oct4-POUS, Oct4 
POUHD, Oct4-POUS-HD, Klf4-2ZFs, and Klf4-3ZFs from the corresponding 
crystal structures using areaimol from the CCP4 package (Lee and Richards, 
1971). 
The X-ray crystal structures of Mitf (4ATK, 4ATI), NeuroD (2QL2), MyoD 
(1MDY), and Tal1 (2YPB) were obtained from the RCSB protein data bank (El 
Omari et al., 2013; Longo et al., 2008; Ma et al., 1994; Pogenberg et al., 2012). 
The Ascl1 and Olig2 structures were obtained from the SWISS-Model server 
based on their sequence homology to NeuroD (2QL2) (Kiefer et al., 2009; Kopp 
and Schwede, 2006). The images used in the figures were ray-traced and 
created using the PyMOL molecular graphics system (Version 1.5.0.1 
Schrödinger, LLC). 
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DNA Binding Sites 
 
The DNA oligonucleotides used as binding sites (top and lower strands) 
are shown below. The Cy5 5′-end-labeled oligonucleotides were obtained from 
IDT (Integrated DNA Technologies). The double stranded probes were generated 
by annealing the single strands using the following reaction: 1 nano-moles of 
each strand (10 μl of 100 μM) were mixed in 50 μl final volume annealing buffer 
(20 mM Tris-HCl pH7.6, 50 mM NaCl, 0.1 mM DTT, 1 mM EDTA). The reaction 
was incubated at 70°C for 10 min, and slowly cooled at room temperature 
overnight. 
name_TF Upper Strand 
FGF4 TTTAAGTATCCCATTAGCATCCAAACAAAGAGTTTTC 
NANOG CTTACAGCTTCTTTTGCATTACAATGTCCATGGTGGA 
NS CTGCAGGTGGGATTAACTGTGAATTCA 
lEFTY GAGCTCCCAGGAGGTCCCAGGGGTGTGACCTCTCT 
CDKN2D AGGAGCCTGCAGCTGCCACGTGGGAAGGCCTGAGAGGACATAGT 
 
PCR Primers 
 
The DNA oligonucleotides used as primers for PCR to generate the 
LIN28B sequence (162 bp) from human genomic DNA are shown. The chemical 
modifications at the end of each oligonucleotide are also shown. All the DNA 
oligonucleotides were obtained from IDT (Integrated DNA Technologies). 
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Sequence 
Name Bases Sequence 
Modifications and 
Services 
lin28B- FWD 27 AGT GGT ATT AAC ATA TCC 
TCA GTG GTG 
Standard Desalting 
Cy5-lin28B-
FWD 
27 /5Cy5/AGT GGT ATT AAC 
ATA TCC TCA GTG GTG 
5′ Cy5 HPLC Purification 
6-FAM-
lin28B-FWD 
27 /56-FAM/AGT GGT ATT AAC 
ATA TCC TCA GTG GTG 
5′ 6-FAM Standard 
Desalting 
lin28B-RVS 25 TGT CTT TAT TCA CAA GCT 
TGC ACA A 
Standard Desalting 
Cy5-lin28B-
RVS 
25 /5Cy5/TGT CTT TAT TCA 
CAA GCT TGC ACA A 
5′ Cy5 HPLC Purification 
6-FAM-
lin28B-RVS 
25 /56-FAM/TGT CTT TAT TCA 
CAA GCT TGC ACA A 
5′ 6-FAM Standard 
Desalting 
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CHAPTER 3: STRUCTURAL FEATURES OF TRANSCRIPTION 
FACTORS ASSOCIATING WITH NUCLEOSOME BINDING 
 
3.1 Preface 
 The manuscript presented in this chapter was originally published online 
July 11th, 2019 in Molecular Cell, Volume 75 (Fernandez Garcia et al., 2019). It 
has been reformatted here in accordance with University of Pennsylvania 
dissertation formatting guidelines. Supplemental tables S1 through S3 are 
publically-available with this dissertation at: 
http://repository.upenn.edu/edissertations/. 
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3.2 Respective Contributions 
 The majority of the experiments and analyses presented in this chapter 
were designed and performed by myself, under the guidance of Dr. Kenneth S. 
Zaret.  I carried out genomic data analysis with the guidance of Greg Donahue 
from Dr. Zaret’s lab, recombinant protein purifications, nucleosome 
reconstitutions, EMSAs, DNase footprinting experiment, mid-stage and final data 
processing of protein microarray, and 3D protein structure modeling. Oscar 
Alberto purified CEBPb DBD and mutants under my supervision. Dr. Katharine N. 
Schulz purified ZELDA and consulted on ZLD-binding experiments. Cedric D. 
Moore. carried out protein microarray experiments and initial data processing 
collected. Dr. Kenneth S. Zaret supervised personnel, data interpretation, and 
writing the manuscript, while Dr. Melissa M. Harrison, Dr. Cedric Moore, Dr. 
Heng Zhu and Dr. Dario Nicetto provided comments to the manuscripts. The 
manuscript was written by me, with the assistance of Dr. Zaret. 
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3.3 Abstract 
 Fate-changing transcription factors (TFs) scan chromatin to initiate new 
genetic programs during cell differentiation and reprogramming. Yet the protein 
structure domains that allow TFs to target nucleosomal DNA remain unexplored. 
We screened diverse TFs for binding to nucleosomes containing motif-enriched 
sequences targeted by pioneer factors in vivo. FOXA1, OCT4, ASCL1/E12a, 
PU1, CEBPa, and ZELDA display a range of nucleosome binding affinities that 
correlate with their cell reprogramming potential.  We further screened 593 full-
length human TFs on protein microarrays against different nucleosome 
sequences, followed by confirmation in solution, to distinguish among factors that 
bound nucleosomes, such as the neuronal AP-2a/b/g, versus factors that only 
bound free DNA.  Structural comparisons of DNA binding domains revealed that 
efficient nucleosome binders use short anchoring a-helices to bind DNA, 
whereas weak nucleosome binders use unstructured regions and/or b-sheets. 
Thus, specific modes of DNA interaction allow nucleosome scanning that confers 
pioneer activity to transcription factors. 
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3.4 Introduction 
 Diverse genomic studies have established that a subset of fate-changing 
transcription factors (TFs) can target nucleosomal sequences in chromatin, and 
hence act as pioneer TFs (Heinz et al., 2010; Iwafuchi-Doi and Zaret, 2014; Li et 
al., 2018; Wapinski et al., 2013). However, the principles that predict whether a 
given TF may target sites on nucleosomal DNA are not clear. DNA sequences 
containing clusters of TF binding sites at active enhancers and promoters that 
were considered to be “nucleosome-free regions” have been shown to harbor 
histones variants H3.3 and H2A.Z (de Dieuleveult et al., 2016; Jin et al., 2009), 
histone modifications such as H3K4me1/2, H3K27Ac (Calo and Wysocka, 2013),  
and exposed or "fragile" nucleosomes (Iwafuchi-Doi et al., 2016; Mieczkowski et 
al., 2016). Still, the presence of a nucleosome can be refractory to TF binding 
and transcriptional activity (Blomquist et al., 1996; Taylor et al., 1991). In this 
study, we investigate the intrinsic nucleosome-binding properties of diverse TFs 
to identify features that enable nucleosome binding. 
We focused on TFs that drive cell differentiation and reprogramming. 
Analysis of the pioneer factor FOXA, a winged helix factor required for liver 
development (Lee et al., 2005), revealed that FOXA1 can bind its target 
sequence on nucleosomes and induce local nucleosomal accessibility in vitro 
(Cirillo et al., 2002; Cirillo and Zaret, 1999a). In vivo, FOXA1 can displace linker 
histone to promote local chromatin opening and allow cooperative binding of 
other TFs (Iwafuchi-Doi et al., 2016). Similar to FOXA, the hematopoietic factors 
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PU1 and CEBPa target compacted chromatin and induce chromatin accessibility, 
while CEBPa binding to nucleosome-enriched regions is more dependent on 
PU.1 and EBF1 (Heinz et al., 2010; van Oevelen et al., 2015). EBF1 has also 
been shown to bind compacted chromatin and induce lineage-specific chromatin 
accessibility (Boller et al., 2016; Li et al., 2018). 
Genomic assessment of the ectopic OCT4, SOX2, KLF4 (OSK) targeted 
sites and nucleosome occupancy by MNase-seq on pre-existing chromatin 
showed that OSK target partial motifs on nucleosomal DNA that mirrors their 
relative nucleosome affinity in vitro. By contrast, c-MYC bind nucleosomes poorly 
and localizes at its nucleosomal targets via cooperative interaction with other 
factors (Soufi et al., 2015b). Thus, TFs show a differential preference for 
nucleosomes and a hierarchy by which they enable cell fate changes. Yet the 
structural basis for nucleosome motif targeting, apart from the inherent 
adaptability of the DNA binding domains (DBDs) (Soufi et al., 2015b), remains 
unclear.  
While there are over 2,000 predicted human TFs (Messina et al., 2004; 
Vaquerizas et al., 2009), only a fraction has been tested for nucleosome binding 
(Haswell and O'Shea, 1999; Hayes, 1992; Liu and Kraus, 2017; Perlmann, 
1988). Recently, an assessment of TF DBDs interacting with nucleosomes, 
based on SELEX enrichment of bound populations in vitro, revealed diverse 
binding behaviors as revealed by the positions of motifs at different targeted 
positions across the nucleosome (Zhu et al., 2018). However, the study did not 
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provide a direct quantitative assessment of free DNA vs. nucleosome binding 
and left open the question of how protein structure relates to nucleosome 
binding.  Transcription factors can exhibit slow on-rates to nucleosomes, allowing 
time for thermal motions to elicit motif exposure, which can be compensated by 
slow off-rates, resulting in nucleosome binding in the nanomolar range of 
dissociation constant (kD)  as seen for free DNA (Cirillo and Zaret, 1999b; 
Donovan et al., 2019) 
 Protein microarrays are a powerful tool for high-throughput assessment of 
intermolecular interactions (Chen et al., 2008; Hu et al., 2009). However, 
interactions determined by solid-state methods may not truly reflect interactions 
under physiological conditions (Sun et al., 2013) and sequence-specific binding 
needs to be confirmed in solution. To gain a broader view of how TFs target 
nucleosomes, we used a high-throughput protein microarray that contained 593 
unique full-length human TFs, after filtering for technical accessibility, followed by 
validation in-solution of the most significant interactors. Using in vitro 
reconstituted nucleosomes with three different endogenous sequences enriched 
in TF motifs, we find that TFs bind with a range of nucleosome binding affinities 
that positively correlate with TF reprogramming potential. Notably, we find that 
strong nucleosome binding is associated with an anchoring a-helix that interacts 
with no more than half of the DNA’s circumference, leaving the opposite side of 
DNA free to engage in histone interactions. These findings improve our ability to 
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predict transcription factors that can directly scan and bind nucleosomes and 
thus act as pioneer factors. 
 
3.5 Results 
 Recombinant Nucleosomes from Endogenous Nucleosomal 
Sequences Targeted by Pioneer TFs 
 To establish conditions for a large scale study of TFs that can directly 
interact with nucleosomes, we selected seven TFs (Table 1) suggested to have 
pioneering activity on the basis of nucleosomal or closed chromatin targeting in 
vivo, during fibroblast reprogramming to hepatocytes, neurons, or macrophages 
(Heinz et al., 2010; van Oevelen et al., 2015; Wapinski et al., 2013). Pioneer TF 
FOXA1 can drive the conversion of fibroblasts to hepatocytes and, during liver 
development, directly interacts with nucleosome particle N1 within the ALB 
enhancer to stimulate expression (Chaya et al., 2001; McPherson et al., 1993; 
Sekiya and Suzuki, 2011). Therefore, FOXA1 was used as a positive control for 
nucleosome binding on ALBN1 in vitro, assembled into 160 bp nucleosomes 
containing motifs for FOXA1 and other liver TFs (Figure 3.1B, 3.1C). 
ASCL1 and BRN2 drive reprogramming from fibroblasts to neurons 
(Vierbuchen et al., 2010), with ASCL1 targeting closed fibroblast chromatin 
(Wapinski et al., 2013). By integration of genomic datasets (Figure 3.1A) we 
identified an ASCL1 and BRN2 nucleosomal target sequence at the neuron-glia-
CAM-related cell adhesion molecule (NRCAM) locus (Figure 3.1D). The NRCAM 
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gene plays a role in neurite outgrowth and schizophrenia development (Honer et 
al., 1997; Vawter et al., 1999). The NRCAM site was selected by consideration of 
its high nucleosomal MNase-seq signal enrichment in fibroblasts before Ascl1 
and Brn2 expression (Figure 3.1D, 3.S1A), ASCL1 and BRN2 targeting to the 
site by ChIP-seq, the presence of respective DNA binding motifs (Figure 3.1D, 
3.1E), its enrichment for enhancer associated marks H3K4me1, H3K27Ac, 
DNase-hypersensitivity (Figure 3.1D), and gene expression associating with 
neuronal function by gene ontology (Figure 3.S1A, 3.B).  
Genomic and chromatin state analysis by MNase-seq of PU1, CEBPa, 
and CEBPb targeting during B cell to macrophage reprogramming suggests that 
hematopoietic TFs PU1 and CEBPa target nucleosome-enriched chromatin 
(Barozzi et al., 2014; Heinz et al., 2010; van Oevelen et al., 2015), yet the pre-
bound chromatin state was not evaluated. Comparison of fibroblast nucleosome 
occupancy by MNase-seq signals and TFs ChIP-seq in macrophages (Figure 
3.S1C-D) revealed CX3 chemokine receptor 1 (CX3CR1) locus as a candidate 
nucleosomal targeted site (Figure 3.1F). CX3CR1-DNA shows enrichment for 
H3K4me1, H3K27Ac and DNase-hypersensitivity in macrophages (Figure 3.1F) 
and it contains the respective DNA binding motifs (Figure 3.1G). DNA fragments 
of 160 bp of ALBN1-DNA, and 162 bp of NRCAM-DNA and CX3CR1-DNA were 
PCR amplified, Cy5-end labeled (Figure 3.S1E), and prepared as free DNA and 
nucleosomal templates by urea-salt step dialysis (Figure 3.S1F).  
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At a low concentration of DNaseI, ALBN1, NRCAM, and CX3CR1 
nucleosomes exhibited nearly complete resistance to cleavage, compared to free 
DNA (Figure 3.1H-J). Using 20 fold more DNase-I on nucleosomes elicited a 
markedly different cleavage pattern than seen on free DNA.  Each of the 
nucleosomes revealed several interspersed ~10 bp cleavage repeat patterns, 
indicative of different rotational frames that expose diverse DNA binding motifs 
within 120 bp central core of the nucleosome populations (Figure 3.1H-J, bottom 
panels). Our method of curating endogenous nucleosomal sites enriched for 
pioneer factor binding in vivo appears robust for discovering DNA sequences that 
make stable nucleosomes in vitro. 
  
 ASCL1 Heterodimerization with E12a Enhances DNA Binding and 
Specificity  
 To establish conditions for a large-scale TF-nucleosome screen, we 
purified full-length FOXA1, GATA4, HNF1a, ASCL1, BRN2, PU1, and CEBPa 
from E. coli, validated their identity by predicted size and immunoblotting (Figure 
3.2A, 3.S2A), and measured free DNA binding activity. Apparent dissociation 
constants were determined by electromobility shift assays (EMSAs) with short 
Cy5-DNA probes (Figure S2B-D) and quantified by two methods; total 
dissociation constant (total KD), determined by decrement of free probe, and 
specific dissociation constant (specific KD), determined by the appearance of 
specific TF-complexes (Soufi et al., 2015b). As expected, all TFs but ASCL1 
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displayed nanomolar dissociation constants for probes containing canonical DNA 
binding motifs (Figure 3.S2C, Table 1), but not for probes lacking binding motifs 
(Figure 3.S2D). We concluded that most of the purified full-length TFs were 
highly active and bound DNA specifically.  
ASCL1 homodimer DNA binding was not detectable within the nM range, 
agreeing with previous studies estimating a high dissociation constant (KD) 140 
μM (Figure 3.S2E-F) (Meierhan et al., 1995). Basic helix-loop-helix (bHLH) TFs 
heterodimerize with other bHLHs (Longo et al., 2008; Powell and Jarman, 2008) 
and interaction network analysis revealed the ubiquitously expressed E12a 
(Tcf3) as an ASCL1 interacting partner (Figure 3.S2G) (Henke et al., 2009). 
Therefore, we co-purified ASCL1/E12a heterodimers (Figure 3.2A), which formed 
a DNA-bound complex that migrated faster than E12a homodimers (Figure S2E, 
lanes 6, 11) and with a markedly increased DNA binding affinity of ~3.1 nM 
(Figure 3.S2E,F, Table 3.1). We considered ASCL1/E12a heterodimers suitable 
for further analysis.  
 
Reprogramming TFs Interact with Nucleosomal Substrates with a 
Nanomolar Range of Affinities 
 TFs bound to their respective 160 bp free DNAs of ALBN1-DNA, NRCAM-
DNA, CX3CR1 within the low nM range (Figure 3.2B-G, lanes 1-6). As expected, 
the TFs show a higher affinity for the longer 160 bp DNA, compared to shorter 
DNA probes (Table 3.1) due to increased non-specific DNA interactions with 
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longer DNA templates.  Thus, at low concentrations of TFs (0.1-1 nM), each of 
the factors bound to the 160 bp DNA fragments in a single shifted band, while at 
higher concentrations we detected additional shifted complexes with distinct 
dissociation constants (Figure 3.2B-G, 3.S3A-B). The use of an EMSA assay 
allowed us to make these distinctions, which could correspond to redundant 
“periodic” TF binding to nucleosomes detected by SELEX (Zhu et al., 2018). 
 We then assessed binding of the TFs to the same sequences on 
nucleosomes. FOXA1, GATA4, ASCL1/E12a, BRN2, HNF1a, and PU1 showed 
high affinity for nucleosomes, with apparent KDs of 3.0 nM, 3.8 nM, 2.6 nM, 2.0 
nM, 4.7 nM, 5.6 nM, respectively (Figure 3.2B-G lanes 7-12, Table 3.1). 
Comparison of TFs by their KDDNA and KDNuc, including prior data on iPS 
reprogramming factors OCT4, SOX2, KLF4, and c-MYC (Soufi et al., 2015b), 
showed that nucleosome binding factors segregate among each other by a slight 
difference in DNA affinity, with strong reprogrammers showing a slightly higher 
DNA affinity (lower KD) compared to BRN2, KLF4, and HNF1a which are 
suggested to have supporting roles in reprogramming (Figure 3.2H) (Chanda et 
al., 2014; Raposo et al., 2015; Wapinski et al., 2013). CEBPa displayed the 
lowest nucleosome affinity of the nucleosome-binding TFs, with a 5-fold higher 
KD of 18 nM compared to the other TFs (Figure 3.2G lanes 7-12, Table 3.1).  In 
general, TF affinity for DNA was slightly higher than that for nucleosomes, 
demonstrating that the presence of histone octamer can attenuate, but not inhibit, 
DNA binding of the reprogramming pioneer TFs. 
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 The isoforms CEBPa and CEBPb target the same DNA motif and share a 
high degree of structural homology (Jakobsen et al., 2013; Nerlov, 2007). 
Posttranslational modifications within the DBD of CEBPs can negatively regulate 
DNA binding, with the few exceptions of positive DNA binding regulation by 
sequential phosphorylation of CEBPb at residues T167 and S163, corresponding 
to S184 and T188 in CEBPb LAP* isoforms (Li et al., 2007; Piwien-Pilipuk et al., 
2002; Tang et al., 2005). We generated phospho-mimic variants of CEBPb 
(T167D) and (S163D, T167D) of the LAP isoform (Figure 3.S3E). CEBPb T167D 
showed a weak increase of free DNA binding (Figure 3.2I, lanes 3,5) and no 
discernable effect on nucleosome binding (Figure 3.2I, lanes 8,10). CEBPb 
S163D, T167D showed no DNA binding or nucleosome binding enhancement 
(Figure 3.2I, lanes 3,12,8,14). Our results show that engagement of histones with 
DNA limit CEBPa/b binding to DNA and that post-translational modifications of 
CEBPb at T167 or S163, T167 may not enhance nucleosome binding. 
 
Nucleosomes Enhance Reprogramming TF Binding Specificity 
 TFs engage DNA through specific and non-specific DNA interactions 
(Biggin, 2011). To measure the contribution of sequence specificity on TF binding 
to DNA vs. nucleosomes, we carried out EMSA in the presence of increasing 
amounts of short specific and non-specific double stranded DNA (dsDNA) 
validated as competitors (Figure 3.S2C, D). An 80X molar excess of non-labeled 
short dsDNA containing specific binding sites minimally displaced free DNA-TF 
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complexes for FOXA1, ASCL1/E12a, PU1, and C/EBPa (Figure 3.S3F, lanes 
2,5), similar to competition with non-specific probes (Figure 3.S3F, lane 2,8); 
while BRN2 exhibited specific competition. Strikingly, competition experiments on 
nucleosomes, with a low 20X molar excess of specific competitor, completely 
displaced all TF-nucleosome complexes (Figure 3.3A, B lanes 2,3). By contrast, 
an 80X excess of non-specific competitor failed to displace them (Figure 3.3A, B 
lanes 2,8). Moreover, specific ASCL1/E12a binding to nucleosomes occurs 
without histone octamer dissociation, as determined by EMSA followed by 
Western blotting with antibodies for core histones H2B and H3 (Figure 3.3C). It 
appears that TFs generally engage in specific interactions with nucleosomes due 
to decreased DNA availability by presence of histone octamers, while free DNA 
is more accessible, allowing the TFs to engage in more non-specific interactions.  
 DNase footprinting reveals that ASCL1/E12a blocks cleavages on two of 
its motifs on each of the NRCAM and CX3CR1 nucleosomes (Figure 3.3D, E, 
middle panels, filled circles).  One of the ASCL1 motifs on the NRCAM 
nucleosome is in the nucleosome center and was DNase-resistant, precluding 
the ability to assess further protection by ASCL1/E12a. By contrast, the ALBN1 
nucleosome lacks an ASCL motif and ASCL1/E12a gave no evidence of 
protections (Figure 3.3F, middle panel).  PU1 exhibited protections on one of its 
two motifs on the NRCAM nucleosomes and protections on the single motifs of 
each of the CX3CR1 and ALBN1 nucleosomes (Figure 3.3D-F, lower panels, 
filled circles).  ASCL1/E12a and PU1 also show protections and enhanced 
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DNase cleavages (Figure 3.3D-F, closed and open circles) at additional sites, 
compared to the nucleosomes alone, suggesting that the TFs stabilize a 
preferred rotational frame that exposes the target motif (Shim et al., 1998) or 
induce local conformational changes in the nucleosomal DNA. The data indicate 
that ASCL1/E12a and PU1 bind their motifs in multiple nucleosome sequences 
contexts. 
 
Zygotic Genome Activator Zelda Binds Nucleosomes Like Human Pioneer 
Factors  
 We compared the ability of the Drosophila TF Zelda (ZLD) to bind 
nucleosomes like the human TFs. ZLD reprograms the zygotic genome for 
transcriptional activation during the maternal-to-zygotic transition (Foo et al., 
2014; Liang et al., 2008; Schulz et al., 2015; Sun et al., 2015) and binds in vitro 
assembled nucleosomes from the bottleneck  locus (McDaniel, 2019). 
Recombinant full-length ZLD binds a short dsDNA containing a canonical ZLD-
binding motif (CAGGTAG), but not to dsDNA with mutated motif, in agreement 
with previous studies (Figure 3.4A) (Hamm et al., 2015).  
We identified fortuitous ZLD binding motifs (CAGGCAG) in the NRCAM-
DNA sequence (Figure 3.4B).  ZLD robustly bound both NRCAM-DNA and 
NRCAM-NUC (Figure 3.4C), without histone octamer displacement (Figure 3.4E) 
with a KDNuc of 1.8 nM (Figure 3.2H), comparable to strong reprogramming TFs. 
Similar to the human reprogramming TFs we tested, EMSA competition 
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experiments identified non-specific binding of ZLD to free DNA (Figure 3.4D left 
panel). However, sequence-independent features also contributed to the binding 
of ZLD to nucleosomes, as demonstrated by the requirement for 160X unlabeled 
specific competitor to compete the ZLD-NUC complex as compared to 20X 
competitor for the previously tested human TF-nucleosome complexes (Figure 
3.4D, right panel). Thus, ZLD can directly engage nucleosomes, consistent with 
chromatin targeting seen in vivo, and supports a comparable role of nucleosome 
binding for reprogramming factors in multiple organisms.  
 
Protein Array Screen for Nucleosome Binding TFs Identified TFAP-2 and 
HMG Transcription Factors as Strong Nucleosome Binders 
 Having detailed the nucleosome binding of a subset of human-
reprogramming factors and a well-studied insect TF, we were interested in more 
generally identifying TFs with the fundamental feature of nucleosome binding. To 
date only a small subset of the estimated 2,000 TFs in the human genome has 
been tested for direct nucleosome binding (Kummerfeld and Teichmann, 2006; 
Messina et al., 2004; Vaquerizas et al., 2009). We therefore screened human 
full-length TFs, purified from yeast and printed on microarrays in duplicates, for 
binding to Cy5-labeled ALBN1, NRCAM, CX3CR1 as free DNA and nucleosomes 
(Figure 3.5A) (Hu et al., 2013).  The three different templates have a fortuitous 
occurrence of 116, 121, and 112 TF binding motifs, respectively, as determined 
by TRANSFAC database, enabling us to assess many TFs binding to these 
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natural nucleosome sequences (Table 3.S1) (Matys et al., 2006). Moreover, the 
occurrence of multiple rotational positions on the nucleosomes provide a myriad 
of accessible motifs (Figure 3.1H-J). Cy5 fluorescence of probed protein 
microarrays, incubated with Cy5-labeled ALBN1, NRCAM, CX3CR1 DNAs or 
nucleosomes, was measured and positive protein-nucleic acid signals were 
processed (Figure 3.S4A) by protein auto-fluorescence subtraction (Figure 
3.S4B), minimal protein amount per spot cutoff (Figure 3.S4C,D), background 
normalization (Figure 3.S4E), and determination of positive versus negative 
signal thresholds (Figure 3.S4F). Protein microarrays contained 1,755 nuclear 
proteins spotted, which after the cutoffs resulted in 1,592 proteins. Finally, out of 
1,755 proteins, 593 TFs showed a fluorescent intensity after probing for free DNA 
and nucleosomes that passed the positive/negative signal threshold; we 
considered these proteins to be experimentally accessible (Table 3.S2).  
The protein microarray screen provisionally identified 326 TFs that interact 
with both DNA and nucleosomes, 104 that interact with DNA-only, and 163 that 
interact with nucleosomes-only. Protein microarray screening with Cy5 NRCAM 
free DNA and nucleosomes identified TFAP2a as a possible nucleosome binding 
TF (Figure 3.5B). AP2 TFs are crucial for neuronal crest development and 
regulate the fragile X mental retardation-1 gene (Schorle et al., 1996; Zhang et 
al., 1996). Validation of TFAP2a-nucleosome interaction with an in-solution 
EMSA showed that TFAP2a binds DNA and nucleosomes comparable to 
ASCL1/E12a (Figure 3.5C).  
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To further validate interactions detected from the screen, we purified 81 
more of the proteins. Surprisingly, 57 of the proteins exhibited no free DNA or 
nucleosome binding by EMSA, including 9 transcription factors that scored as 
"nucleosome only binders" on the arrays. Twenty-four full-length human TFs 
resulted in detectable DNA binding by EMSA on one of the ALBN1, NRCAM, or 
CX3CR1 free DNA and nucleosome sequences that contained motifs for each 
respective TF located within the central domain of the nucleosomes (Figure 
3.S5). TF-nucleosome binding was tested at 3X, 6X, or 9X nM higher 
concentration of TF compared to TF-DNA concentrations (Figure 3.S6A). 
Quantification of the free DNA and nucleosome bound fraction by EMSA 
revealed that 11 of the 24 TFs bound to DNA and nucleosomes, 13 to DNA only, 
and none to nucleosomes only (Figure 3.5D, 3.S6B-E). Thus, the nucleosome-
only interactors by protein microarrays could not be confirmed in solution. 
Furthermore, the DNA only TFs, IRF3 and CREM1, lacked nucleosome binding 
in multiple nucleosome sequences contexts harboring their target motifs (Figure 
3.S6F-G).  The IRF3 DBD is a modified version of the helix-turn-helix (HTH) motif 
that includes a four-stranded antiparallel β-sheet (De Ioannes et al., 2011). Our 
results showed that lack of nucleosomes binding is not sequence context 
dependent.  
Clustering of TFs by bound fraction, quantified from EMSAs, identified TFs 
as strong DNA and nucleosome binders (cluster 1), low DNA binders (cluster 2), 
and high DNA binders with low nucleosome affinity (cluster 3) (Figure 3.5D). 
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Cluster 1 TFs with high nucleosome binding affinity also display high DNA affinity 
(Figure 3.5D). This included TFAP-2 isoforms TFAP-2β and TFAP-2γ which also 
showed strong nucleosome binding similar to reprogramming TFs, as quantified 
by EMSA (Figure 3.5D). In addition, we also observed that in solution, members 
of the high mobility group superclass HMGA1, HMGN1, HMGN5, and SOX5 
show high affinity to nucleosomes (Figure 3.S6D, lane 10, 3.S6E, lanes 8, 12, 
and 16).  Thus, we were able to identify the TFAP-2 and HMG families of TFs as 
nucleosome binding factors. 
In contrast, sorting TFs by the nucleosome bound fraction revealed a 
more heterogeneous DNA binding preference, with IRF3, T-Box factors TBX20 
and Brachyury (T), and the TALE-MEINOX TF PKNOX displaying high DNA 
binding but undetectable nucleosome binding, regardless of a higher 9X fold TF 
concentration on nucleosomes compared to DNA (Figure 3.5E, 3.S6B) and the 
presence of DNA binding motifs (Figure 3.S5). We conclude that high DNA 
affinity does not necessarily translate to nucleosome binding. Thus, nucleosome 
binding TFs are also strong DNA binders and yet nucleosome binding is not an 
obligate feature of TFs with high DNA affinity.  
 
Common Structural Features Associated with Pioneer TFs programming 
TFs  
 To identify structural commonalities among strong relative to weak 
nucleosome binders, we compared the 3D structures of the above tested 
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transcription factors’ DBDs. TFs were classified into strong nucleosome binders 
(group I) and weak nucleosome binders (group II). Group I TFs, validated in 
solution, exclusively include structural DBD superclasses characterized by a-
helical folds (Wingender et al., 2015), including basic helix-loop-helix (bHLH), 
helix-turn-helix (HTH), homeodomains (HD), and zinc fingers (ZnF) (Figure 3.6A). 
ZLD is a C2H2-ZnF TF that could fit within group I, even though its structure is not 
known. Two main types of DNA anchoring modes are observed; a scissor-like 
binding mode by dimers of bHLH TFs, and the HTH module characteristic of 
HMG TFs such as SOXs, homeodomain TFs OCT4, BRN2, and ETS TFs PU1. 
Although structurally different, we observed that strong nucleosome binders 
anchor DNA through a short recognition a-helix (Figure 3.6A). TALE-PBC class 
TFs such as PBX adopt a DNA binding arrangement with a kink in the 
recognition helix, resulting in a truncated recognition helix similar to group I short 
recognition a-helix (Figure 3.6D). This is in agreement with in vivo data 
suggesting PBX1 has pioneer activity (Berkes et al., 2004). Therefore, structural 
comparison of PBX1 with group I strong nucleosome binders predicts strong 
nucleosome binding potential.  
Group II TFs include weak nucleosome binders, which we further 
subdivided into groups IIA and IIB. Similar to group I TFs, group IIA TFs MYOG, 
CREM, and previously tested weak nucleosome binder USF1 (Adams and 
Workman, 1995) display a scissor-like arrangement, but contain an extended 
recognition a-helix that protrudes past the diameter of the DNA helix (Figure 
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3.6B). This suggest that a scissor-like recognition mode with an extended 
anchoring a-helix results in weak nucleosome binding (Soufi et al., 2015b) and 
would include bZIP TFs such as cMYC, MYOG, and CEBP.  
Group IIB weak nucleosome binders TFs Brachyury and TBX20, 
homologous to the TBX1 DBD, lack a recognition a-helix and instead use short 
helical twist or unstructured regions (Figure 3.6C). These factors are members of 
the immunoglobulin superclass characterized by a b-sheet core structure, 
hypervariable loops, and DNA recognition through unstructured regions (Bork et 
al., 1994; Wingender et al., 2015). Interestingly, group IIB TFs have been 
previously shown to engage in a multitude of cooperative interactions with 
homeodomain TFs binding partners resembling group I strong nucleosome 
binders, such as PITX2 and NKX2 (Naiche and Kelly, 2005), and thus appear 
more dependent on direct nucleosome binders for their genetic activity.   
 
3.6 Discussion 
 It has been well established that the presence of nucleosomes can impair 
DNA binding of many transcription factors and DNA repair enzymes (Schild-
Poulter et al., 1996; Taylor, 1991). We have addressed how lineage-specific TFs 
engage nucleosomes to initiate regulatory events in silent chromatin during 
development and cell programming. We previously showed that the pioneer TFs 
FOXA and OSK are able to target nucleosomes in vivo and comparably interact 
with nucleosomes in vitro (Cirillo et al., 1998; Iwafuchi-Doi et al., 2016; Soufi et 
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al., 2015b). Here we show that TFs that drive reprogramming toward hepatic, 
neuronal, macrophage lineages and the maternal-to-zygotic transition can 
directly interact with nucleosomes. Additionally, we identify TFs with previously 
unreported nucleosome binding ability. Given that nucleosome binding is the 
defining characteristic of pioneer factors, our study defines the DNA binding 
domain characteristics that endow pioneer activity.  
Using nucleosomes assembled with endogenous sequences, we show 
that ASCL1 heterodimerization with E12a markedly increases ASCL1 DNA and 
nucleosome binding affinity (Figure 3.S2E,F). E12a is ubiquitously expressed in 
fibroblasts, suggesting that, during neuronal reprogramming, ASCL1 
heterodimerizes with ubiquitously expressed fibroblast TFs to target neuron 
specific regulatory elements in nucleosome enriched chromatin. This agrees with 
previous findings, where tethering of ASCL1 to E12a results in increased 
transcriptional activity (Henke et al., 2009). Additionally, we find that BRN2 also 
directly interacts with nucleosomes (Figure 3.2F). This is in agreement with in 
vivo chromatin targeting of these factors during neuronal reprogramming where 
ASCL1 and BRN2 engage chromatin (Wapinski et al., 2013). 
PU1 is a strong nucleosome binder, while CEBPa shows a weaker 
nucleosome affinity (Figure 3.2H). During B cell reprogramming, knockdown of 
PU1 results in a decreased CEBPa binding to pre-existing and de novo 
enhancers, suggesting that in the absence of PU1, CEBPa targeting to closed 
chromatin might be driven by cooperative interactions (van Oevelen et al., 2015). 
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Comparison among reprogramming TFs show a range of DNA and nucleosome 
binding affinities that correlate with TF reprogramming potential and chromatin 
targeting strength, suggesting that the intrinsic nucleosome binding preferences 
of these TFs contributes to the hierarchy driving cellular reprogramming. 
By utilizing protein microarrays as a discovery tool, we identified the 
TFAP-2 family as a family of pioneer TFs. By contrast, TBX20 and Brachyury of 
the T-BOX family lack detectable nucleosome binding, even while possessing 
high DNA affinity to sequences containing specific motifs. Nucleosome-only 
binders, suggested by protein microarrays, could not be validated in solution, 
probably due to aberrant protein folding or unnatural domain exposure in a solid-
state environment.  We note that our nucleosome binding results with full-length 
proteins agree partially but not entirely with Zhu et. al., who mostly studied DBDs 
in a SELEX assay. Regardless, both studies find that high DNA affinity does not 
necessarily result in nucleosome binding, which presents a different model than 
where TFs would engage nucleosomal sites simply by displacing the octamer. 
 Interestingly, sequence alignment of HMGN proteins and SOX2, SOX5, 
and SOX9 revealed a high degree of conservation between the SOX group B 
homology domain, with unknown function (Weina, 2014), and the C-term of the 
HMGN nucleosome binding domain (NBD) (Figure 3.S6H). C-term truncation of 
the HMGN1 NBD greatly impairs chromatin binding (Ueda et al., 2008), 
suggesting that SOX homology group B, outside of the SOX DBD, is required for 
the nucleosome binding and chromatin targeting ability of SOX TFs. 
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Pioneer TFs contain diverse DBD structures (Figure 3.6A), suggesting 
diverse modes of DNA targeting in chromatin. For example, FOXA has been 
suggested to compete with linker histone, due to its resemblance with H1 DBD 
(Clark, 1993; Iwafuchi-Doi et al., 2016), while OCT4 has been suggested to 
initially interact with chromatin using either of its POU or homeodomain DNA 
binding modules (Soufi et al., 2015b). We find that DNA recognition via a short 
scissor-like module or a HTH module is compatible with nucleosome binding 
(Figure 3.6A). Recent studies in agreement with our findings showed  that Reb1, 
a yeast HTH factor, displays slower dissociation rates from nucleosomes, 
compared to free DNA, without histone octamer eviction (Donovan et al., 2019). 
More recently additional HTH TFs, such as Isl1, have been proposed play a 
pioneering role in cardiomyocyte reprogramming (Gao et al., 2019). 
In contrast, we predict that TFs of the immunoglobulin superclass, lacking 
an a-helix recognition helix, such as T-Box factors, would need cooperative 
interactions for nucleosome binding (Figure 3.6C). In agreement with our 
findings, the TBOX factor Tpit binding to closed target sites in vivo is restricted 
and mainly driven by the pioneer TF PAX7 (Mayran et al., 2018). Furthermore,  
TP53, an immunoglobulin fold TF, was shown to bind nucleosomes at their 
edges, at histone-free DNA (Yu and Buck, 2019). Similarly, BZLF1, a bZIP TF 
similar to group IIB, showed minimal nucleosome binding at high TF 
concentrations (Schaeffner et al., 2019). 
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Our study reveals that nucleosome binding positively correlates with 
reprogramming potential and suggests a hierarchical model where pioneer TFs 
work as trailblazers for epigenome regulators and modifiers during 
reprogramming. Furthermore, we reveal commonalities and structural length 
limitations among the DNA binding modes of pioneer TFs, compared to non-
pioneer TFs. Our study provides insight into how diverse groups of TFs engage 
in nucleosomal interactions via common structural features. Further studies of 
the domains of pioneer factors that modulate nucleosomal interactions will unveil 
how other factors are enabled to bind closed, silent chromatin and initiate cell 
fate changes. 
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3.7 Main Figures 
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Figure 3.1 | Endogenous TF-Nucleosomal Targets Assemble into Stable 
Nucleosomes In Vitro 
(A) Schematic diagram showing genomic data processing for the identification of 
TFs nucleosomal targets. 
(B-G) ChIP-seq profile for reprogramming TFs at identified nucleosomal targets 
and 3D representation of the DNA sequences used for nucleosome assembly 
containing TFs canonical motifs indicated (yellow). (B) FOXA1, GATA4 and 
HNF1a ChIP-seq (red) in liver and MNase-seq profile (green) in fibroblasts 
across the ALBN1  enhancer within the displayed genomic location. (C)  3D 
representation of the 160 bp- ALBN1-DNA. (D) ASCL1 and BRN2 ChIP-seq  
(red) at 48 hr induction in fibroblast and MNase-seq profile in fibroblasts near the 
NRCAM gene. (E) 162 bp NRCAM-DNA. (F) PU1, CEBPa, and CEBPb ChIP-seq  
in macrophages and MNase-seq profile in fibroblasts near the CX3CR1 gene. 
(G) 162 bp- CX3CR1-DNA. 
(H-J) DNase-I footprinting showing the protection of (H) ALBN1-DNA, (I) 
NRCAM-DNA, (J) CX3CR1-DNA before and after nucleosome reconstitution in 
vitro. Electropherograms generated by digesting 5’-6 FAM end-labeled free DNA 
(top panel) and nucleosomes with low DNaseI (middle panel)  and  high DNaseI 
(bottom panel). Concentrations of DNase-I indicated. Dashed lines indicate 
central histone octamer protection within nucleosomes.   
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Figure 3.2 | Reprogramming TFs bind Nucleosomes with Nanomolar 
Affinity 
(A) Recombinant purified full-length TFs analyzed by SDS-PAGE and Coomassie 
staining. The factors are grouped by reprogramming to iHEP (induced 
hepatocytes), iN (induced neurons), and iMAC (induced macrophages). 
Recombinant single purification of ASCL1, E12a, and co-purification of 
ASCL1/E12a (right panel). 
(B-G) Representative EMSA showing the affinity of increasing amounts of TFs 
(B) FOXA1, (C) PU1, (D) ASCL1/E12a,  (E) GATA4, (F) BRN2 and (G) CEBPa 
to Cy5-labelled DNA (lanes 1-6) and nucleosome (lanes 7-12). Black arrowheads 
indicate TF-DNA complexes. White arrowheads indicate TF-nucleosome 
complexes.  
 (H) 2D plot of TFs dissociation constants for DNA (x-axis) and nucleosomes (y-
axis). 
(I) Representative EMSA showing the affinity of CEBPb WT, mutants T167D and 
S163D, T167D to CX3CR1-DNA and nucleosomes.  
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Figure 3.3 | TFs Bind Nucleosomes with Specificity  
(A-B)Representative EMSA of competition assays showing the affinity of 
recombinant  (A) FOXA1, ASCL1/E12a and PU1 to ALBN1-NUC, NRCAM-NUC, 
and CX3CR1-NUC in the presence of 20-, 40- and 80-fold molar excess of 
specific competitor ( “s” lanes) or non-specific competitor (“ns” lanes) or absence 
of competitor (“-“ lanes). (B) Same as (A) for BRN2 and CEBPa.  
(C) Representative WEMSA showing the binding of ASCL1/E12a to NRCAM-
NUC. ASCL1/E12a :Nuc complex from EMSA were transferred onto a PVDF 
membrane (WEMSA) and blotted for H3, H2B, ASCL1 as indicated (the three 
panels on the right). White arrow heads indicate the observed TF-nucleosome 
complexes. 
(D-F) DNase-I footprinting electropherograms of 5’-6 FAM-labeled (D) NRCAM-
NUC, (E) CX3CR1-NUC, and (F) ALBN1-NUC in absence (top) or presence of 
ASCL1/E12a (middle) or PU1 (bottom) end-labeled free DNA (top strand). 3D 
DNA representation (red) with each TF motif (yellow)..Filled circles, protections; 
open circles, enhancements. "deg. motif" = degenerate motif for PU1. 
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Figure 3.4 | ZnF TF Zelda Bind to Nucleosomes 
(A) Representative EMSA of ZLD showing affinity to short dsDNA probes a 
containing canonical ZLD-binding motif ( “s” lanes) or mutated motif ( “ns” lanes). 
 (B) Graphical representation of ZLD motifs (yellow) identified on NRCAM-DNA 
sequence.  
(C) Representative EMSA showing the affinity of increasing amounts of 
recombinant ZLD to Cy5- NRCAM-DNA (lanes 1-5) and nucleosome (lanes 6-
10).  
(D) Quantification competed fraction of ZLD:DNA (left panel) or ZLD:nucleosome 
(right panel) complexes by addition of molar excess of specific competitor ( “s” 
lanes),  non-specific competitor (“ns” lanes) or absence of competitor (“-“ lanes). 
Molar excess listed. 
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(E) Representative WEMSA of ZLD :Nuc complex from EMSA transferred onto a 
PVDF membrane (WEMSA) and blotted for H3, H2B as indicated (the two panels 
on the right). White arrow heads indicate the observed TF-nucleosome 
complexes.  
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Figure 3.5 | Systematic Assessment of Nucleosome Binding of Human TFs 
with Protein Microarrays 
(A) Graphical scheme used to identify nucleosome interacting human TF using 
DNA and nucleosome probes binding to protein microarrays.  
(B) Cy5 fluorescence of TAP2-a on protein microarray printed spot in duplicate in 
absence (“-“)  or hybridized with NRCAM-DNA or NRCAM-NUC. 
(C) Representative EMSA comparing the affinity of ASCL1/E12a with TFAP-2a 
to NRCAM-DNA or NRCAM-NUC. Black arrow heads indicate TF-DNA 
complexes. White arrow heads indicate the TF-nucleosome complexes. 
(D-E). Heatmap representations of TFs bound fractions to DNA (left)  and 
nucleosome (right) by quantification from EMSA. (D) Clustered heatmap showing 
strong DNA and nucleosome binders (red-cluster 1), low DNA binders and 
(yellow-cluster 2), high DNA binders with low nucleosome affinity (blue-cluster 3) 
(E) Heatmap sorted on TF nucleosome bound fraction. TFs concentrations used 
on Figure 3.S6A. 
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Figure 3.6 | Strong Nucleosome Binding TFs Recognize DNA with Short 
Recognition a-Helixes 
(A)  Group I pioneer TFs DBDs crystal structures of FOXA3 (pdb 1VTN) (Clark, 
1993), OCT4 (pdb 3L1P) (Esch et al., 2013), PU1 (pdb 1PUE) (Kodandapani et 
al., 1996), KLF4 (pdb 2WBS) (Schuetz et al., 2011) and, GATA3 (pdb 4HC9) 
(Chen et al., 2012). ASCL1 (SMR P50553). 
(B) Group IIA TFs with scissor-like DBDs crystal structures and extended 
recognition a-helixes of cMYC/MAX (pdb 1NKP) (Nair and Burley, 2003), CEBPa 
(pdb 1NWQ) (Miller et al., 2003), USF (pdb 1AN4) (Ferre-D'Amare et al., 1994), 
MYOG (SMR P15173), and CREM (SMR Q03060).  
(C) Group IIB TFs with immunoglobulin-like fold DBDs crystal structures of TBX1 
(pdb 4A04) (El Omari et al., 2012), Brachyury (pdb 1XBR) (Muller and Herrmann, 
1997), NF-kB p50 subunit (pdb 1SVC) (Muller et al., 1995) and, GAL4 (pbd 
3COQ) (Hong et al., 2008). 
 (D) TALE-PBC PBX1 (pdb 1PUF) (LaRonde-LeBlanc and Wolberger, 2003) and 
UBX (pbd 4UUS) (Foos et al., 2015) crystal structures showing scissor-like 
binding in dimer form with HOX TFs showing kink in recognition a-helixes (blue 
arrow). 
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 3.8 Supplemental Figures 
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Figure 3.S1 | Reprogramming TFs Target MNase Enriched Target Sites 
Associated with cell identity Genes.  Related to Figure 3.1. 
 (A-B) Genomic data integration for ASCL1 and BRN2 nucleosomal target site 
identification. (A) Venn diagram of TFs ChIP-seq peaks association with 
upregulated/downregulated nearest genes and their nucleosome occupancy as 
determine by MNase-seq tag enrichment or depletion at 48 hr ASCL1, BRN2 and 
MYT1L ectopic expression in fibroblast. (B) Gene ontology analysis of nearest 
genes associated with TFs ChIP-seq peaks in 48 hr ASCL1, BRN2 and MYT1L 
ectopic expression in fibroblast. 
(C-D) Venn diagram of PU1, CEBPa and, CEBPb ChIP-seq peaks association 
with upregulated/downregulated nearest genes in macrophages and nucleosome 
occupancy of fibroblast determine by MNase-seq tag enrichment at expected 
target sites according to macrophage PU1, CEBPa and, CEBPb ChIP-seq 
targeting. (D) Gene ontology analysis of nearest genes associated with for PU1, 
CEBPa and, CEBPb ChIP-seq peaks in macrophages. 
(E) Schematic diagram showing 3’ end enzymatic Cy5 labeling of DNA with 
Klenow-exo 
(F) Nucleosome reconstitution of ALBN1-NUC, CX3CR1-NUC and NRCAM-NUC 
(white arrows) compared to free DNA (black arrows). 
 
  
 
 
124 
 
 
 
125 
Figure 3.S2 | Recombinant Purified Full-Length TFs Bind Their Canonical 
Motifs on Short dsDNA.  Related to Figure 3.2. 
 (A) TFs identity verification by Western blot analysis.  
(B) Cy5 detection of labeled short double stranded DNA containing canonical 
binding motifs for reprogramming TFs. Base pair length of each DNA shown at 
the bottom. 
(C-D) TFs binding curves showing the affinity of E. coli. expressed full-length TFs 
to Cy5 labelled DNA probes containing or lacking TFs respective canonical 
binding sites, (C) specific DNA and (D) non-specific respectively. TFs were 
titrated at 0, 0.1, 0.3, 1, 3 and 9 nM concentrations with 1 nM DNA. DNA 
sequences of the Cy5-labelled probes are in the star methods and equations for 
total and specific dissociation constants ( KdTotal , KdSpecific are described in (Soufi 
et al., 2015b). 
(E) Representative EMSA showing the affinity of increasing amounts of purified 
ASCL1, ASCL1/E12a and, E12a homodimers proteins to Cy5- MCK-DNA 
containing an ASCL1 E-box binding motif. 
(F) Binding curves or ASCL1, ASCL1/E12a and, E12a to Cy5-MCK DNA based 
on (E). 
(G) ASCL1 STRING functional association network of protein-protein 
interactions. 
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Figure 3.S3 | Recombinant Purified Full-Length TFs Bind with Specificity to 
DNA and Nucleosomes.  Related to Figures 3.2 and 3.3. 
(A-D) TFs binding curves related to EMSAs fraction bound quantification of 
Figures 3.2B-G showing the affinity of TFs to Cy5-160bp-DNA (left panels) or 
Cy5-160bp-NUC (right panels). TFs were titrated on 1 nM DNA or NUC. 
(E) Recombinant purified full-length CEBPb WT and, CEBPb-T163, CEBPb-
S163D, T167D phosphomimetic mutants analyzed by SDS-PAGE and 
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coomassie staining. The TFs bands run at the expected sizes when compared to 
the sizes of protein standards. All proteins in the same gel.  
(F) FOXA1, ASCL1/E12a, PU1, BRN2, CEBPa binding to ALBN1-DNA, NRCAM-
DNA and CX3CR1-DNA in the presence of 20-, 40- and 80-fold molar excess of 
specific competitor ( “s” lanes) or non-specific competitor (“ns” lanes) or absence 
of competitor (“-” lanes).  
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Figure 3.S4 | Pipeline for Protein Microarray Data Processing.  Related to 
Figure 3.5. 
(A) Schematic diagram showing protein microarray data processing for the 
identification novel nucleosome binding TFs. 
(B) Representative protein microarray chip showing printed proteins auto-
fluorescence on chip edge. 
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(C) Representative protein microarray zoom showing relative printed protein 
amounts per spots differences by fluorescence detection with primary anti-GST-
Tag antibody and Cy5-conjugated secondary antibody. 
 (D) Removal of proteins with low concentration per spot to yield positive signal. 
Scatter plot showing protein amounts of all protein spots in all experiments (left 
panel), and scatter plot showing proteins removed from the analysis due to low 
estimated concentration (right panel). 
(E) Representative protein microarrays probed with Cy5 labeled ALBN1, NRCAM 
and CX3CR1 DNA or NUC showing the difference in background intensity.  
(F) Examples of spots duplicates showing the range of fluorescence intensities 
(shown above each spot) detected when probed with Cy5 labeled ALBN1, 
NRCAM and CX3CR1 DNA or NUC. Threshold for a positive hit (binding) and 
negative hit (not binding) was determined to be F-B of 80 (black arrow). 
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Figure 3.S5 | 3D Representation of DNA Sequences Showing Positioning of 
TFs Binding Motifs of Tested Factors.  Related to Figure 3.5. 
For each TF tested by EMSA (see Figure 3.5D) the DNA and nucleosome 
sequence which the TF was tested for bindings is shown, consensus motif for the 
factor, motif sequence within the tested DNA sequence, strand location of the 
motif, and 3D representation of tested sequences showing TF motif (yellow) 
localization within the sequence are shown. 
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Figure 3.S6 | HMG TFs Interact with Nucleosomes.  Related to Figures 3.5 
and 3.6. 
(A) Heatmap representation of TFs DNA bound fraction showing tested TFs (nM) 
concentration on DNA and nucleosomes. Concentrations were determined 
experimentally.  
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(B-E) Representative EMSA of identified microarray hits for nucleosome 
interaction with (B) NRCAM-DNA, (C,E) CX3CR1-DNA and, (C) ALBN1-DNA 
(black arrows) or nucleosome (white arrows). (E) Representative EMSA showing 
DNA and nucleosome binding of HMG TFs. 
(F-G) EMSA of DNA only binders (F) IRF3 (G) CREM1 to ALBN1 and CX3CR1 
DNA and nucleosomes containing TFs binding motifs.  
(H) Sequence alignment of SOX2, SOX5, SOX9 with HMGN1, HMGN2, HMGN5 
TFs showing high conservation between SOX group B homology domain and 
HMGN C-term nucleosome binding domain. 
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3.9 Tables 
Apparent KD 
(nM) FOXA1 GATA4 HNF1A ASCL1/E12a E12a BRN2 PU1 CEBPa ZLD 
Total canonical 1.3 2.4 2.7 3.1 ND 1.2 4.5 ND - 
Specific 
canonical 0.9 2.1 2.5 3.0 31.4 4.9 3.0 7.5 - 
Total DNA 0.3 0.5 1.1 0.7 - 0.7 0.6 4.6 0.4 
Specific DNA 0.4 0.5 1.7 0.9 - 2.3 0.7 5.3 0.6 
Total nuc 2.5 1.6 3.5 1.6 - 1.4 4.9 13 1.3 
Specific nuc 3.0 3.8 4.7 2.6 - 2.0 5.6 18 1.8 
Table 3.1 | Recombinant TF Dissociation Constants 
Apparent dissociation constants (KD) were derived from quantified EMSA bands 
to represent the relative affinities of TFs to their canonical sites or respective free 
DNA and nucleosomes (nuc). Apparent KDs were derived from two separate 
binding curves, each representing two experimental replicates, and fitted to the 
experimental data within R2 values of 0.8-0.99, expressed in nM units. Apparent 
KDs were quantified from the fractional decrement of free DNA or nuc, designated 
as “total” binding, or from the first bound-DNA/nuc complexes, representing 
“specific” binding. ND, not determined. “-“ not measured (Figure 3.S2C, 3.S3A-
D). 
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3.10 Supplemental Tables  
Table 3.S1 | Fortuitous Motif Occurrence in DNA Sequences by Motif Scan.  
Related to Figure 3.5.  (see accompanying online spreadsheet) 
Each of the ALBN1-DNA, NRCAM-DNA and CX3CR1-DNA sequences were 
scanned with PROMO (Messeguer et al., 2002) for identification of putative TFs 
binding sites (TFBS) defined by TRANSFAC databased and used as weight 
matrices for TFBS prediction. 
 
Table 3.S2 | Protein Microarray Data.  Related to Figure 3.5.  (see 
accompanying online spreadsheet) 
Unprocessed and processed protein microarray data containing the 1,755 
proteins name, identifier lists and their respective (F-B)+Cy5 signals for in each 
experiment, 1,592 proteins after data processing and 593 positive hits TFs in at 
least one experiment.  
 
Table 3.S3 | Short DNA oligonucleotides containing TFs binding sites used 
as unlabeled competitors. Related to Figure 3.3 (see accompanying online 
spreadsheet) 
Oligonucleotide DNA sequences used as dsDNA containing TFs binding sites in 
EMSA competition experiments as specific or non-specific competitors. 
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3.11 Key Resources  
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
anti-mouse ASCL1 Abcam ab74065 
anti-human H2B Abcam ab1790 
anti-human H3 Abcam ab1791 
Cy5-dCTP GE Healthcare Life 
Sciences 
PA55021 
 
Klenow Fragment (3ÅL→5ÅL exo-) New England Biolabs M0212S 
Bacterial and Virus Strains  
6HIS_pRSF_TEV Gifft from Ronen 
Marmorstein lab 
6HIS_pRSF_TEV 
FUW-TetO-Gata4 Buganim et al., 2012 Addgene 41084 
pCMW-SPORT6-Hnf1 Dharmacon mammalian 
gene collection 
 MMM1013-202761012 
Tet-O-FUW-Ascl1 Vierbuchen et al., 2010 Addgene 27150 
pBABE-E12-cTAP Yang et al., 2009 Addgene 20916 
pET-28b-FoxA1 Zaret Lab pET-28b-FoxA1 
pET-28b-Gata4 Zaret Lab pET-28b-Gata4 
pET-28b-Hnf1a Zaret Lab pET-28b-Hnf1a 
pET-28b-Ascl1 Zaret Lab pET-28b-Ascl1 
pET-28b-Tcf3 Zaret Lab pET-28b-Tcf3 
pRSFDUET1-Ascl1+Tcf3 Zaret Lab pRSFDUET1-Ascl1+Tcf3 
pET-28d-Brn2 Gift from Marius Wernig pET-28d-Brn2 
pET-28b-Spi1 Zaret Lab pET-28b-Spi1 
pET-28b-Cebpa Zaret Lab pET-28b-Cebpa 
pET-28b-Cebpb Zaret Lab pET-28b-Cebpb 
pET-28b-Cebpb-T167D Zaret Lab pET-28b-Cebpb-T167D 
pET-28b-Cebpb- S163D,T167D Zaret Lab pET-28b-Cebpb- 
S163D,T167D 
Chemicals, Peptides, and Recombinant Proteins 
His6x-FOXA1 Zaret Lab His6x-FOXA1 
His6x-GATA4 Zaret Lab His6x-GATA4 
His6x-HNF1a Zaret Lab His6x-HNF1a 
His6x-ASCL1 Zaret Lab His6x-ASCL1 
His6x-E12a Zaret Lab His6x-E12a 
His6x-ASCL1/E12a Zaret Lab His6x-ASCL1/E12a, 
GST-His6x-BRN2 Zaret Lab GST-His6x-BRN2 
His6x-PU1 Zaret Lab His6x-PU1 
His6x-CEBPa Zaret Lab His6x-CEBPa 
His6x-CEBPb WT Zaret Lab His6x-CEBPb WT 
His6x-CEBPb T167D Zaret Lab His6x-CEBPb T167D 
His6x-CEBPb S163D,T167D Zaret Lab His6x-CEBPb 
S163D,T167D 
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GST-MYOG Hu et al., 2013 GST-MYOG 
GST-TBX20 Hu et al., 2013 GST-TBX20 
GST-NHLH2 Hu et al., 2013 GST-NHLH2 
GST-CREM1 Hu et al., 2013 GST-CREM1 
GST-IRF3 Hu et al., 2013 GST-IRF3 
GST-RBPJ Hu et al., 2013 GST-RBPJ 
GST-HMGN1 Hu et al., 2013 GST-HMGN1 
GST-HMGN5 Hu et al., 2013 GST-HMGN5 
GST-HMGA1 Hu et al., 2013 GST-HMGA1 
GST-SOX5 Hu et al., 2013 GST-SOX5 
Critical Commercial Assays 
MinElute PCR purification kit QIAGEN 28004 
Quick change II XL Site-Directed mutagenesis 
Kit 
Agilent 200521 
Deposited Data 
ASCL1 and BRN2 ChIP-seq Vierbuchen et al., 2013 GEO GSE43916 
PU1, CEBPa and CEBPb ChIP-seq Heinz et al., 2010 GSE21512 
FOXA1 and HNF1a ChIP-seq Faure et al., 2012 E-MTAB-941 
GATA4 ChIP-seq Zheng et al., 2013 GSE49132 
Fibroblast MNase-seq  Teif et al., 2012 GSE40910 
FOXA3-DBD:DNA co-crystal structure Clark et al., 1993 RCSB PDB 1VTN 
OCT4-DBD:DNA co-crystal structure Esch et al., 2013 RCSB PDB 3L1P 
PU1-DBD:DNA co-crystal structure Kodandapani et al., 1996 RCSB PDB 1PUE 
KLF4-DBD:DNA co-crystal structure Schuetz et al., 2011 RCSB PDB 2WBS 
GATA3-DBD:DNA co-crystal structure Chen et al., 2012 RCSB PDB 4HC9 
ASCL1 SWISS-MODEL SMR P50553 
cMYC/MAX-DBD:DNA co-crystal structure Nair and Burley, 2003 RCSB PDB 1NKP 
CEBPa-DBD:DNA co-crystal structure Miller et al., 2003 RCSB PDB 1NWQ 
USF-DBD:DNA co-crystal structure Ferre-D'Amare et al., 
1994 
RCSB PDB 1AN4 
MYOG SWISS-MODEL SMR P15173 
CREM SWISS-MODEL SMR Q03060 
TBX1-DBD:DNA co-crystal structure El Omari et al., 2012 RCSB PDB 4A04 
Brachyury-DBD:DNA co-crystal structure Muller and Herrmann, 
1997 
RCSB PDB 1XBR 
NF-kB p50-DBD:DNA co-crystal structure Muller et al., 1995 RCSB PDB 1SVC 
GAL4-DBD:DNA co-crystal structure Hong et al., 2008 RCSB PDB 3COQ 
PBX1-DBD:DNA co-crystal structure LaRonde-LeBlanc and 
Wolberger, 2003 
RCSB PDB 1PUF 
UBX-DBD:DNA co-crystal structure Foos et al., 2015 RCSB PDB 4UUS 
Raw gel images Mendeley  https://doi.org/10.17632/5
dnznn9kwt.1 
Experimental Models: Cell Lines 
Rosetta (DE3)pLysS Competent Cells Novagen Novagen # 70956-3 
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Experimental Models: Organisms/Strains 
   
Oligonucleotides 
Table S3   
Recombinant DNA 
GATCCTGTCTCCTGCTCTGTCAGCAGGGCA
CTGTACTTGCTGATACCAGGGAATGTTTGTT
CTTAAATACCATCATTCCGGACGTGTTTGCC
TTGGCCAGTTTTCCATGTACATGCAGAAAGA
AGTTTGGACTGATCAATACAGTCCTCTGCCT
TGGATC 
 
Zaret Lab 160 bp ALBN1-DNA 
GATCCATTACTTCTGAAACAGATGACTCCCA
GCAGCTGCTGCCTGTGGCCCACAGGGCTTC
CTGCCCTGCATGACAGCTGCACATCACATC
CTGTGGTCATACTACTTCAGCCGCTTCTACG
GCCAGATACAAAAGTGGGTGGGGAACATAG
GCAAGGGATC 
 
Zaret Lab 162 bp NRCAM-DNA 
GATCCGCAGGGCCTCTCGGCTGCTGATCTT
CAGCTGGTTGCTGAGAGTTGCAGCATTGCT
GAGTCTTAGCAATGGATACTTCCCGATTCCC
CTCACAAAAATAGGTCAGTCTGTCTGGCTAG
TTCTGTACTTGCAGACACAGGGCATGTGGG
GTTCCGGATC 
 
Zaret Lab 162 bp CX3CR1-DNA 
Software and Algorithms 
Gene Mapper v4.1  Thermo Fisher Cat no. 4440915 
Peak Scanner module Thermo Fisher Scientific 
Cloud 
https://www.thermofisher.
com/us/en/home/life-
science/sequencing/frag
ment-analysis/fragment-
analysis-
fundamentals/fragment-
analysis-software-data-
analysis.html 
Pymol Schrodinger https://pymol.org/2/ 
PRISM 7 GraphPad https://www.graphpad.co
m/scientific-
software/prism/ 
PROMO Messeguer et al., 2002 http://alggen.lsi.upc.es/cgi
-
bin/promo_v3/promo/pro
moinit.cgi?dirDB=TF_8.3 
GenePix Pro 7 Molecular Devices, LLC. http://mdc.custhelp.com/a
pp/products/detail/p/129/~
/version-7 
R studio  https://www.rstudio.com/  
Fiji is Just ImageJ (Fiji) version 2.0.0-rc/1.51f  https://imagej.net/ 
SWISS-MODEL Bienert et al., 2017 https://swissmodel.expas
y.org/ 
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Other 
Human TF Protein microarrays Hu et al., 2013 Human TF Protein 
microarrays 
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3.11 Materials and Methods 
 
Experimental model and subject details 
 
 Escherichia coli bacterial strain Rosetta (DE3)pLysS Competent Cells 
were used for recombinant protein expression.  
 
Genomic Data Analysis 
 
 The ASCL1 and BRN2 ChIP-seq were obtained from GEO GSE43916 
(Vierbuchen et al., 2013); PU1, CEBPa and CEBPb from GSE21512 (Heinz et 
al., 2010); FOXA1 and HNF1a from  E-MTAB-941 (Faure et al., 2012); and 
GATA4 from GSE49132 (Zheng et al., 2013). ChIP-seq and MNase-seq data 
GSE40910 (Teif et al., 2012) were aligned to build version NCBI37/mm9 of the 
mouse genome. The MNase-seq reads were extended to 150 bp to cover one 
nucleosome.  
 
Protein Expression and Purification 
 
 The bacterial expression plasmids: pET-28b-FoxA1, pET-28b-Gata4, pET-
28b-Hnf1a, pET-28b-Hnf4a, pET-28b-Ascl1, pET-28b-Tcf3, pRSFDUET1-
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Ascl1+Tcf3, pET-28d-Brn2, pET-28b-Spi1, pET-28b-Cebpa, pET-28b-Cebpb 
encode the mouse FOXA1, GATA4, HNF1a, HNF4a, ASCL1, E12a, 
ASCL1+E12a, BRN2, PU1, CEBPa, and CEBPb proteins respectively, fused to 
an N-terminal 6X histidine tag.  BRN2 was expressed fused to a N-terminal 6X 
histidine tag followed by a GST-tag. pRSFDUET1 contained 6X his tagged Ascl1 
in MCS1 between restriction sites BamH1 and HindIII and untagged E12a (tcf3 
gene) in MCS2 between restriction sites NdeI and XhoI. Plasmid containing TFs 
cDNA were obtained as follow; FUW-TetO-Gata4 (Addgene plasmid #41084) 
(Buganim et al., 2012b), pCMW-SPORT6-Hnf1a from Dharmacon mammalian 
gene collection (MMM1013-202761012), pGCDNsam-Hnf4a (Addgene plasmid # 
33002) (Sekiya and Suzuki, 2011), Tet-O-FUW-Ascl1 (Addgene plasmid # 
27150) (Vierbuchen et al., 2010), pBABE-E12-cTAP (Addgene plasmid # 
20916)(Yang et al., 2009), pET28d-mBrn2 was a gift from Marius Wernig,  LZRS 
PU.1 WT (Addgene plasmid #34835) (Anderson et al., 2002), CEBPalpha NGFR 
(Addgene plasmid #44627) (Del Real and Rothenberg, 2013), pcDNA 3.1 (-
)mouse C/EBP beta (LAP) was a gift from Peter Johnson (Addgene  plasmid # 
12557). TF cDNA sequences were generated by PCR from the respective 
constructs, introducing restriction sites; NdeI and HindII for FoxA1, Hnf1a, Hnf4a; 
NdeI and XhoI for Gata4, Spi1, Cebpa, Cebpb, Ascl1; XbaI and XhoI for Brn2 for 
insertion into their respective plasmid. pET-28b-Cebpb-T167D and pET-28b-
Cebpb-S163D,T167D plasmids were generated from pET-28b-Cebpb plasmid 
with Quick change II XL Site-Directed mutagenesis Kit (Agilent). 
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The histidine-tagged proteins were expressed in E. Coli Rosetta (DE3) 
pLysS (Novagen # 70956-3). Transformed cells were grown at 37 °C to a density 
of 0.5-0.7 at an absorbance of 600 nm and protein expression was induced with; 
1  mM IPTG at 37 °C for 4 hr with a 30 min delay addition of 20 mg/mL rifampicin 
for FOXA1; 1 mM IPTG at 16 °C for 16 hr for ASCL1, BRN2 and PU1; 1 mM 
IPTG at 37 °C for 4 hr for  HNF1a, HNF4a, CEBPb;  2 mM IPTG at 37 °C for 4 hr 
GATA4 and CEBPa. ZLD was purified as previously described (Harrison et al., 
2010; McDaniel, 2019) 
The proteins were purified over Hi-trap HP nickel-charged columns (GE 
healthcare #17-5248-01) or with Ni-NTA resin under denaturing conditions (20 
mM Tris-HCl pH 8.0, 0.5M NaCl, 6M Urea) with 5 mM imidazole and 20-300 mM 
single step imidazole changes follow by 4M and 2M urea step dialysis. The 
recombinant human full length histones H2A, H2B, H3, and H4 were expressed 
and purified as described previously (Tanaka et al., 2004). Histone expression 
plasmids were a gift from Shelley Berger. Protein concentrations were calculated 
by quantifying the intensity of each of the protein bands running at the expected 
sizes in SDS-PAGE fitted to a BSA standard curve. To reduce error, the band 
intensities were quantified at various concentrations. 
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Cy5 DNA Labeling of Short Canonical-DNA Binding Sites 
 
  The DNA oligonucleotides used as binding sites are shown in Table S3. 
The expected binding sites are highlighted in red. The short oligonucleotide 
fragments were labeled with Cy5-dCTP (GE Healthcare Life Sciences) by end-
repair with Klenow fragment DNA polymeraase (3ÅL→5ÅL exo-) (NEB) as 
follows. Cy5 5’-end-labelled double stranded probes were generated by 
annealing complementary single strand DNA probes to give rise to a two 
nucleotide 3’ overhang (with the last annealed nucleotide being a G) using the 
following reaction: 1 nanomoles of each ssDNA strand (10 μl of 100 μM) were 
mixed in 50 μl final volume annealing buffer (20 mM Tris-HCl pH7.5, 50 mM 
NaCl, 0.1 mM DTT, 1 mM EDTA). The reaction was incubated at 70 ºC for 10 
min, and slowly cooled at room temperature overnight. Cy5-DNA labeling 
reactions were carried out at final concentrations of 1.26 μM dsDNA, 4 μM Cy5-
dCTP and 0.5 U/uL Klenow fragment in the presence of excess 4 mM dATP, 4 
mM dTTP, and 4 mM dGTP in NEB buffer 2 (50 mM NaCl, 10 mM Tris-HCl, 10 
mM MgCl2, 1 mM DTT). The reaction was incubated at 37 oC for 1 hr.  After Cy5 
labeling, the probe was purified using Illustra MicroSpin G-25 columns (GE 
Healthcare Life Sciences). 
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Nucleosome Preparation 
 
 The 160 bp ALBN1-DNA fragment containing BamH1 flanking sequences 
corresponds to the genomic location: mm9 chr5:90879148-90879300  
GATCCTGTCTCCTGCTCTGTCAGCAGGGCACTGTACTTGCTGATACCAGGGAATGTTTG
TTCTTAAATACCATCATTCCGGACGTGTTTGCCTTGGCCAGTTTTCCATGTACATGCAG
AAAGAAGTTTGGACTGATCAATACAGTCCTCTGCCTTGGATC 
 
The 162 bp NRCAM-DNA fragment containing BamH1 flanking sequences 
corresponds to the genomic location: mm9 chr12:45445284-45445450 
GATCCATTACTTCTGAAACAGATGACTCCCAGCAGCTGCTGCCTGTGGCCCACAGGGCT
TCCTGCCCTGCATGACAGCTGCACATCACATCCTGTGGTCATACTACTTCAGCCGCTTC
TACGGCCAGATACAAAAGTGGGTGGGGAACATAGGCAAGGGATC 
 
The 162 bp CX3CR1-DNA containing BamH1 flanking sequences fragment 
corresponds to the genomic location: mm9 chr9:119946611-119946762 
GATCCGCAGGGCCTCTCGGCTGCTGATCTTCAGCTGGTTGCTGAGAGTTGCAGCATTGC
TGAGTCTTAGCAATGGATACTTCCCGATTCCCCTCACAAAAATAGGTCAGTCTGTCTGG
CTAGTTCTGTACTTGCAGACACAGGGCATGTGGGGTTCCGGATC 
 
The DNA sequences were created by PCR of genomic mouse DNA with 
EcoRI-BamHI and BamH1-XbaI restriction sites into pUC19 plasmid to generate 
pUC19-EB-NRCAM-BX, pUC19-EB-ALBN1-BX, and pUC19-EB-CX3CR1-BX. 
Plasmid were amplified in E.coli, purified, and digested with BamHI to release 
fragments. DNA sequences were purified by agarose gel electroelution, 
phenol:chloroform extraction, and ethanol precipitation followed by Cy5 
enzymatic labeling as described above and purified with QIAquick PCR 
purification kit (Qiagen 28106) 
 
 
145 
The nucleosomes were reconstituted by dialysis as described previously 
(Tanaka et al., 2004). Briefly, 10 μg of Cy5 end labelled DNA sequences were 
mixed with purified and refolded H2A/H2B dimers and H3/H4 tetramers at a 1:1 
DNA:histone-octamer molar ratio in 10 mM Tris-HCl pH 8.0, 4 M Urea, 2 M NaCl, 
0.1 mg/ml BSA. The nucleosomes were assembled by salt-urea step dialysis 
against buffers containing 1.5, 1, 0.8, and then 0.6 M NaCl with 10 mM Tris–HCl 
pH 8.0, 5 M Urea, 1 mM EDTA, 10 mM 2-b mercaptoethanol for 2-4 hr at 4 °C. 
The nucleosomes were then dialyzed against a no urea buffer containing 0.6 M 
NaCl and 10 mM Tris–HCl pH 8.0, 1 mM EDTA, 1 mM 2-b mercaptoethanol and 
then the same buffer containing 0.1 M NaCl for 6 hrs at 4 °C. The reconstituted 
nucleosomes were then heat shifted by incubating at 42 °C for 2 hr, and further 
purified with a 10-30% glycerol gradient in 50 mM Tris pH 7.5, 1 mM EDTA and 
0.03 mg/mL BSA at 35,000 rpm for 18 hr at 4 °C. Gradients were fractionated 
and nucleosome-containing factions were pooled and concentrated.  
 
DNA and Nucleosome Binding Reactions 
 
 The end-labelled oligonucleotides containing specific or non-specific sites 
(see above for sequences), free DNA sequence and nucleosomes were 
incubated with recombinant proteins in DNA-binding buffer (10 mM Tris-HCl 
pH7.5, 1 mM MgCl2, 10 μM ZnCl2, 1 mM DTT, 50 mM KCl, 3 mg/ml BSA, 5% 
Glycerol) at room temperature for 30 min. Free and bound DNA were separated 
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on 4% non-denaturing polyacrylamide gels run in 0.5X Tris–borate–EDTA. Gels 
were visualized using with an Amersham Typhoon RGB Biomolecular Imager 
using Cy5 fluorescence setting (excitation at 633 nm and emission filter 670 BP 
30) and a high sensitivity setting. The apparent dissociation constant (Kd) were 
calculated as previously described (Soufi et al., 2015b). For competition assays 
excessive amounts (from 20 to 80 fold) of non-labelled probes containing specific 
and non-specific sites were added to the binding reaction and incubated for an 
additional 30 min at room temperature to reach equilibrium. The binding 
reactions were loaded on the 4% EMSA gels as described above. EMSA gels 
were run at 90 volts at room temperature.  
 
Western Blotting After EMSA (WEMSA) 
 
  EMSAs were carried out as described above with 10-fold more protein 
and nucleosomes run on a 1.5 mm thick mini-gel cassette (life technologies # 
NC2015) containing 5% non-denaturing polyacrylamide gels run in 0.5X Tris–
borate–EDTA. To avoid Cy5 fluorescence saturation, 90% of the nucleosomes 
used in binding reactions was not labelled. The gel was then visualized using 
Cy5 fluorescence as described above. Western blot was done as described 
previously (Soufi et al., 2015b). Primary antibody incubations with anti-mouse 
ASCL1 antibody (1:1000; Abcam # ab74065), anti-human H3 (0.5 μg/ml; abcam 
# ab1791), and anti-human H2B (0.8 μg/ml; abcam # ab1790) were performed 
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for 2 hr at room temperature. The secondary antibody incubations with goat anti-
rabbit IgG-HRP (1:5000 dilution; Santa Cruz # sc-2004) and donkey anti- goat 
IgGHRP (1:2000; Santa Cruz # sc-2020) were performed for 1 hr at room 
temperature. Blots were visualized by using SuperSignal West Pico 
chemiluminescent substrate (Thermo-Scientific # 34080) in Fujifilm LAS-4000 
imaging system. The membranes were stripped by incubating with Restore 
Western-Blot Plus Stripping Buffer (Thermo- Scientifc # 46430) for 30 min at RT 
and re-blocked after blotting with each antibody. The same membrane was 
serially blotted and stripped with all antibodies shown. 
 
DNase Footprinting on Free DNA and Nucleosomes 
 
 DNase footprinting reactions were carried out as previously described 
(Soufi et al., 2015b). In brief, 6-FAM end labeled free DNA or nucleosomes (50 
ng) were incubated in the presence or absence or the purified ASCL1/E12a (60 
nM) and PU1 (100 nM)  for 45 min at room temperature in a total volume of 50 μl 
in DNA-binding buffer (10 mM Tris-HCl pH 7.5, 1 mM MgCl2, 10 μM ZnCl2, 1 mM 
DTT, 50 mM KCl, 3 mg/ml BSA, 5% glycerol). The binding reactions were then 
supplemented with an additional 50 μl of 10 mM MgCl2 and 5 mM CaCl2 at room 
temperature for 1 min (total 100 μl). Binding reactions were treated with DNase-I 
(Worthington) by addition of 3 μl of DNase-I yielding a final concentration of 9x10-
5 U/ μl for free DNA or 1.8x10-3 U/ μl  for nucleosomes  for 1 min at room 
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temperature. The reactions were stopped by adding 90 μl of 200 mM NaCl, 30 
mM EDTA,1%SDS buffer immediately followed by phenol extraction. One tenth 
of reaction volume (20 μl) of 3 M NaOAc (pH 5.2) was added to the reaction 
before the DNA fragments were extracted with saturated phenol. The DNA 
fragments were further purified using MinElute PCR purification kit (QIAGEN) 
and eluted in 10 μl of EB buffer. The digested DNA fragments were separated by 
capillary electrophoresis. Briefly, the DNA fragments (5 μl) were added to 4.9 ml 
HiDi formamide (Applied Biosciences) and 0.1 ml GeneScan-500 LIZ size 
standards (Applied Biosciences). After denaturing at 95 oC for 10 min, the 
samples were run on an ABI 96-capillary 3730XL Sequencer, using G5 dye 
setting, running a genotyping module with an increased injection time of 30 s and 
injection voltage of 3 kV. The generated electropherograms were analyzed using 
the Gene mapper V4.1 (Applied Biosciences) and Peak Scanner module 
(Thermo Fisher Scientific Cloud). 
 
Protein Microarrays 
 
 Full length human proteins were purified as GST fusion proteins from 
yeast using a high-throughput protein purification protocol as described 
previously (Zhu et al., 2001). Purified human proteins predicted to bind DNA 
were arrayed in a 384-well format and printed on FAST slides (Whatman, 
Germany) in duplicate, as described previously (Hu et al., 2009). To estimate 
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protein amount printed per spot, prepared chips were incubated with anti-GST 
antibody conjugated with Cy5 binding targeting the printed proteins GST-tags. 
The protein microarrays were probed without (- control) or with Cy5-labeled 
ALBN1, NRCAM, CX3CR1 DNA or NUC using a similar protocol described 
previously (Hu et al., 2009). In brief, a protein chip was blocked for 3 hr at 4 oC 
with 3% BSA in 25 mM HEPES pH 8.0, 50 mM KGlu, 8 mM MgCl2, 3 mM DTT, 
10% glycerol, 0.1% triton x-100 buffer and then incubated with Cy5-labeled 
ALBN1, NRCAM, CX3CR1 DNA or NUC at a final concentration of 20 nM in 80 
μL of binding buffer (10 mM Tris-HCl pH 8.0, 1 mM MgCl2, 10 μM ZnCl2, 1 mM 
DTT, 50 mM KCl, 3 mg/ml BSA, 5% Glycerol) overnight at 4 oC. The chip was 
washed once with TBST (0.1% triton x-100) for 5 min at 4 oC, rinsed with water 
and spun dry. The slides were finally scanned with a GenePix 4000B scanner 
(Molecular Devices, Sunnyvale, CA) and the binding signals were acquired by 
aligning an array list over the chip, foreground and background signals for each 
protein spot were then extracted by the using the GenePix Pro 7 software, and 
fluorescence minus background (F-B) signals were obtained for each spots.  
  
3D Structural Model Assemblies 
 
 MYOG, CREM, and ASCL1/E12a structural models (SMR P15173, SMR 
Q03060, SMR P50553) were constructed based on SWISS-MODEL sequence 
alignment (Bienert et al., 2017) with MYOD (pdb 1MDY) showing 74.2% DBD 
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sequence identity, CREB1 (pdb 1DH3) showing 76.3% DBD sequence identity 
with CREM1, and NEUROD1 of the NEUROD1/E12a (pdb 2QL2) showing 
42.86% DBD sequence identity with ASCL1. Structural models assemblies were 
aligned to published crystal structures of MYOD, CREB1, and NEUROD1/ E12a  
using Pymol.  
 
EMSA Processing 
 
 For image processing, we used ImageJ version 2.0.0-rc/1.51f.  Before 
displaying, the images were corrected for brightness and contrast; a linear range 
was maintained. 
 
Dissociation Constant Analysis 
 
 Apparent KDs were derived from two separate binding curves, each 
representing two experimental replicates as described by (Soufi et al., 2015b).  
Experimental data was fitted to non-linear regressions “One site – Specific 
binding”, “One site – Total” or Specific binding with Hill slope” with a Bmax less 
than 1 constrain within R2 values of 0.8-0.99, expressed in nM units using 
GraphPad Prism 7 software.  
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Protein Microarray Analysis 
 
 
 To quantify the signal intensity for each spot, the signal intensities were 
calculated as the fluorescent median intensity minus its local background median 
intensity (F-B) followed by averaging of printed duplicate spots F-B (Table 
S2)(Hu et al., 2009). F-B signals were further processed to minimize artifacts 
(Figure 3.S4A). Auto-fluorescent edging (Figure 3.S4B) was corrected by 
subtraction of the F-B signal of microarrays incubated with binding buffer (F-B)-ctrl  
from the F-B signal of microarrays incubated with Cy5-labeled samples (F-B)+Cy5. 
Heterogeneity in printed protein amounts per spot (Figure 3.S4C) was 
considered by estimating relative protein levels per spot amount using chips 
incubated with anti-GST antibody conjugated to Cy5 (F-B)GST, a  (F-B)GST < 170 
signal cutoff was assigned (Figure 3.S4D). The cutoff removed proteins spots 
with below threshold levels amounts to yield significant binding events from our 
analysis.  To eliminate artifacts resulting from uneven washing and drying of the 
chips after incubation with Cy5 probes (Figure 3.S4E), we performed a within-
chip normalization by the median normalization method. Known chromatin 
modifiers were removed from our analysis.  Finally, to identify proteins that bind 
to DNA or nucleosomes, an intensity cutoff value of  (F-B)+Cy5 equal to 80 was 
assigned (Figure 3.S4F), where spots producing a signal greater than the cuttoff 
were identified as “positive hits”. 
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Heatmap Representation of DNA and Nucleosome Binding by Transcription 
Factors 
 
 Heatmaps in Figure 3.5D, E were generated by first quantifying the TFs 
total bound fraction from EMSAs as described in the methods section “DNA and 
Nucleosome Binding Reactions” and in (Soufi et al., 2015a). Total bound fraction 
for each TF was measured for their respective free DNA and nucleosome 
template shown in Figure 3.S5, at the concentrations shown in Figure 3.S6A.  K-
means clustering of the TF total bound fraction for free DNA and nucleosomes 
was done with R studio software and the pheatmap package. We defined a K 
means clustering function with an optimal number of 6 cluster centers (k); no Z 
score normalization was applied to the data. Cluster number was further 
simplified by manually regrouping of highly similar clusters resulting in three 
clusters.  
Data and Software Availability 
 
 All the original unprocessed gel images in this manuscript have been 
deposited with Mendeley and can be accessed with 
https://doi.org/10.17632/5dnznn9kwt.1. 
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CHAPTER 4: PERSPECTIVES AND FUTURE DIRECTIONS 
 
4.1 Summary of Major Conclusions and Implications 
Early work on FOXA1 interactions with  chromatin in vivo and in vitro 
defined pioneer TFs by their ability to directly associate with nucleosomes and 
induce local changes in chromatin accessibility, to allow competence for gene 
expression at the initial stages of cell differentiation (Cirillo et al., 1998; Iwafuchi-
Doi and Zaret, 2014; McPherson et al., 1993; Zaret and Carroll, 2011). The 
subsequent identification of FOXA1 as a direct reprogramming TF (Huang et al., 
2011; Huang et al., 2014) then raised questions about the potential pioneering 
activity of other reprogramming TFs and the role of TF nucleosome binding 
during cell reprograming.  
Our lab previously demonstrated that OCT4, SOX2, and KLF4 (OSK) can 
access closed chromatin during the initial days of fibroblast to iPSCs 
reprogramming (Soufi et al., 2012). Furthermore, OSK was found to directly 
interact with nucleosomes and target nucleosomes-enriched sites in vivo, while 
cMYC target sites are mainly nucleosome-depleted (Figure 2.4,5). We therefore 
showed that in vivo OSKM chromatin targeting tendencies are mirrored by the 
TFs ability to directly interact with nucleosomes in vitro (Figure 2.1). Thus, we 
established the identity of OSK but not M as pioneer TFs (Chapter 2). Based on 
these findings, we propose that the inherent ability of these factors to target 
chromatin is determined by their intrinsic ability to recognize partial motifs on 
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nucleosomes and by the structural adaptability of the TFs DBD (Soufi et al., 
2015b). 
Studies correlating TF binding co-occurrence with chromatin accessibility 
in vivo suggest a hierarchical model of TF-mediated genome re-activation during 
reprogramming where early expressed developmental TF are also sufficient for 
reprogramming, such as OSK. These early developmental and now 
reprogramming TFs preferentially access compacted chromatin, induce 
chromatin opening and subsequently recruit factors with weak nucleosome 
binding activity (Mall et al., 2017; Soufi et al., 2012; Soufi et al., 2015b; Wapinski 
et al., 2013). The reprogramming hierarchical model places TF nucleosome 
binding ability and thus pioneering activity as a determinant of a TF 
reprogramming potential. Nonetheless, what dictates the preference of OSK to 
closed chromatin remains unknown. The studies presented in Chapter 2 and 3 
were based on mono-nucleosomes substrates. Therefore, we suggest that a 
more complex chromatin structure allows a higher level of nucleosome 
interactions and provides multiple binding sites for TFs that could increase the 
nucleosome affinity of these factors in chromatin. Therefore, a more complex 
substrate such as chromatin could explain the preferential targeting of these TFs 
to closed chromatin.  
  Following our findings of OSKM pioneer activity in vivo and in vitro during 
iPSC reprogramming, I extended our analysis to include TFs driving the direct 
cell reprogramming of fibroblast to neurons, hepatocytes, macrophages and B 
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cells (Chapter 3). We purified 9 cell reprogramming TFs under denatured 
conditions and measured their apparent dissociation constant on short dsDNA 
containing the respective TFs motif to validate specific DNA binding of the TFs 
compared to non-specific DNA (Figure 3.S2C-D). We showed that each TF is 
able to specifically interact with their respective motif by EMSA, competition 
experiments and DNase I footprinting (Figure 3.3). Additionally, by estimation of 
the percent of fraction bound by the TF to free DNA at 1 nM we estimate that 
90% of the purified FOXA1, PU1 and ASCL1/E12aa are properly folded since a 
1:1 molar ratio of TF:DNA shows almost complete saturation of binding to the 
free DNA probe (Figure 3.2B-D). We estimate GATA4 and BRN2 to be 75% 
folded by this method (Figure 3.2E-F). Still, more quantitative experiments such 
as isothermal titration calorimetry can be done to determine the stoichiometric 
ratio of TF:DNA binding in order to accurately quantify the percentage of folded 
TF. Assessment of  the nucleosome binding of these cell reprogramming TFs 
revealed these factors display a range of nucleosome binding affinities that 
correlate with the reprogramming strength of TFs (Fernandez Garcia et al., 
2019). Moreover,  by DNase I footprinting experiments, we observe that upon TF 
binding, nucleosomes become DNase I protected at TF binding sites but also 
show enhancement of DNase I sensitivity at other regions (Figure 3.3). 
Therefore, suggesting that TF binding to nucleosomes can induce allosteric 
conformational changes in the histone octamer that lead to changes in 
nucleosomes rotational positioning. 
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Transcription factors cannot be functionally understood without knowledge 
of the DNA sequences that they bind. Therefore, many efforts have been made 
to understand the DNA binding preferences of TFs resulting in the creation of TF 
motif databases such as JASPAR, TRANSFAC, UNiPROBE, and CIS-BP that 
use TFs ontology and structural databases (Jolma et al., 2013; Mathelier et al., 
2014; Matys et al., 2006; Yin et al., 2017). Still, nucleosome-TFs studies have 
been mainly restricted to low-throughput analyses due to the requirement of 
specific DNA sequences for TFs binding. Moreover, the complexity of TFs post-
translational modifications, TF dimerization, and TF binding partners, all of which 
contribute to TF stability and DNA binding, have made it challenging to screen for 
sequence–specific nucleosome binders and to determine the underlying features 
that permit or inhibit nucleosome binding. This study precisely addressed this 
gap in our knowledge. 
Using protein microarray technology, we screened 593 TFs for 
nucleosome binding on sequence specific DNA and identified factors with 
previously unreported pioneer activity, including the AP2 TF family (Figure 3.5C). 
In solution validation, of sequence specific nucleosome-TF interactions identified 
from the protein microarray screen, showed that while nucleosome binding TFs 
typically have a high DNA binding affinity this does not equate to nucleosome 
binding activity (Figure 3.5D). Based on these findings and earlier work on 
pioneer FOXA1 (Cirillo et al., 2002) we suggest that DNA curvature induced by 
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association with the histone octamer or with histones themselves plays a role 
facilitating TFs-nucleosome binding interactions.  
TFs are classified by their DBDs into 10 structural superclasses that 
represent the topology of the TFs DBD. The 3 largest superclasses, zinc-
coordinating, helix-turn-helix, and basic domain, account for 90% of all human 
TFs. Following in size are the superclasses containing b-sheet structures 
including the immunoglobulin fold DBDs, and the b-hairpin exposed superclasses 
(Lambert et al., 2018; Wingender et al., 2015). My comparison between strong 
and weak nucleosome binders revealed that strong nucleosome binding factors 
engage DNA through a short anchoring a-helix while weak TFs engage DNA 
through an extended anchoring a-helix (Figure 3.6A,B). A long anchoring a-helix 
that extends past the diameter of the DNA can be incompatible with nucleosome 
structure and cause steric hindrance to the association of the histone octamer 
with DNA. It has now become evident that pioneer TFs fall within superclasses 
with a- helical structures (Figure 3.6).  
We also identified a second group of weak nucleosome binders that 
contains DBDs mainly composed of b-sheets and that interact with DNA through 
short helical twists or unstructured loops. This group of non-pioneer TFs include 
TFs of the immunoglobulin-like superclass family.  Therefore, this group of non-
pioneer TFs are part of the b-sheet containing TF superclasses (Figure 3.6C). 
Not surprisingly, these TFs which include p63 and TBX5, have been shown to be 
insufficient for direct cell reprogramming protocols versus. For example, p63 is 
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insufficient for keratinocyte reprogramming and requires pioneer TFs AP2 or 
KLF4 (Li et al., 2019; Lin-Shiao et al., 2019). Additionally, reprogramming into 
cardiomyocytes with MEF2A and TBX5 is also insufficient for reprogramming and 
requires pioneer TF GATA4 (Ieda, 2013; Ieda et al., 2010). MEF2A is classified 
as a MADS-box TF which contains a DBD structure mainly composed of a-helical 
structures exposed by b-sheet scaffold (Santelli and Richmond, 2000; Wu et al., 
2010). Comparison of these factors with non-pioneer TBX20 (Figure 3.5D), 
suggests that b-sheet-containing DBDs are insufficient for nucleosome binding 
and thus cell reprogramming.  
Structural comparison of weak versus strong nucleosome binders 
revealed key structural differences between pioneer and non-pioneer factors. 
Identification of such features revealed DNA binding modes associated with 
nucleosome binding strength and reprogramming dominance (Fernandez Garcia 
et al., 2019).  The findings from my thesis work provide strong evidence to 
suggest that the intrinsic nucleosome binding preferences of pioneer TFs 
contribute to their hierarchy of cellular reprogramming (Fernandez Garcia et al., 
2019). Furthermore, the work presented here gives insight into how such a 
diverse group of TFs from multiple structural superclasses engage in 
nucleosomal interactions via common structural features.  
My thesis works provides a knowledge base that allows prediction of the 
TFs with pioneer and reprogramming potential based on their TFs DBD 
structures. Such knowledge may be used to improve the generation of induced 
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reprogrammed hematopoietic stem and progenitor cells (iHSPCs), since efficient 
generation of Induced HSPCs from somatic cells has yet to be developed (Ebina 
and Rossi, 2015). Runx3 has been proposed to initiate chromatin accessibility 
during memory cytotoxic T lymphocyte differentiation (Wang et al., 2018), yet 
RUNX is insufficient for reprogramming protocol toward hematopoietic lineages 
and reprogramming (Ebina and Rossi, 2015). Current RUNX-based strategies for 
iHSPCs reprogramming using RUNX, from closely related lymphoid progenitors, 
require the use of at least 7 TFs for efficient reprogramming (Wang et al., 2018). 
RUNX DBD adopts an immunoglobulin fold conformation (Tahirov et al., 2001) 
and can therefore be predicted as a non-pioneer TF. We speculate that RUNX 
inability to efficiently reprogram cells is due to structural similarities with non-
pioneer TFs. DBD-based prediction of pioneer TFs will instruct the informed 
selection of better reprogramming TFs cocktails for the reprogramming of cells 
yet to be produced. 
 
4.2 Future directions 
Advancement in structural biology techniques, growth in the number of 
nucleosome structures, and proteomic based mass-spectrometry has allowed  
the analysis of nucleosome-protein complexes with higher resolution and has 
provided new insight the landscape of the nucleosome interactome (Kale et al., 
2019). These advancements have revealed the principles of nucleosome 
recognition and the effect of histone and DNA post translational modifications on 
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nucleosome recognition by epigenetic factors (Bartke et al., 2010; Dann et al., 
2017; Makowski et al., 2018; Nguyen et al., 2014). However, these studies 
mainly provided understanding of non-specific nucleosome binding proteins by 
relaying on nucleosomes assembled with DNA sequences shown to restrict TFs 
nucleosome binding, due to high rigidity (Appendix B) (Takizawa et al., 2018).  
Currently, there is no published structure of full-length sequence-specific TFs 
bound to nucleosomes, which therefore limits our understanding on the 
nucleosome recognition mode of full-length, sequence-specific factors.  
The development of nucleosome libraries assembled with diverse DNA 
sequences bypassed the limitations of TF DNA sequence specificity (Zhu et al., 
2018). The study revealed distinct nucleosome interacting behaviors of TF DBDs 
based on sequence-specific DNA motif analysis. Still, further experiments need 
to be done for the validation of such nucleosome interacting behaviors. Structural 
manipulation of the DNA anchoring a-helix of pioneer TFs DBDs followed by 
nucleosome affinity assays will determine the role of the proposed secondary 
structures in dictating nucleosome interacting behaviors (Chapter 3). Conversely, 
it would be interesting to determine whether non-pioneer TFs can acquire 
pioneering activity and reprogramming activity by substitution of DNA-anchoring 
loops with an anchoring a-helix.  
Different mechanisms have been suggested for the action of pioneer TFs 
to induce local chromatin changes in DNA accessibility.  For example, 
comparison of FOXA with histone 1 (H1) showed that the FOXA DBD contains a 
 
 
161 
winged-helix domain resembling H1 (Clark, 1993). This extends to other FOX  
family TFs such as FOXE1 and FOXO1, which also interact with nucleosome 
through a winged-helix domain (Hatta and Cirillo, 2007). Interestingly, H1 and 
FOX TFs execute opposing functions – H1 compacts nucleosomes while FOXA 
induces DNA chromatin accessibility (Cirillo et al., 2002; Osipova et al., 1980). 
These differences are potentially dictated by accessory domains outside of the 
DBD since both H1 and FOXA1 interact near the nucleosome dyad (Chaya et al., 
2001; McPherson et al., 1993; Sekiya et al., 2009). For instance, H1 is known to 
interact with linker DNA while FOXA is not (Allan et al., 1986; Thomas, 1999). 
Nonetheless, structural similarities between FOXA and H1 suggest FOXA- 
displacement of H1 may play a role in the pioneer function of FOXA1 (Iwafuchi-
Doi et al., 2016). 
 Our lab has also shown that FOXA1 contain a highly conserved C-terminal 
a-helix that establishes direct histone contacts with the histone octamer (Cirillo et 
al., 2002). Deletion of FOXA a-helix in the C-term (FOXA1Da-helix) inhibits 
FOXA1 chromatin accessibility activity in nucleosomes arrays in vitro (Cirillo et 
al., 2002). Therefore, the presence of FOXA C-term-a-helix suggests the 
existence of external DBD domains that mediate nucleosome binding and the 
chromatin opening activity of pioneer TFs. Interestingly, preliminary experiments 
measuring dissociation constants of FOXA1Da-helix showed it retain nucleosome 
affinity similar to FOXA1 WT (Appendix C, Figure C3). Additional experiments on 
FOXA1-DBD fragment showed that the FOXA DBD alone is sufficient for 
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nucleosome binding, albeit with a lower affinity (Cirillo et al., 2002). Preliminary 
work from our lab indicates that a FOXADa-helix  mutants triggers an increase in 
chromatin compaction at FOXA1 target sites in undifferentiated mouse 
embryonic endoderm (manuscript submitted). These results indicate that 
domains outside of FOXA1-DBD are needed for chromatin opening (Appendix 
C). Similarly, studies of the pioneer TF EBF1 have also shown EBF1 promotes 
chromatin accessibility of B-cell specific genes (Boller et al., 2016; Li et al., 
2018). Detailed analysis of EBF1 DC-term mutants showed a decrease in 
chromatin accessibility and limited the co-occupancy of secondary TFs at these 
genomic regions (Boller et al., 2016). Therefore, EBF1 C-term confers chromatin 
opening ability. These results show that nucleosome binding ability can be 
uncoupled from the chromatin opening activity of pioneer TFs. Based on these 
findings we suggest that accessory domains external to TFs DBDs mediate the 
establishment of TF-histone interaction and disruption of nucleosome-
nucleosome histone contacts to induce local chromatin accessibility.  
 As discussed in Chapter 3, through my thesis work I identified previously 
unreported pioneer TFs and confirmed the pioneering activity of proposed 
reprogramming TFs that direct reprogramming toward three different cell types 
(Fernandez Garcia et al., 2019). Identification of pioneer TFs form diverse 
structural families now place us in position to determine whether these factors 
also interact with histones and which domains are involved in these interactions. 
Studies comparing pioneer TFs specific nucleosome binding with non-specific 
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nucleosome binding proteins will determine whether TFs also establish similar 
histone-nucleosome interactions through association of the histone acidic patch 
(Figure 1.4) or through distinct interactions (McGinty and Tan, 2016). Detailed 
structural studies in TF-histone interactions will aid in the elucidation of the 
similar or differential mechanisms by which pioneer TFs interact with 
nucleosomes and will determine whether nucleosome binding by TFs stabilize or 
destabilize nucleosome structures to induce chromatin accessibility. Future 
research on pioneer TF mechanisms of nucleosome binding will elucidate the 
initial steps silent chromatin targeting by TFs and will unveil the mechanisms by 
which cells reactivate developmentally silenced gene networks.  
 At a higher level of DNA compaction our lab has shown that OSK cannot 
access highly compacted chromatin that is enriched for H3K9me3, thus revealing 
the sensitivity of these pioneer TFs to highly compacted chromatin subtype 
(Becker et al., 2017; Soufi et al., 2012). As the chromatin sensitivity of these 
pioneer factors limits their ability to induce activation of late reprogramming 
genes resulting in incomplete activation of new cell fate regulatory networks 
(Becker et al., 2017; Soufi et al., 2012). Knowledge of the histone marks, DNA 
modifications, and chromatin-specific interacting proteins that influence pioneer 
TFs chromatin sensitivity may be used to enhance cellular reprogramming. 
These gaps in knowledge can be addressed by the use of DNA-barcoded mono-
nucleosome libraries of chemically-modified histones, histone variants and 
methylated DNA (Dann et al., 2017; Nguyen et al., 2014). Such libraries would be 
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generated with native DNA sequences specific to TF of interest (Figure 3.1) in 
order to profile the biochemical susceptibility of a pioneer TF to diverse types of 
sequence-specific nucleosomes.    
 In addition, we have shown that although some reprogramming TFs can 
associate with closed chromatin, not all TFs have nucleosome binding activity 
(Chapter 2). c-MYC was shown to have weak nucleosome binding and a minority 
of cMYC target sites within nucleosome-enriched chromatin in vivo are also 
enriched for Oct4 and Sox2 binding sites (Soufi et al., 2015b). Therefore, we 
suggest that cMYC associates with chromatin through cooperative interactions 
with pioneer TFs. Similarly, CEBPA has been associated with the induction of 
chromatin accessibility during B-cell reprogramming, although we showed that 
CEBPA displays the weakest nucleosome binding affinity of the TFs tested in 
Chapter 3. Furthermore, a majority of CEBP target sites have shown to be 
dependent on PU1 (van Oevelen et al., 2015). Therefore, future studies should 
also address the role of cooperative binding of non-pioneering TFs at closed 
chromatin in inducing chromatin accessibility during reprogramming.  
The question of which reprogramming TFs can directly induce chromatin 
opening in an ATP-independent mechanism, and whether chromatin opening 
activity is limited by nucleosome affinity can be directly tested in vitro by high 
precision mapping techniques such as DNAse footprinting using compacted 
chromatin arrays. Our lab has shown that FOXA1 and GATA4 can bind 
nucleosomes. GATA4 showed a lower nucleosome affinity and decreased 
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chromatin opening compared to FOXA1 on H1 compacted arrays (Cirillo and 
Zaret, 1999a). DNAse footprinting experiments of in vitro reconstituted chromatin 
can therefore elucidate the dependence of chromatin opening activity on 
nucleosome binding affinities of the newly identified pioneer TFs. Furthermore, 
coupling of these experiments with newly developed DNA-sequencing 
technologies, in vitro, will provide further details and mapping of the ATP-
independent mechanism by which pioneer TFs induce chromatin opening.  
 
4.3 Final Remarks 
Just about over 10 years ago the explosion and refinement of high-
throughput genome-wide technologies have highlighted the importance of 
chromatin compaction and 3D genome folding in the establishment of cell 
identity. Discoveries of genome wide changes in chromatin accessibility during 
cell differentiation shifted the perception of transcription factors as merely static 
DNA binding proteins into proteins that target nucleosomes and lead to local  
structural perturbations. Now, thanks to the extensive identification and validation 
of pioneer TFs in addition to FOXA, after much skepticism pioneer TFs have now 
become widely accepted as mediators of chromatin accessibility. Therefore, 
pioneer TFs nucleosome and chromatin binding preference should be 
incorporated into the functional analysis of TFs in order to understand how TFs 
regulate gene expression in the nucleus, a highly compacted and tightly 
regulated environment.  
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APPENDIX A: ENZYMATIC 3’ DNA LABELING WITH CY5 
FLUOROPHORE 
 
 
  This appendix provides a detailed overview of the enzymatic 3’ DNA 
labeling with Cy5 fluorophore protocol used in Chapters 2 and 3. The protocol 
has been robustly used by other labs, including Doris Wagner and Shelly 
Berger’s labs. The protocol was developed and optimized by myself with 
guidance from Dr. Zaret. 
 
I. Objective 
 Label DNA at the 3’ end with Cy5 fluorophore for EMSA experiments and 
for Cy5 fluorescence detection. 
 
II. Reagents and Kits 
Reagents  
Cy5-dCTP [1mM] 
Unlabeled dATP [100 mM] 
Unlabeled dTTP [100 mM] 
Unlabeled dGTP [100 mM  
Klenow fragment (-exo) 
 
Purification column illustra MicroSpin G-25 columns (GE healthcare) 
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Note: If using DNA longer than ~150 bp DNA, cleanup can be done with Qiagen 
PCR Purification Kit. 
DNA Sequences 
Double stranded DNA (dsDNA) should be longer than 32 bps otherwise the 
purification (removal of unincorporated dNTPs) by size exclusion will not be 
efficient as the size difference between dNTP and DNA will be minimal.  
Designed oligonucleotides should contain sticky ends of at least 2 bp on each 
side, the last of which will be labeled with a Cy5 labeled C. This protocol works 
for both annealed ssDNA (top strand) and ssDNA (bottom strand) or dsDNA 
fragments.  
 
Buffers 
10X Annealing Buffer: 200 mM Tris, pH 7.6; 500 mM NaCl; 1 mM DTT; 10 mM 
EDTA 
 
III. Protocol 
Note: Skip to Step 2 if starting from dsDNA (Cy5 labeling reaction). 
1. Anneal complementary strands of ssDNA: 
a. Prepare annealing reaction: 
10 uL ssDNA (top) 100 µM stock 
10 uL ssDNA (bottom) 100 µM stock 
  5 uL 10X annealing buffer 
25 uL ddH2O 
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b. Heat the reaction at 70˚C for 10 min. on a heat block. Turn the heat 
block off and let the sample gradually cool down in the heat block 
overnight. 
c. Determine the DNA concentration on a Nanodrop. 
2. Labeling reaction: 
a. Prepare 5X dNTP mix: 
 
 
 
 
 
b.  Prepare reaction: 
 
1
C
a
l
c
Calculate how much DNA you want to label: 50 ug 160 bp DNA  
2 Then calculate the total volume needed to have 50 ug DNA with a final 
concentration of 1.26 µM. Do not exceed 10 µL if DNA < 150 bp. Do not 
exceed the maximum loading volume if using G-25 spin columns since 
this will decrease the purification efficiency. Additionally, if more DNA is 
Stock Final Concentration 
100 mM dATP 20 mM  
100 mM dTTP 20 mM 
100 mM dGTP 20 mM 
1 mM Cy5-dCTP 20 µM 
Stock Final Concentration 
1dsDNA (50 ug) [1.260 µM ] final concentration  
3 10X NEB Buffer #2 1X 
3 5X dNTP Mix 1X (4mM dATP, dTTP, dGTP, 0.004 mM Cy5-dCTP) 
3Klenow Fragment  (-exo) 5 
U/uL 0.5 U/µL 
4ddH2O Subtract everything from total volume 
2Total volume Adjust to DNA final conc. 
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desired make sure to keep the ratio of DNA:Cy5-dCTP the same 
otherwise efficiency of labeling can be compromised. 
3 Calculate how much 10X buffer, 5X dNTP mix and Klenow you need to 
add to have 1X, 1X and 0.5 U/uL final concentrations. 
4 Subtract the volume of DNA, buffer, dNTPs, and Klenow from the total 
to get the volume of H2O to add. 
c. Incubate at 37˚C for 1 hr in a water bath.  
3. DNA purification 
a. DNA < 150 bp: proceed as per the illustra MicroSpin G-25 column 
manufacturer protocol, with a few modifications: 
i. Load the sample into the column and add an additional 10 µL 
ddH2O for a final volume of 20 µL. 
ii. Spin at 2,800 RPM for 1.5 min.  
iii. To verify purity of the sample run on a 10 % Acrylamide, 0.5X TBE 
gel (non-denaturant). Make a ~1:60 dilution of your sample and 
load 10 µL of the dilution + 2 µL 30% sucrose. Additionally, run one 
lane with 2 µL 6X DNA loading dye just to have an estimate of 
how far off your sample has run. Run the gel in 0.5X TBE at 90 V 
for ~ 1.5 hr. Scan the gel in a fluorimeter scanner with Cy5 
detection. Note: be sure to use sucrose when loading your sample, 
as DNA loading dye will obscure the Cy5 signal.  
b. DNA ≥ 150 bp: purify using Qiagen PCR Purification Kit.  
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i. Note: Do not load more than 10 µg DNA per column otherwise purification 
yields will be lower. 
ii. Elute 10 µg in 50 µL EB buffer.  
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APPENDIX B: WIDOM 601 DNA SEQUENCE AS A TEMPLATE FOR  
TF-NUCLEOSOME INTERACTIONS 
  
 This appendix contains unpublished analyses which test FOXA1 
nucleosome binding affinity for Widom 601 asymmetric nucleosomes containing 
or lacking FOXA1 binding sites at multiple nucleosome rotational phasing 
positions. Experimental design, reagents, experiments, and analysis was done 
by me. 
 
I. Objective 
 The goal of the experiments presented here is to determine the viability of 
using a synthetic DNA sequence, such as the Widom 601 asymmetric DNA, as a 
universal and modifiable template for nucleosome assembly. Such a template will 
be useful for testing the binding affinities of multiple transcription factors on 
nucleosomes containing binding sites at various rotational positions. The Widom 
601 sequence has been the standard for in vitro nucleosome biochemical assays 
due to its exceptional histone octamer affinity and favorable DNA bending and 
distortion, both of which allows stable nucleosome assembly in vitro (Vasudevan, 
J. Mol. Bio, 2010; Chua et al., NAR, 2012; Lowary & Widom, J. Mol. Bio, 1998).  
The 601 sequence is extensively used for nucleosome structural analyses 
(Makde et al., 2010) nucleosome interaction assessment ( Lone, et al, PLOS 
Gentics, 2013), and nucleosome mechanics (Chua et al.,NAR, 2012) and 
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disassembly studies (Gansen et al. PNAS 2009). Therefore, we did preliminary 
work testing FOXA1 binding to 601 nucleosomes constraining or lacking a FOXA 
binding site at multiple rotational positions.  
II. Reagents 
DNA Sequences 
601 asymetric-162 bp 
5’-
ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACGCG
GGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’ 
 
601-eG (D) 
5’-
ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAAGAAT
GTTTGTTCTTAGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’ 
 
601-eG (D-1) 
5’-
ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAGAATG
TTTGTTCTTACGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’ 
 
601-eG (D-5): 5 bp shift causes a shift of  34° degrees. 
5’-
ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTGAATGTTTG
TTCTTAAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’ 
 
601-TA mut at superhelical location -0.5, 1.5 
5’-
ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTGGAAACGCG
GGGGACAGCGCGGGCGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’ 
 
601-eG (D)-TA mut at superhelical location -0.5, 1.5 
5’-
ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTGGAAAGAAT
GTTTGTTCTTAGGGCGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’ 
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Purified Proteins 
Mouse FOXA1 full-length 
 
III. Assessment of FOXA1-specific binding at multiple rotational positions 
on 601 nucleosomes	
Goal 
 To compare FOXA1 binding to Widom 601 free DNA and Widom 601 
nucleosomes with our without a single FOXA1 binding motif and determine 
whether different rotational phasing inhibits or allows FOXA1 binding to 
nucleosomes. 
 
Approach 
   pUC19-601 plasmid (gift from Karolyn Luger) was used as a template for 
mutagenesis of the FOXA eG binding site at positions near the 601 nucleosome 
dyad (D), 1 bp away from the dyad towards the DNA super helix (SH) 1.5, or 5 bp 
away from dyad toward SH 1.5 (Figure B1B). The FOXA1 eG site in the dyad is 
considered assessible. From the dyad, a 1 bp shift of the eG site in the 
nucleosome causes a 34° rotation and a 5 bp shift causes it to be inaccessible to 
FOXA1, as shown by molecular modeling (Figure B1C). The eG site orientation 
was placed so that wing 2 of the FOXA1-DBD structure is closest to the dyad, 
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similar to the orientation that FOXA1 adopts on the alb1- N1 nucleosomes 
(Figure B1D).  
  PCR with Cy5 labeled primers was performed to generate 162-bp of 601, 
601-eG (D), 601-eG (D-1), and 601-eG(D-5) DNAs. The sequences were then 
assembled into nucleosomes by urea-salt gradient dilution with purified 
recombinant, full-length human histones. FOXA1 free DNA and nucleosome 
binding was determined by Electromobility Shift Assay (EMSA).  
Results 
 FOXA1 binds with higher affinity to 601 DNA containing the eG site at 
positions D, D-1 and D-5 (Figure B2A). In contrast, FOXA1 shows minimal 
binding to all 601 nucleosomes containing or lacking the eG site (Figure B2B). 
 
IV. Assessing FOXA1 binding to less rigid 601 nucleosomes 
Goal 
 To make flexible 601 nucleosomes that are less rigid and more closely 
resemble natural nucleosome structures to allow FOXA1 binding.   
 
Approach 
 Widom 601 nucleosomes have been characterized as very rigid 
nucleosomes compared to nucleosomes assembled with the 5S DNA sequence 
or with the albN1 enhancer. Therefore, to generate a more natural and flexible 
 
 
196 
nucleosome I mutated the H3/H4 TA steps super helical locations -0.5 and 1.5 
closest to the dyad (Figure B3A,B). H3/4 TA steps serve as histone-DNA 
interaction points. These two TA steps were mutated to GC in order to increase 
nucleosome flexibility near dyad.  
 
Results 
 Mutagenesis of 601 H3/4 TA steps near the dyad and eG site did not 
affect FOXA1 specific binding to 601 free DNA. EMSA of FOXA1 to 601-eG (D) 
TA mut nucleosomes showed minimal FOXA1 nucleosome binding enhancement 
compared to 601-eG(D) nucleosomes (Figures B2B-C) and nucleosome 
saturation could only be observed at 90 nM FOXA1 concentrations.  
 
V. Conclusions 
 Here I have shown that the Widom 601 asymmetric DNA can be used to 
test TF-specific binding with the insertion of TF target site and that mutagenesis 
of 601 does not disrupt nucleosome assembly. Nonetheless, 601 nucleosomes 
showed to be too rigid and inhibited FOXA1 nucleosome binding ability, 
regardless of the DNA binding motif orientation within the nucleosome structure. 
These conclusions are in agreement with a recent publication comparing the 
albN1 nucleosomes to 601 nucleosomes by cryo-EM (Takizawa et al., 2018). 
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VI. Figures  
 
 
 
Figure B1 | Design of 601-eG nucleosomes. 
(A) Schematic diagram showing plasmid generation to DNA purification workflow 
of Cy5-601 DNA sequences and FOXA1 eG binding site insertion.  
(B) 3D representation of the 601 DNA sequences used for nucleosome assembly 
containing FOXA1 eG binding site (yellow) and DNA nucleotide sequence of 
FOXA1 with highlighted FOXA1 specific contacts (green and red) and DNase 
protected nucleotides shown by McPherson et al 1993, Cell. 
(C) Modeled crystal structure of 601 nucleosomes (pdb 3LZ0) with docked 
FOXA3 DBD (pdb IVNT) by alignment of FOXA3 eG containing DNA from crystal 
structure with 601 DNA at eG site insertion positions shown in (B). 
(D) AlbN1-DNA sequence with MNase and  DNAase I cleavages in liver nuclei. Arrows 
indicate sites of enhanced MNase cleavage in liver nuclei; large arrows represent the 
strongest cleavages that define the real nucleosome boundaries. Sequences contained 
within the N1site (red box) which were inserted into 601 (B) show the orientation of the 
FOXA3 secondary structural folds with respect to the dyad. Bars indicate areas 
protected from cleavage by DNAase I in liver nuclei, and dots indicate positions of 
enhanced liver-specific cleavage by DNAase I. (Liu et al., 1991, McPherson et al 1993, 
Cell) 
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Figure B2 | The Widom 601 nucleosomes fail to Recapitulate FOXA1 
nucleosome binding regardless of TF binding motif rotational positing. 
(A) Representative EMSA showing the affinity of increasing amounts of FOXA1 
WT to 160 bp 601 free DNAs. Black arrowheads indicate free DNA and 
DNA:FOXA1 complexes. 
(B) Representative EMSA showing the affinity of increasing amounts of FOXA1 
WT to 160 bp 601 free DNAs and nucleosomes. Black arrowheads indicate free 
DNA and DNA:FOXA1 complexes; white arrow indicate nucleosomes and 
nuc:FOXA1 complexes. 
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Figure B3 | Mutagenesis of 601 H3/4 TA steps does not enhance FOXA1 
nucleosome binding.  
(A) 601 nucleotide sequence showing the dyad position (F) and highlighted  H3/4 TA 
steps (orange). 
(B) Crystal structure of 601 nucleosomes (pdb 3LZ0) showing H3/4 TA steps (orange 
base pairs) and mutated super helical locations (SHL) -0.5 and 1.5. 
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APPENDIX C: FOXA1 CHROMATIN OPENING-DEFICIENT MUTANTS 
BINDING TO NUCLEOSOMES 
 
 
  This appendix contains unpublished analyses which measure FOXA1 WT 
and FOXA1 C-terminal mutant affinity to albN1 DNA and nucleosome. While 
FOXA1 double mutant protein expression plasmids and FOXA1 purifications 
were done by Naomi Takenaka, I generated the single FOXA1 mutant plasmids 
for protein expression, EMSA experiments, dissociation curve analysis, and 
histone octamer pulldown assays. 
 
I. Objective 
 
 Unpublished work from our lab have shown that FOXA1 contains two 
highly conserved lysines, K270 and K414, that interact with the nucleosome core 
histone octamer by FOXA1–core histone octamer crosslinking followed by mass 
spectrometry (in revision; Iwafuchi-Doi et al, Nature Genetics). mFOXA1 residues 
K270 and K414 reside within the C-terminus of FOXA1. K270 is located in close 
proximity to the FOXA1 DBD and within highly conserved EKQ (269-271) 
residues while residue K414 resides within the FOXA1 C-terminal a-helix 
structure (In revision; Iwafuchi-Doi et al, Mol Cell, 2019). Deletion of the FOXA1 
C-term a-helix was shown to decrease DNA accessibility at FOXA1 bound sites 
in vivo observed by ATAq-seq experiments, while in in vitro experiments it 
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causes chromatin opening inhibition and loss of FOXA1 histone interactions (In 
revision; Iwafuchi-Doi et al, Nature Genetics). Therefore, to determine the role of 
the K270 and K414 residues to FOXA1 nucleosome binding I measured free and 
DNA affinity of FOXA1 C-term mutants to 160 bp albN1 DNA and nucleosomes. 
 
II. Reagents 
DNA Sequences 
See section 3.11 Key Resource Table -160 bp ALBN1-DNA 
Purified Proteins 
FOXA1 WT 
FOXA1 DBD aa168-268,  
FOXA1 eDBD aa144-294  
FOXA1 eDBD aa144-294: EKQ (269-271) AAA  
FOXA1 (A415P, A419P)  
FOXA1 DF413-Q421 
FOXA1 EQK (269-271) AAA 
FOXA1 EQK (269-271) AAA + (A415P, A419P)  
FOXA1 EQK (269-271) AAA + D413-421 
 
 
III. FOXA1 chromatin opening-deficient mutants binding to short dsDNA  
 
Goal 
 To compare the ability of WT and chromatin opening deficient FOXA1 
mutants to specifically bind to short dsDNA.  
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Approach 
 
 FOXA1 WT and mutant plasmids were generated and recombinant 
proteins were purified (Figures C1A-C) from E. coli under denaturing conditions 
as described above. Purified recombinant proteins where tested and validated for 
specific and non-specific DNA binding to short ds-DNA containing or lacking the 
FOXA1 eG site by EMSA (Figure C1D). 
 
Results 
FOXA1 chromatin opening deficient mutants bind short dsDNA DNA with 
specificity and similar affinity compared to WT.  
 
IV. FOXA1 chromatin opening-deficient mutants bind to 160 bp albN1 free 
DNA and nucleosomes 
Goal 
 Determine whether FOXA1 K270 or K414, are required for FOXA1 
nucleosome binding ability.  
Approach 
Electromobility shift assays (EMSA) were used to determine the apparent 
dissociation constants of WT and mutant FOXA1 to 160 bp albN1 free DNA and 
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nucleosomes (Figure C2A-F). Dissociation constants were quantified by two 
methods: total dissociation constant (total KD), determined by decrement of free 
probe, and specific dissociation constant (specific KD), determined by the 
appearance of specific TF-complexes (Soufi et al., 2015b) (Figures C3A-C).  
Results 
 FOXA1 mutants bind 160 bp albN1 DNA and nucleosomes with similar 
affinities within the low nanomolar range of 1-2.5 nM for nucleosomes compared 
to WT, albeit with less affinity for nucleosomes compared to DNA, as was also 
seen for FOXA1 WT.  
 
V. FOXA1 EKQ (269-271) residues contribute to FOXA1 interactions with 
the histone octamer 
 
Goal 
 Determine FOXA1 EKQ (269-271) amino acid contribution to FOXA1- 
histone octamer interaction.  
 
Approach 
 Constructs of FOXA1 truncations containing either the DBD lacking 
residues EKQ 269-271, an extended DBD (eDBD), or eDBD with EKQ (269-271) 
AAA mutation were generated (Figure C4A). These plasmids were then used for 
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protein expression and purification from E. coli under denatured conditions 
(Figure C4B). Purified recombinant proteins where initially tested and validated 
for specific and non-specific DNA binding to short dsDNA containing or lacking 
the FOXA1 eG site (Figure C4C). Histone octamer pulldown assays are 
described in Cirillo et al., 2002, Mol Cell (Figure C4C). Initially we compared 
histone interaction of FOXA1 full-length WT with FOXA1 full-length EKQ (269-
271) AAA mutant followed by comparison of FOXA1 DBD lacking residues EKQ 
269-271 and extended DBD (eDBD). 
Results 
FOXA1 eDBD, short DBD, and eDBD-AAAmut show similar affinities for 
short dsDNA containing a FOXA eG binding site (Figure C4C). We show that full-
length FOXA1 is able to interact with histone octamers, in agreement with 
previous published experiments (Cirillo et al., 2002), but AAA substitution of EKQ 
residues in full-length FOXA1 causes a partial decrease in FOXA1-histone 
octamer interaction (Figure C4E). Further truncation of FOXA1 eDBD fragment 
which removes adjacent amino acids, including the EQK residues, greatly inhibits 
FOXA1 DBD fragment interactions with histone octamers (Figure C4F).  
 
VI. Conclusions 
Here we show that purified FOXA1 WT and chromatin opening-deficient 
mutants bind nucleosomes with similar affinities. Nonetheless mutation of 
residues EQK, adjacent to FOXA1 DBD, limit histone octamer interaction of 
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FOXA1. Previous work from our lab has shown that FOXA1 DBD fragment is 
sufficient for nucleosome binding but show decrease affinity compared to full-
length FOXA1 (Cirillo et al., 2002). Moreover the DBD alone is insufficient for 
FOXA1 chromatin opening ability (Cirillo et al., 2002). Therefore, comparison of 
histone octamer interaction by pull down assay between FOXA1 eDBD (includes 
EQK) and short DBD fragments (exclude EQK), show that truncation of adjacent 
amino acids such as EQK result in inhibition of FOXA1-DBD interaction with 
histone octamers in vitro. These experiments provide evidence that FOXA1 
nucleosome binding and chromatin opening functions can be uncoupled and that 
domains outside of the DBD might play a role mediating FOXA1 histone 
interactions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
206 
VII. Figures 
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Figure C1 | FOXA1 WT and mutants bind short dsDNA with specificity 
(A) Amino acid sequence of FOXA1, highlighting the predicted α-helix and 
conserved region III (CR III) in red. 
(B) Representation of FOXA1 WT, truncations, mutants and deletions displaying 
FOXA1 DNA binding domain (DBD), K270 and K414. 
(C) Purified recombinant, full-length FOXA1 and mutants were analyzed by SDS-
PAGE and Coomassie staining. The TFs bands run at the expected sizes when 
compared to the protein standards. All proteins were run on the same gel. 
(D) Representative EMSA showing the affinity of increasing amounts of FOXA1 
WT and mutants to specific, short dsDNA Cy5-eG and non-specific short, dsDNA 
Cy5-lefty. Black arrowheads indicate free DNA and DNA:FOXA1 complexes. 
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Figure C2 | Mutation of FOXA1 K270 or C-term αHelix does not inhibit 
nucleosome binding. 
(A-F) Representative EMSAs showing the affinity of increasing amounts of 
FOXA1 WT and mutants to (A-C) Cy5- albN1 DNA and (D-F) nucleosomes. 
Black arrowheads indicate free DNA and DNA:FOXA1 complexes, white 
arrowheads indicate nucleosomes and nuc:FOXA1 complexes. 
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Figure C3 | Purified recombinant, full-Length FOXA1 WT and mutants bind 
free DNA and nucleosomes with similar nucleosome binding affinities. 
(A) FOXA1 binding curves related to EMSAs fraction bound quantification of 
Figures B2-A,F showing the dissociation constants of FOXA1 mutants to Cy5-
160bp-albN1 DNA (blue) or to Cy5-160bp-albN1-NUC (orange). Proteins were 
titrated on 1 nM DNA or NUC. 
(B) FOXA1 WT and mutant binding curves of total fraction bound to free DNA 
(left) and nuc (right) in a single graph for comparison. 
(C) Same as B, but binding curves of specific fraction bound to free DNA (left) 
and nuc (right). 
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Figure C4 | FOXA1 residue K270 contributes to FOXA1 histone octamer 
interaction.  
(A) Representation of FOXA1 DNA binding domain (DBD) truncations aa 168-
268, extended DBD 144-294 (eDBD), which includes K270 and mutants eDBD, 
and 144-294 with EKQ (269-271) AAA triple alanine mutant. 
(B) Purified recombinant FOXA1 DBD, eDBD, and eDBD EKQ (269-271) AAA 
truncations analyzed by SDS-PAGE and Coomassie staining. The TFs bands run 
at the expected sizes when compared to the protein standards. All proteins were 
run on the same gel. 
(C) Representation of Sepharose-conjugated FOXA1 pull down with purified 
recombinant histone octamers. 
(D) Histone octamer pulldown assays with FoxA1 full-length (FL) protein and 
FoxA1 FL-AAA mutant bound to sepharose beads to assess binding to histone 
octamers. 
(E) Representative EMSA showing the affinity of increasing amounts of FOXA1 
DBD, eDBD, and eDBD-AAA to specific “s” short dsDNA Cy5-eG and non-
specific “ns” short dsDNA Cy5- lefty. Black arrowheads indicate free DNA. 
(F) Same as E but with eDBD and DBD.  
 
 
 
 
